drug_normalized,diseaseId,diseaseName,mechanism_score,safety_penalty,trial_penalty,phenotype_boost,final_score
10 x 10^6 cells,EFO_0000616,neoplasm,8.344301499066509,0.0,0.0,0,8.3443
10 x 10^6 cells,MONDO_0012703,lissencephaly due to TUBA1A mutation,8.288154731377205,0.0,0.0,0,8.2882
10 x 10^6 cells,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,8.283598225638386,0.0,0.0,0,8.2836
10 x 10^6 cells,MONDO_0007254,breast cancer,8.202302978684605,0.0,0.0,0,8.2023
10 x 10^6 cells,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,8.187787001463917,0.0,0.0,0,8.1878
10 x 10^6 cells,EFO_0003060,non-small cell lung carcinoma,8.124676882473253,0.0,0.0,0,8.1247
10 x 10^6 cells,MONDO_0014421,glucocorticoid resistance,8.119302224664306,0.0,0.0,0,8.1193
10 x 10^6 cells,MONDO_0008315,prostate cancer,8.095747851454894,0.0,0.0,0,8.0957
10 x 10^6 cells,MONDO_0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",8.067329307927917,0.0,0.0,0,8.0673
10 x 10^6 cells,Orphanet_183506,Genetic central nervous system malformation,8.052600960724,0.0,0.0,0,8.0526
10 x 10^6 cells,MONDO_0004976,amyotrophic lateral sclerosis,8.021892564610788,0.0,0.0,0,8.0219
10 x 10^6 cells,MONDO_0004992,cancer,7.957621776363707,0.0,0.0,0,7.9576
10 x 10^6 cells,EFO_0000341,chronic obstructive pulmonary disease,7.95499335216053,0.0,0.0,0,7.955
10 x 10^6 cells,EFO_0000565,leukemia,7.936310356441922,0.0,0.0,0,7.9363
10 x 10^6 cells,EFO_0000574,lymphoma,7.906646894686174,0.0,0.0,0,7.9066
10 x 10^6 cells,EFO_1001985,congenital fibrosis of the extraocular muscles,7.862852176168641,0.0,0.0,0,7.8629
10 x 10^6 cells,MONDO_0015372,autosomal dominant macrothrombocytopenia,7.850278501511964,0.0,0.0,0,7.8503
10 x 10^6 cells,MONDO_0100153,tubulinopathy,7.835587782613472,0.0,0.0,0,7.8356
10 x 10^6 cells,MONDO_0008329,autosomal dominant pseudohypoaldosteronism type 1,7.807540079962438,0.0,0.0,0,7.8075
10 x 10^6 cells,EFO_0000537,hypertension,7.786130062036715,0.0,0.0,0,7.7861
10 x 10^6 cells,MONDO_0012905,hypomyelinating leukodystrophy 6,7.762627164934834,0.0,0.0,0,7.7626
10 x 10^6 cells,EFO_0003869,breast neoplasm,7.699421676099922,0.0,0.0,0,7.6994
10 x 10^6 cells,EFO_0000305,breast carcinoma,7.676067665187123,0.0,0.0,0,7.6761
10 x 10^6 cells,Orphanet_404469,Female infertility due to fertilization defect,7.656992889552664,0.0,0.0,0,7.657
10 x 10^6 cells,Orphanet_300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,7.65529957224248,0.0,0.0,0,7.6553
10 x 10^6 cells,Orphanet_139441,Hypomyelination with atrophy of basal ganglia and cerebellum,7.628047848076842,0.0,0.0,0,7.628
10 x 10^6 cells,MONDO_0014337,complex cortical dysplasia with other brain malformations 5,7.571776696119168,0.0,0.0,0,7.5718
10 x 10^6 cells,MONDO_0020738,multiple benign circumferential skin creases on limbs 1,7.571576593247232,0.0,0.0,0,7.5716
10 x 10^6 cells,MONDO_0013541,complex cortical dysplasia with other brain malformations 1,7.492660278398774,0.0,0.0,0,7.4927
10 x 10^6 cells,EFO_0003144,heart failure,7.482053804504583,0.0,0.0,0,7.4821
10 x 10^6 cells,EFO_0001378,multiple myeloma,7.478237025299797,0.0,0.0,0,7.4782
10 x 10^6 cells,Orphanet_98805,"Primary dystonia, DYT4 type",7.448520441375891,0.0,0.0,0,7.4485
10 x 10^6 cells,EFO_0000612,myocardial infarction,7.445081898660403,0.0,0.0,0,7.4451
10 x 10^6 cells,EFO_0000275,atrial fibrillation,7.408988598919742,0.0,0.0,0,7.409
10 x 10^6 cells,EFO_0004274,gout,7.368268023206871,0.0,0.0,0,7.3683
10 x 10^6 cells,Orphanet_171871,Renal pseudohypoaldosteronism type 1,7.352780499791845,0.0,0.0,0,7.3528
10 x 10^6 cells,MONDO_0005301,multiple sclerosis,7.318038889939676,0.0,0.0,0,7.318
10 x 10^6 cells,MONDO_0007493,torsion dystonia 4,7.233008465446657,0.0,0.0,0,7.233
10 x 10^6 cells,EFO_0000183,Hodgkins lymphoma,7.224119021642552,0.0,0.0,0,7.2241
10 x 10^6 cells,EFO_0000403,diffuse large B-cell lymphoma,7.157314212554268,0.0,0.0,0,7.1573
10 x 10^6 cells,EFO_0000729,ulcerative colitis,7.153316892811044,0.0,0.0,0,7.1533
10 x 10^6 cells,EFO_0000544,infection,7.130428612485296,0.0,0.0,0,7.1304
10 x 10^6 cells,MONDO_0018088,familial Mediterranean fever,7.12323113948202,0.0,0.0,0,7.1232
10 x 10^6 cells,MONDO_0008170,ovarian cancer,7.047316304663706,0.0,0.0,0,7.0473
10 x 10^6 cells,EFO_0000673,prostate adenocarcinoma,6.9329859804878495,0.0,0.0,0,6.933
10 x 10^6 cells,EFO_0005952,non-Hodgkins lymphoma,6.870164616805525,0.0,0.0,0,6.8702
10 x 10^6 cells,MONDO_0007990,multiple benign circumferential skin creases on limbs,6.828316872483039,0.0,0.0,0,6.8283
10 x 10^6 cells,EFO_0007160,autoimmune thrombocytopenic purpura,6.823460230742159,0.0,0.0,0,6.8235
10 x 10^6 cells,EFO_0006859,head and neck malignant neoplasia,6.8045620123451025,0.0,0.0,0,6.8046
10 x 10^6 cells,MONDO_0011517,pseudohyperaldosteronism type 2,6.793783841801844,0.0,0.0,0,6.7938
alirocumab,EFO_0004911,familial hypercholesterolemia,2.9058569262750287,1.0,0.0,0,2.0341
alirocumab,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",2.70586465886561,1.0,0.0,0,1.8941
alirocumab,HP_0003124,Hypercholesterolemia,2.6539123081398346,1.0,0.0,0,1.8577
alirocumab,EFO_0001645,coronary artery disease,2.503624314117451,1.0,0.0,0,1.7525
alirocumab,EFO_0000319,cardiovascular disease,2.4722584043751024,1.0,0.0,0,1.7306
alirocumab,EFO_0000589,metabolic disease,2.3055488757387117,1.0,0.0,0,1.6139
alirocumab,Orphanet_309005,Disorder of lipid metabolism,2.2170512532759004,1.0,0.0,0,1.5519
alirocumab,MONDO_0018328,homozygous familial hypercholesterolemia,2.206284704788466,1.0,0.0,0,1.5444
alirocumab,MONDO_0021187,hyperlipidemia,2.203136859660998,1.0,0.0,0,1.5422
alirocumab,EFO_0000612,myocardial infarction,2.1383678544611064,1.0,0.0,0,1.4969
alirocumab,EFO_0003914,atherosclerosis,2.11003330899773,1.0,0.0,0,1.477
alirocumab,EFO_1001375,Myocardial Ischemia,1.8796123064811092,1.0,0.0,0,1.3157
alirocumab,MONDO_0007750,"hypercholesterolemia, familial, 1",1.7836214902334102,1.0,0.0,0,1.2485
alirocumab,HP_0003077,Hyperlipidemia,1.773337140058782,1.0,0.0,0,1.2413
alirocumab,MONDO_0021661,coronary atherosclerosis,1.763336321760802,1.0,0.0,0,1.2343
alirocumab,MONDO_0001336,familial hyperlipidemia,1.7621089943612105,1.0,0.0,0,1.2335
alirocumab,EFO_0003913,angina pectoris,1.733713012728092,1.0,0.0,0,1.2136
alirocumab,EFO_0003777,heart disease,1.720350777630642,1.0,0.0,0,1.2042
alirocumab,GO_0036273,response to statin,1.6929627454314395,1.0,0.0,0,1.1851
alirocumab,EFO_0000195,metabolic syndrome,1.6508188367808607,1.0,0.0,0,1.1556
alirocumab,HP_0001626,Abnormality of the cardiovascular system,1.544989115822175,1.0,0.0,0,1.0815
alirocumab,HP_0003146,Hypocholesterolemia,1.519787603332834,1.0,0.0,0,1.0639
alirocumab,MONDO_0009387,familial lipoprotein lipase deficiency,1.477404180953503,1.0,0.0,0,1.0342
alirocumab,HP_0003119,Abnormal circulating lipid concentration,1.4715700044219706,1.0,0.0,0,1.0301
alirocumab,EFO_0000400,diabetes mellitus,1.4497025252387634,1.0,0.0,0,1.0148
alirocumab,EFO_0004214,Abdominal Aortic Aneurysm,1.4288552428438437,1.0,0.0,0,1.0002
alirocumab,MONDO_0008692,abetalipoproteinemia,1.3915521393970829,1.0,0.0,0,0.9741
alirocumab,MONDO_0013144,hereditary antithrombin deficiency,1.3529384233905548,1.0,0.0,0,0.9471
alirocumab,HP_0001976,Reduced antithrombin III activity,1.259039852698564,1.0,0.0,0,0.8813
alirocumab,EFO_0000712,stroke,1.2359095786396606,1.0,0.0,0,0.8651
alirocumab,EFO_0004286,venous thromboembolism,1.2276020375212808,1.0,0.0,0,0.8593
alirocumab,EFO_0000275,atrial fibrillation,1.2246559981045952,1.0,0.0,0,0.8573
alirocumab,EFO_1000985,intermediate coronary syndrome,1.2118467948374598,1.0,0.0,0,0.8483
alirocumab,EFO_0008583,acute myocardial infarction,1.2064338630397655,1.0,0.0,0,0.8445
alirocumab,EFO_0004264,vascular disease,1.195063853700586,1.0,0.0,0,0.8365
alirocumab,EFO_0005672,acute coronary syndrome,1.1946395370223528,1.0,0.0,0,0.8362
alirocumab,EFO_0003144,heart failure,1.1943910450436237,1.0,0.0,0,0.8361
alirocumab,HP_0011428,Short fetal femur length,1.187066470233723,1.0,0.0,0,0.8309
alirocumab,MONDO_0016085,Cole-Carpenter syndrome,1.1861271155659427,1.0,0.0,0,0.8303
alirocumab,HP_0004936,Venous thrombosis,1.160990275789953,1.0,0.0,0,0.8127
alirocumab,EFO_0004329,alcohol drinking,1.153512135309475,1.0,0.0,0,0.8075
alirocumab,MONDO_0100096,COVID-19,1.1527810225729451,1.0,0.0,0,0.8069
alirocumab,Orphanet_79211,Combined hyperlipidemia,1.1360479736028382,1.0,0.0,0,0.7952
alirocumab,EFO_0003776,coronary artery bypass,1.1279602973638454,1.0,0.0,0,0.7896
alirocumab,EFO_0003940,physical activity,1.1225894210654916,1.0,0.0,0,0.7858
alirocumab,EFO_0003951,percutaneous transluminal coronary angioplasty,1.1225894210654916,1.0,0.0,0,0.7858
alirocumab,EFO_0003907,deep vein thrombosis,1.101982647890135,1.0,0.0,0,0.7714
alirocumab,EFO_0003884,chronic kidney disease,1.0458297478468073,1.0,0.0,0,0.7321
alirocumab,EFO_0003086,kidney disease,1.0396200487798937,1.0,0.0,0,0.7277
alirocumab,EFO_0009578,placental retention,0.9852322328973993,1.0,0.0,0,0.6897
angiotensin 1-7,EFO_0000537,hypertension,1.2395972200813008,0.0,0.0,0,1.2396
angiotensin 1-7,MONDO_0017609,renal tubular dysgenesis,1.2017511378334431,0.0,0.0,0,1.2018
angiotensin 1-7,EFO_0010702,opioid use disorder,1.1564263384674014,0.0,0.0,0,1.1564
angiotensin 1-7,HP_0012531,Pain,1.1530053375354918,0.0,0.0,0,1.153
angiotensin 1-7,MONDO_0009970,renal tubular dysgenesis of genetic origin,1.1507575486671622,0.0,0.0,0,1.1508
angiotensin 1-7,EFO_0005611,opioid dependence,1.094739056230181,0.0,0.0,0,1.0947
angiotensin 1-7,MONDO_0004992,cancer,1.0751945324232943,0.0,0.0,0,1.0752
angiotensin 1-7,EFO_0003086,kidney disease,1.033572998362213,0.0,0.0,0,1.0336
angiotensin 1-7,EFO_0003144,heart failure,1.0301239404233142,0.0,0.0,0,1.0301
angiotensin 1-7,EFO_0000612,myocardial infarction,1.0285670821790962,0.0,0.0,0,1.0286
angiotensin 1-7,MONDO_0007781,"essential hypertension, genetic",1.0249852458218305,0.0,0.0,0,1.025
angiotensin 1-7,MONDO_0001134,essential hypertension,1.0165304035440093,0.0,0.0,0,1.0165
angiotensin 1-7,EFO_0000712,stroke,1.0083208171532043,0.0,0.0,0,1.0083
angiotensin 1-7,MONDO_0007079,alcohol dependence,0.977364438339319,0.0,0.0,0,0.9774
angiotensin 1-7,EFO_0003890,drug dependence,0.9730996295634804,0.0,0.0,0,0.9731
angiotensin 1-7,EFO_0003884,chronic kidney disease,0.969947251542562,0.0,0.0,0,0.9699
angiotensin 1-7,HP_0012532,Chronic pain,0.9670198403404134,0.0,0.0,0,0.967
angiotensin 1-7,HP_0002014,Diarrhea,0.957762425825498,0.0,0.0,0,0.9578
angiotensin 1-7,HP_0002019,Constipation,0.9577162630870492,0.0,0.0,0,0.9577
angiotensin 1-7,EFO_0005762,neuropathic pain,0.9558657413264998,0.0,0.0,0,0.9559
angiotensin 1-7,EFO_0000373,congestive heart failure,0.952628643950579,0.0,0.0,0,0.9526
angiotensin 1-7,EFO_0000400,diabetes mellitus,0.9493805703908492,0.0,0.0,0,0.9494
angiotensin 1-7,EFO_0000401,diabetic nephropathy,0.9401290468381912,0.0,0.0,0,0.9401
angiotensin 1-7,EFO_0000319,cardiovascular disease,0.9388335421513864,0.0,0.0,0,0.9388
angiotensin 1-7,MONDO_0005148,type 2 diabetes mellitus,0.9286793538791056,0.0,0.0,0,0.9287
angiotensin 1-7,HP_0000093,Proteinuria,0.8933641730110159,0.0,0.0,0,0.8934
angiotensin 1-7,EFO_0000555,irritable bowel syndrome,0.8854999633290198,0.0,0.0,0,0.8855
angiotensin 1-7,EFO_0022041,response to tramadol,0.8702858609788808,0.0,0.0,0,0.8703
angiotensin 1-7,EFO_0004194,IGA glomerulonephritis,0.8569205827605783,0.0,0.0,0,0.8569
angiotensin 1-7,EFO_0003913,angina pectoris,0.8428621585049674,0.0,0.0,0,0.8429
angiotensin 1-7,EFO_0801084,cancer pain,0.8361507964361243,0.0,0.0,0,0.8362
angiotensin 1-7,EFO_0006834,septic shock,0.8246250926988299,0.0,0.0,0,0.8246
angiotensin 1-7,HP_0000924,Abnormality of the skeletal system,0.7957100370794491,0.0,0.0,0,0.7957
angiotensin 1-7,MONDO_0005277,migraine disorder,0.7710769998462864,0.0,0.0,0,0.7711
angiotensin 1-7,HP_0012735,Cough,0.7499938281425708,0.0,0.0,0,0.75
angiotensin 1-7,EFO_0020911,overdose,0.7379800941342481,0.0,0.0,0,0.738
angiotensin 1-7,MONDO_0002203,constipation disorder,0.7357850022109853,0.0,0.0,0,0.7358
angiotensin 1-7,MONDO_0002046,alcohol abuse,0.7157685198377711,0.0,0.0,0,0.7158
angiotensin 1-7,EFO_0000616,neoplasm,0.6830072958106693,0.0,0.0,0,0.683
angiotensin 1-7,MONDO_0100096,COVID-19,0.6827527373882668,0.0,0.0,0,0.6828
angiotensin 1-7,EFO_0000764,HIV infection,0.6793061242535315,0.0,0.0,0,0.6793
angiotensin 1-7,HP_0003419,Low back pain,0.6714028561558373,0.0,0.0,0,0.6714
angiotensin 1-7,EFO_0004329,alcohol drinking,0.6651998118496882,0.0,0.0,0,0.6652
angiotensin 1-7,MONDO_0005178,osteoarthritis,0.6613920621675271,0.0,0.0,0,0.6614
angiotensin 1-7,EFO_0004240,heroin dependence,0.6574852210374056,0.0,0.0,0,0.6575
angiotensin 1-7,MONDO_0005090,schizophrenia,0.6550124451870637,0.0,0.0,0,0.655
angiotensin 1-7,EFO_0000275,atrial fibrillation,0.6474839847469869,0.0,0.0,0,0.6475
angiotensin 1-7,MONDO_0004567,ileus,0.6455685827072316,0.0,0.0,0,0.6456
angiotensin 1-7,EFO_0004616,"osteoarthritis, knee",0.645324668031237,0.0,0.0,0,0.6453
angiotensin 1-7,HP_0003418,Back pain,0.6395386168075152,0.0,0.0,0,0.6395
aspirin,EFO_0000729,ulcerative colitis,6.720469093450703,1.0,0.0,0,4.7043
aspirin,MONDO_0005277,migraine disorder,6.711668805233021,1.0,0.0,0,4.6982
aspirin,EFO_0004274,gout,6.681922972942671,1.0,0.0,0,4.6773
aspirin,MP_0001914,hemorrhage,6.677234004794785,1.0,0.0,0,4.6741
aspirin,MONDO_0005178,osteoarthritis,6.642928340406933,1.0,0.0,0,4.65
aspirin,EFO_0001645,coronary artery disease,6.58665522813714,1.0,0.0,0,4.6107
aspirin,HP_0012531,Pain,6.584407103789333,1.0,0.0,0,4.6091
aspirin,EFO_0000685,rheumatoid arthritis,6.539518023614357,1.0,0.0,0,4.5777
aspirin,HP_0002315,Headache,6.512944258594928,1.0,0.0,0,4.5591
aspirin,HP_0001945,Fever,6.49574158242965,1.0,0.0,0,4.547
aspirin,EFO_0002609,juvenile idiopathic arthritis,6.487623421804666,1.0,0.0,0,4.5413
aspirin,HP_0100607,Dysmenorrhea,6.475457846133503,1.0,0.0,0,4.5328
aspirin,EFO_0003898,ankylosing spondylitis,6.456511036812518,1.0,0.0,0,4.5196
aspirin,HP_0001643,Patent ductus arteriosus,6.420848690605366,1.0,0.0,0,4.4946
aspirin,MONDO_0002258,pharyngitis,6.416113194466542,1.0,0.0,0,4.4913
aspirin,EFO_0000712,stroke,6.410643201606182,1.0,0.0,0,4.4875
aspirin,EFO_0007214,common cold,6.401763788848964,1.0,0.0,0,4.4812
aspirin,EFO_0005755,rheumatic disease,6.387309607435615,1.0,0.0,0,4.4711
aspirin,EFO_0010072,toothache,6.382845164859952,1.0,0.0,0,4.468
aspirin,HP_0003418,Back pain,6.371341452010584,1.0,0.0,0,4.4599
aspirin,MP_0001845,inflammation,6.351956424758907,1.0,0.0,0,4.4464
aspirin,MONDO_0005129,cataract,6.3183371807236846,1.0,0.0,0,4.4228
aspirin,EFO_0005856,arthritis,6.297793354541399,1.0,0.0,0,4.4085
aspirin,EFO_0000612,myocardial infarction,6.255979842231969,1.0,0.0,0,4.3792
aspirin,HP_0003326,Myalgia,6.245505300770125,1.0,0.0,0,4.3719
aspirin,MONDO_0003937,spondylitis,6.225628940647523,1.0,0.0,0,4.3579
aspirin,HP_0002829,Arthralgia,6.224500188582215,1.0,0.0,0,4.3572
aspirin,EFO_0009846,muscle cramp,6.221710510054445,1.0,0.0,0,4.3552
aspirin,EFO_0007328,influenza,6.1660979963537175,1.0,0.0,0,4.3163
aspirin,EFO_0009582,sprain,6.137527841707515,1.0,0.0,0,4.2963
aspirin,EFO_0002496,actinic keratosis,6.125657977586125,1.0,0.0,0,4.288
aspirin,EFO_0005752,eye inflammation,5.985097297702477,1.0,0.0,0,4.1896
aspirin,EFO_0000319,cardiovascular disease,5.929424228770532,1.0,0.0,0,4.1506
aspirin,HP_0002018,Nausea,5.921738854494638,1.0,0.0,0,4.1452
aspirin,HP_0002014,Diarrhea,5.920705434483268,1.0,0.0,0,4.1445
aspirin,MONDO_0002471,bursitis,5.913541512728093,1.0,0.0,0,4.1395
aspirin,EFO_0009454,gastric ulcer,5.845281501255728,1.0,0.0,0,4.0917
aspirin,HP_0200026,Ocular pain,5.843903848398338,1.0,0.0,0,4.0907
aspirin,Orphanet_733,Familial adenomatous polyposis,5.736237970658315,1.0,0.0,0,4.0154
aspirin,MONDO_0004857,tendinitis,5.726394647047349,1.0,0.0,0,4.0085
aspirin,EFO_0005628,proctitis,5.717917597207352,1.0,0.0,0,4.0025
aspirin,MONDO_0000831,thrombotic disease,5.559765537815707,1.0,0.0,0,3.8918
aspirin,EFO_0004253,nephrolithiasis,5.50880887662027,1.0,0.0,0,3.8562
aspirin,HP_0004398,Peptic ulcer,5.36552908176904,1.0,0.0,0,3.7559
aspirin,EFO_0005757,vaginal inflammation,5.333419418355719,1.0,0.0,0,3.7334
aspirin,EFO_0009364,non-allergic rhinitis,5.333419418355719,1.0,0.0,0,3.7334
aspirin,EFO_0004607,duodenal ulcer,5.087248807313153,1.0,0.0,0,3.5611
aspirin,EFO_0004142,colorectal neoplasm,5.070653229082636,1.0,0.0,0,3.5495
aspirin,EFO_0008583,acute myocardial infarction,5.018846470885212,1.0,0.0,0,3.5132
aspirin,HP_0004419,Recurrent thrombophlebitis,4.8980382413470895,1.0,0.0,0,3.4286
aspirin + ticagrelor,MONDO_0012354,platelet-type bleeding disorder 8,1.7194684294023383,0.0,0.0,0,1.7195
aspirin + ticagrelor,Orphanet_36355,P2Y12 defect,1.6023435254816034,0.0,0.0,0,1.6023
aspirin + ticagrelor,EFO_0000612,myocardial infarction,1.499999502316808,0.0,0.0,0,1.5
aspirin + ticagrelor,EFO_0001645,coronary artery disease,1.488104565294434,0.0,0.0,0,1.4881
aspirin + ticagrelor,EFO_0005672,acute coronary syndrome,1.4597556147353623,0.0,0.0,0,1.4598
aspirin + ticagrelor,EFO_0008583,acute myocardial infarction,1.425978263976451,0.0,0.0,0,1.426
aspirin + ticagrelor,EFO_0000712,stroke,1.4160623664361789,0.0,0.0,0,1.4161
aspirin + ticagrelor,EFO_0004265,peripheral arterial disease,1.3431350978152992,0.0,0.0,0,1.3431
aspirin + ticagrelor,HP_0004419,Recurrent thrombophlebitis,1.32206549944891,0.0,0.0,0,1.3221
aspirin + ticagrelor,MONDO_0000831,thrombotic disease,1.2950060458128914,0.0,0.0,0,1.295
aspirin + ticagrelor,MONDO_0030030,Nizon-Isidor syndrome,1.1834680998443794,0.0,0.0,0,1.1835
aspirin + ticagrelor,EFO_0000556,ischemia,1.1313115877073967,0.0,0.0,0,1.1313
aspirin + ticagrelor,EFO_0000508,genetic disorder,1.1214267344520552,0.0,0.0,0,1.1214
aspirin + ticagrelor,MP_0001914,hemorrhage,1.1131936560117404,0.0,0.0,0,1.1132
aspirin + ticagrelor,MONDO_0005148,type 2 diabetes mellitus,1.0950218999031285,0.0,0.0,0,1.095
aspirin + ticagrelor,HP_0001249,Intellectual disability,1.011550814273387,0.0,0.0,0,1.0116
aspirin + ticagrelor,HP_0002140,Ischemic stroke,1.00522261735663,0.0,0.0,0,1.0052
aspirin + ticagrelor,EFO_0000275,atrial fibrillation,0.9940877376684802,0.0,0.0,0,0.9941
aspirin + ticagrelor,EFO_0003884,chronic kidney disease,0.9830770900901408,0.0,0.0,0,0.9831
aspirin + ticagrelor,HP_0001873,Thrombocytopenia,0.95948865206519,0.0,0.0,0,0.9595
aspirin + ticagrelor,MONDO_0100096,COVID-19,0.9570458391205484,0.0,0.0,0,0.957
aspirin + ticagrelor,HP_0001892,Abnormal bleeding,0.953577362865437,0.0,0.0,0,0.9536
aspirin + ticagrelor,EFO_0008585,ST Elevation Myocardial Infarction,0.9500770150638485,0.0,0.0,0,0.9501
aspirin + ticagrelor,EFO_0003875,peripheral vascular disease,0.9354034733108256,0.0,0.0,0,0.9354
aspirin + ticagrelor,EFO_1000985,intermediate coronary syndrome,0.8829420026531825,0.0,0.0,0,0.8829
aspirin + ticagrelor,EFO_0000266,aortic stenosis,0.8820835868172695,0.0,0.0,0,0.8821
aspirin + ticagrelor,MONDO_0011382,sickle cell disease,0.8695766833086198,0.0,0.0,0,0.8696
aspirin + ticagrelor,EFO_0007328,influenza,0.8598431686956941,0.0,0.0,0,0.8598
aspirin + ticagrelor,EFO_0003106,pneumonia,0.8522842942277244,0.0,0.0,0,0.8523
aspirin + ticagrelor,EFO_0003914,atherosclerosis,0.841839671704794,0.0,0.0,0,0.8418
aspirin + ticagrelor,EFO_0000341,chronic obstructive pulmonary disease,0.839281695698565,0.0,0.0,0,0.8393
aspirin + ticagrelor,EFO_0002615,internal carotid artery stenosis,0.8092163454316417,0.0,0.0,0,0.8092
aspirin + ticagrelor,MONDO_0024327,chronic renal failure syndrome,0.7823847190176809,0.0,0.0,0,0.7824
aspirin + ticagrelor,EFO_0003870,brain aneurysm,0.7816444113397121,0.0,0.0,0,0.7816
aspirin + ticagrelor,HP_0002239,Gastrointestinal hemorrhage,0.7725742523215346,0.0,0.0,0,0.7726
aspirin + ticagrelor,HP_0030680,Abnormal cardiovascular system morphology,0.7725742523215346,0.0,0.0,0,0.7726
aspirin + ticagrelor,EFO_0003913,angina pectoris,0.7481169656613191,0.0,0.0,0,0.7481
aspirin + ticagrelor,HP_0004866,Impaired ADP-induced platelet aggregation,0.7377470955502146,0.0,0.0,0,0.7377
aspirin + ticagrelor,EFO_0002618,pancreatic carcinoma,0.7166733156564862,0.0,0.0,0,0.7167
aspirin + ticagrelor,EFO_0003764,transient ischemic attack,0.7021465675503611,0.0,0.0,0,0.7021
aspirin + ticagrelor,GO_0070527,platelet aggregation,0.6793012402079219,0.0,0.0,0,0.6793
aspirin + ticagrelor,MONDO_0004992,cancer,0.657005707677732,0.0,0.0,0,0.657
aspirin + ticagrelor,EFO_0009959,diverticular disease,0.6511849190966823,0.0,0.0,0,0.6512
aspirin + ticagrelor,EFO_0003144,heart failure,0.6361434177182461,0.0,0.0,0,0.6361
aspirin + ticagrelor,HP_0011869,Abnormal platelet function,0.6357182419102911,0.0,0.0,0,0.6357
aspirin + ticagrelor,EFO_0009086,arteriosclerosis,0.6303085518272392,0.0,0.0,0,0.6303
aspirin + ticagrelor,EFO_0001365,age-related macular degeneration,0.6294093955478851,0.0,0.0,0,0.6294
aspirin + ticagrelor,EFO_0020925,angina unstable,0.6278642200270136,0.0,0.0,0,0.6279
aspirin + ticagrelor,EFO_1001375,Myocardial Ischemia,0.6267197521198498,0.0,0.0,0,0.6267
aspirin + ticagrelor,EFO_1000044,pancreatic adenocarcinoma,0.6251229378784529,0.0,0.0,0,0.6251
atenolol,EFO_0000537,hypertension,1.744427605531155,1.0,0.0,0,1.2211
atenolol,EFO_0000319,cardiovascular disease,1.6969473135783075,1.0,0.0,0,1.1879
atenolol,EFO_0000712,stroke,1.4546209952027782,1.0,0.0,0,1.0182
atenolol,EFO_0003913,angina pectoris,1.4228032756528322,1.0,0.0,0,0.996
atenolol,MONDO_0004979,asthma,1.414901379019638,1.0,0.0,0,0.9904
atenolol,EFO_0000612,myocardial infarction,1.3766000614618483,1.0,0.0,0,0.9636
atenolol,EFO_0003144,heart failure,1.3493245953774002,1.0,0.0,0,0.9445
atenolol,MONDO_0005041,glaucoma,1.3310610788556705,1.0,0.0,0,0.9317
atenolol,MONDO_0005277,migraine disorder,1.3233297352861153,1.0,0.0,0,0.9263
atenolol,EFO_0001645,coronary artery disease,1.3014675617462002,1.0,0.0,0,0.911
atenolol,MONDO_0001134,essential hypertension,1.2977909698563912,1.0,0.0,0,0.9085
atenolol,EFO_0004190,open-angle glaucoma,1.292528560885883,1.0,0.0,0,0.9048
atenolol,HP_0012531,Pain,1.287155465291934,1.0,0.0,0,0.901
atenolol,EFO_0000373,congestive heart failure,1.2743866020227976,1.0,0.0,0,0.8921
atenolol,HP_0100806,Sepsis,1.2696598295568553,1.0,0.0,0,0.8888
atenolol,HP_0006536,Airway obstruction,1.2498070058370807,1.0,0.0,0,0.8749
atenolol,HP_0004308,Ventricular arrhythmia,1.226512204235,1.0,0.0,0,0.8586
atenolol,EFO_1001069,ocular hypertension,1.2105772449750505,1.0,0.0,0,0.8474
atenolol,EFO_0000275,atrial fibrillation,1.2091584877237636,1.0,0.0,0,0.8464
atenolol,EFO_0006834,septic shock,1.208275851425742,1.0,0.0,0,0.8458
atenolol,EFO_0007486,sinusitis,1.1996115709452,1.0,0.0,0,0.8397
atenolol,EFO_0004278,sudden cardiac arrest,1.1857381005850631,1.0,0.0,0,0.83
atenolol,MONDO_0005271,allergic disease,1.175789089747041,1.0,0.0,0,0.8231
atenolol,EFO_0005251,hypotension,1.158852639401009,1.0,0.0,0,0.8112
atenolol,EFO_0005531,urticaria,1.1383128268604843,1.0,0.0,0,0.7968
atenolol,MP_0001914,hemorrhage,1.1259933666840871,1.0,0.0,0,0.7882
atenolol,EFO_0004269,cardiac arrhythmia,1.1193095523820762,1.0,0.0,0,0.7835
atenolol,MONDO_0005148,type 2 diabetes mellitus,1.1107552613732945,1.0,0.0,0,0.7775
atenolol,HP_0001742,Nasal congestion,1.0871203366741324,1.0,0.0,0,0.761
atenolol,EFO_0000400,diabetes mellitus,1.078578704060288,1.0,0.0,0,0.755
atenolol,MONDO_0021661,coronary atherosclerosis,1.0739203502986738,1.0,0.0,0,0.7517
atenolol,EFO_0003956,seasonal allergic rhinitis,1.0701641953029886,1.0,0.0,0,0.7491
atenolol,EFO_0009492,cardiac arrest,1.055418766332203,1.0,0.0,0,0.7388
atenolol,EFO_1000635,hemangioma,1.043471756362372,1.0,0.0,0,0.7304
atenolol,EFO_0004329,alcohol drinking,1.0293192925434016,1.0,0.0,0,0.7205
atenolol,EFO_0005252,orthostatic hypotension,1.0087670788778094,1.0,0.0,0,0.7061
atenolol,EFO_0001073,obesity,0.9907953948481982,1.0,0.0,0,0.6936
atenolol,MONDO_0019200,retinitis pigmentosa,0.9819599048130446,1.0,0.0,0,0.6874
atenolol,EFO_0000341,chronic obstructive pulmonary disease,0.9658439828351147,1.0,0.0,0,0.6761
atenolol,HP_0032263,Increased blood pressure,0.9559863250133662,1.0,0.0,0,0.6692
atenolol,MONDO_0005180,Parkinson disease,0.9448988807951266,1.0,0.0,0,0.6614
atenolol,EFO_0003777,heart disease,0.9427297695789414,1.0,0.0,0,0.6599
atenolol,EFO_1002048,kidney failure,0.9284573002531024,1.0,0.0,0,0.6499
atenolol,MONDO_0018852,achromatopsia,0.9026471886104168,1.0,0.0,0,0.6319
atenolol,EFO_0001361,pulmonary arterial hypertension,0.8753235005864658,1.0,0.0,0,0.6127
atenolol,Orphanet_1872,Cone rod dystrophy,0.841444054325368,1.0,0.0,0,0.589
atenolol,EFO_1001375,Myocardial Ischemia,0.8412509128802588,1.0,0.0,0,0.5889
atenolol,EFO_0003884,chronic kidney disease,0.837739806539916,1.0,0.0,0,0.5864
atenolol,GO_0009410,response to xenobiotic stimulus,0.8357878754955463,1.0,0.0,0,0.5851
atenolol,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,0.8090891705934107,1.0,0.0,0,0.5664
atorvastatin + aspirin + losartan + amlodipine,EFO_0000319,cardiovascular disease,14.934332778473308,0.0,0.0,0,14.9343
atorvastatin + aspirin + losartan + amlodipine,EFO_0000537,hypertension,14.371304444553788,0.0,0.0,0,14.3713
atorvastatin + aspirin + losartan + amlodipine,MONDO_0014917,"developmental and epileptic encephalopathy, 42",14.190796429750936,0.0,0.0,0,14.1908
atorvastatin + aspirin + losartan + amlodipine,Orphanet_97,Familial paroxysmal ataxia,13.927430514561255,0.0,0.0,0,13.9274
atorvastatin + aspirin + losartan + amlodipine,MONDO_0010979,Timothy syndrome,13.920745479517748,0.0,0.0,0,13.9207
atorvastatin + aspirin + losartan + amlodipine,HP_0001250,Seizure,13.86307241947452,0.0,0.0,0,13.8631
atorvastatin + aspirin + losartan + amlodipine,EFO_0005138,acquired long QT syndrome,13.555769053233355,0.0,0.0,0,13.5558
atorvastatin + aspirin + losartan + amlodipine,EFO_0000275,atrial fibrillation,13.445125892503931,0.0,0.0,0,13.4451
atorvastatin + aspirin + losartan + amlodipine,MONDO_0100062,genetic developmental and epileptic encephalopathy,13.412716203822583,0.0,0.0,0,13.4127
atorvastatin + aspirin + losartan + amlodipine,MONDO_0007163,episodic ataxia type 2,13.172674059977158,0.0,0.0,0,13.1727
atorvastatin + aspirin + losartan + amlodipine,EFO_0000400,diabetes mellitus,13.116925671397489,0.0,0.0,0,13.1169
atorvastatin + aspirin + losartan + amlodipine,MONDO_0020756,"migraine, familial hemiplegic, 1",13.099016060132945,0.0,0.0,0,13.099
atorvastatin + aspirin + losartan + amlodipine,EFO_0000474,epilepsy,13.07683057014714,0.0,0.0,0,13.0768
atorvastatin + aspirin + losartan + amlodipine,MONDO_0013960,sinoatrial node dysfunction and deafness,12.90406885393879,0.0,0.0,0,12.9041
atorvastatin + aspirin + losartan + amlodipine,MONDO_0010241,congenital stationary night blindness 2A,12.823162524001887,0.0,0.0,0,12.8232
atorvastatin + aspirin + losartan + amlodipine,MONDO_0042979,"hypokalemic periodic paralysis, type 1",12.583831009338398,0.0,0.0,0,12.5838
atorvastatin + aspirin + losartan + amlodipine,MONDO_0008457,spinocerebellar ataxia type 6,12.493213730799672,0.0,0.0,0,12.4932
atorvastatin + aspirin + losartan + amlodipine,EFO_0009059,Spinocerebellar ataxia type 42,12.37540150094074,0.0,0.0,0,12.3754
atorvastatin + aspirin + losartan + amlodipine,MONDO_0013464,episodic ataxia type 5,12.328237228973803,0.0,0.0,0,12.3282
atorvastatin + aspirin + losartan + amlodipine,EFO_0003144,heart failure,12.295324427241152,0.0,0.0,0,12.2953
atorvastatin + aspirin + losartan + amlodipine,MONDO_0012742,Brugada syndrome 3,12.135806199592674,0.0,0.0,0,12.1358
atorvastatin + aspirin + losartan + amlodipine,MONDO_0859514,congenital myopathy 18,12.127841546608158,0.0,0.0,0,12.1278
atorvastatin + aspirin + losartan + amlodipine,MONDO_0014200,aldosterone-producing adenoma with seizures and neurological abnormalities,12.049779722981365,0.0,0.0,0,12.0498
atorvastatin + aspirin + losartan + amlodipine,EFO_0001645,coronary artery disease,11.826604746914931,0.0,0.0,0,11.8266
atorvastatin + aspirin + losartan + amlodipine,MONDO_0010371,Aland island eye disease,11.797338000505183,0.0,0.0,0,11.7973
atorvastatin + aspirin + losartan + amlodipine,Orphanet_1872,Cone rod dystrophy,11.755745275384909,0.0,0.0,0,11.7557
atorvastatin + aspirin + losartan + amlodipine,MONDO_0859286,"neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures",11.734855711915673,0.0,0.0,0,11.7349
atorvastatin + aspirin + losartan + amlodipine,MONDO_0060551,"cerebellar atrophy, developmental delay, and seizures",11.693733980834493,0.0,0.0,0,11.6937
atorvastatin + aspirin + losartan + amlodipine,MONDO_0060758,"spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits",11.64892685839759,0.0,0.0,0,11.6489
atorvastatin + aspirin + losartan + amlodipine,MONDO_0016293,congenital stationary night blindness,11.424378965049891,0.0,0.0,0,11.4244
atorvastatin + aspirin + losartan + amlodipine,EFO_0010276,neurodevelopmental disorder with seizures and non-epileptic hyperkinetic movements,11.378964327659697,0.0,0.0,0,11.379
atorvastatin + aspirin + losartan + amlodipine,EFO_0004269,cardiac arrhythmia,11.335523459971732,0.0,0.0,0,11.3355
atorvastatin + aspirin + losartan + amlodipine,EFO_0005762,neuropathic pain,11.255637915557635,0.0,0.0,0,11.2556
atorvastatin + aspirin + losartan + amlodipine,MONDO_0001134,essential hypertension,11.22280175172502,0.0,0.0,0,11.2228
atorvastatin + aspirin + losartan + amlodipine,EFO_0000612,myocardial infarction,11.21339010997352,0.0,0.0,0,11.2134
atorvastatin + aspirin + losartan + amlodipine,EFO_0000508,genetic disorder,11.07841788761312,0.0,0.0,0,11.0784
atorvastatin + aspirin + losartan + amlodipine,MONDO_0004985,bipolar disorder,11.050941890199896,0.0,0.0,0,11.0509
atorvastatin + aspirin + losartan + amlodipine,EFO_0003913,angina pectoris,11.035838141938328,0.0,0.0,0,11.0358
atorvastatin + aspirin + losartan + amlodipine,EFO_1001892,generalized anxiety disorder,11.006491920116632,0.0,0.0,0,11.0065
atorvastatin + aspirin + losartan + amlodipine,EFO_0005687,fibromyalgia,10.838448455107995,0.0,0.0,0,10.8384
atorvastatin + aspirin + losartan + amlodipine,EFO_1000013,Prinzmetal's angina,10.823434819000353,0.0,0.0,0,10.8234
atorvastatin + aspirin + losartan + amlodipine,Orphanet_178333,Ã…land Islands eye disease,10.771252736128451,0.0,0.0,0,10.7713
atorvastatin + aspirin + losartan + amlodipine,HP_0001657,Prolonged QT interval,10.727605320409324,0.0,0.0,0,10.7276
atorvastatin + aspirin + losartan + amlodipine,EFO_0000712,stroke,10.706584331945637,0.0,0.0,0,10.7066
atorvastatin + aspirin + losartan + amlodipine,MONDO_0005090,schizophrenia,10.698061610902196,0.0,0.0,0,10.6981
atorvastatin + aspirin + losartan + amlodipine,MONDO_0010335,X-linked cone-rod dystrophy 3,10.663210574308222,0.0,0.0,0,10.6632
atorvastatin + aspirin + losartan + amlodipine,MONDO_0015263,Brugada syndrome,10.41117504125509,0.0,0.0,0,10.4112
atorvastatin + aspirin + losartan + amlodipine,MONDO_0012507,retinal cone dystrophy 4,10.24831938331889,0.0,0.0,0,10.2483
atorvastatin + aspirin + losartan + amlodipine,HP_0002069,Bilateral tonic-clonic seizure,10.207122087288214,0.0,0.0,0,10.2071
atorvastatin + aspirin + losartan + amlodipine,MONDO_0015993,cone-rod dystrophy,10.181552735887712,0.0,0.0,0,10.1816
bms-823778,Orphanet_168588,Hyperandrogenism due to cortisone reductase deficiency,1.1317646901471916,0.0,0.0,0,1.1318
bms-823778,EFO_0003948,gastroesophageal reflux disease,1.0109868380533782,0.0,0.0,0,1.011
bms-823778,HP_0004398,Peptic ulcer,1.0109868380533782,0.0,0.0,0,1.011
bms-823778,HP_0030839,Knee pain,0.6306784414620139,0.0,0.0,0,0.6307
bms-823778,MONDO_0005148,type 2 diabetes mellitus,0.263874102158652,0.0,0.0,0,0.2639
bms-823778,MONDO_0017919,exstrophy-epispadias complex,0.237685068864794,0.0,0.0,0,0.2377
bms-823778,EFO_0000537,hypertension,0.2036828992910804,0.0,0.0,0,0.2037
bms-823778,EFO_0000616,neoplasm,0.1976207380265295,0.0,0.0,0,0.1976
bms-823778,EFO_0000319,cardiovascular disease,0.1873221405556315,0.0,0.0,0,0.1873
bms-823778,Orphanet_309005,Disorder of lipid metabolism,0.1868056088109242,0.0,0.0,0,0.1868
bms-823778,EFO_0000756,melanoma,0.1858515673539529,0.0,0.0,0,0.1859
bms-823778,EFO_0000195,metabolic syndrome,0.1815993585536852,0.0,0.0,0,0.1816
bms-823778,HP_0001513,Obesity,0.1738834519039859,0.0,0.0,0,0.1739
bms-823778,MONDO_0007763,nonpapillary renal cell carcinoma,0.1547841481444171,0.0,0.0,0,0.1548
bms-823778,MONDO_0004975,Alzheimer disease,0.1534628088947827,0.0,0.0,0,0.1535
bms-823778,EFO_0003095,non-alcoholic fatty liver disease,0.1514829666324061,0.0,0.0,0,0.1515
bms-823778,MONDO_0011719,gastrointestinal stromal tumor,0.1503688178721023,0.0,0.0,0,0.1504
bms-823778,EFO_1001069,ocular hypertension,0.1496673168008001,0.0,0.0,0,0.1497
bms-823778,EFO_1001110,pituitary-dependent Cushing's disease,0.1485531680404963,0.0,0.0,0,0.1486
bms-823778,EFO_1001132,pseudotumor cerebri,0.1485531680404963,0.0,0.0,0,0.1486
bms-823778,MONDO_0013616,"pigmented nodular adrenocortical disease, primary, 3",0.1430158487017868,0.0,0.0,0,0.143
bms-823778,EFO_0000729,ulcerative colitis,0.1281496140417894,0.0,0.0,0,0.1281
bms-823778,MONDO_0013310,congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,0.1249109313468514,0.0,0.0,0,0.1249
bms-823778,MONDO_0018479,congenital adrenal hyperplasia,0.1131938002176571,0.0,0.0,0,0.1132
bms-823778,HP_0000855,Insulin resistance,0.1090347159755504,0.0,0.0,0,0.109
bms-823778,MONDO_0008725,congenital lipoid adrenal hyperplasia due to STAR deficency,0.1067874448459106,0.0,0.0,0,0.1068
bms-823778,MONDO_0958023,"lipodystrophy, congenital generalized, type 5",0.1022029290211055,0.0,0.0,0,0.1022
bms-823778,MONDO_0007080,glucocorticoid-remediable aldosteronism,0.0950628860583145,0.0,0.0,0,0.0951
bms-823778,EFO_0000384,Crohn's disease,0.0929413428395162,0.0,0.0,0,0.0929
bms-823778,MONDO_0008733,familial glucocorticoid deficiency,0.0909442494743917,0.0,0.0,0,0.0909
bms-823778,MONDO_0012923,congenital generalized lipodystrophy type 3,0.0899823677113296,0.0,0.0,0,0.09
bms-823778,Orphanet_228429,Generalized congenital lipodystrophy with myopathy,0.0899823677113296,0.0,0.0,0,0.09
bms-823778,Orphanet_411,Hyperlipoproteinemia type 1,0.0869036033036903,0.0,0.0,0,0.0869
bms-823778,MONDO_0012381,hyperinsulinism due to INSR deficiency,0.0810951744333069,0.0,0.0,0,0.0811
bms-823778,EFO_0000389,cutaneous melanoma,0.0799917545129171,0.0,0.0,0,0.08
bms-823778,HP_0040175,Platelet-activating factor acetylhydrolase deficiency,0.0798324725049626,0.0,0.0,0,0.0798
bms-823778,EFO_1001354,Kleine-Levin Syndrome,0.07963935338651,0.0,0.0,0,0.0796
bms-823778,EFO_0004246,mucocutaneous lymph node syndrome,0.078444325679162,0.0,0.0,0,0.0784
bms-823778,MONDO_0007762,hyperlipoproteinemia type V,0.0781835323397132,0.0,0.0,0,0.0782
bms-823778,Orphanet_70470,Hyperlipoproteinemia type 5,0.0781835323397132,0.0,0.0,0,0.0782
bms-823778,MONDO_0014098,CIDEC-related familial partial lipodystrophy,0.0770025346537912,0.0,0.0,0,0.077
bms-823778,MONDO_0007254,breast cancer,0.0765217564437655,0.0,0.0,0,0.0765
bms-823778,EFO_0001073,obesity,0.0749663632775876,0.0,0.0,0,0.075
bms-823778,EFO_0003875,peripheral vascular disease,0.074276584020248,0.0,0.0,0,0.0743
bms-823778,MONDO_0012396,exercise-induced hyperinsulinism,0.073934911733755,0.0,0.0,0,0.0739
bms-823778,MONDO_0859149,hypertriglyceridemia 2,0.0732218565271606,0.0,0.0,0,0.0732
bms-823778,MONDO_0009734,"hyperinsulinemic hypoglycemia, familial, 1",0.0723453928357216,0.0,0.0,0,0.0723
bms-823778,EFO_1001979,Adrenocorticotropic hormone deficiency,0.0711718228082017,0.0,0.0,0,0.0712
bms-823778,MONDO_0011236,hyperinsulinism due to glucokinase deficiency,0.0710678355905733,0.0,0.0,0,0.0711
bms-823778,EFO_0000478,esophageal adenocarcinoma,0.0698794102462494,0.0,0.0,0,0.0699
bupivacaine liposome,MONDO_0011001,Brugada syndrome 1,1.8023214358886164,0.0,0.0,0,1.8023
bupivacaine liposome,EFO_0004269,cardiac arrhythmia,1.7999604534810545,0.0,0.0,0,1.8
bupivacaine liposome,EFO_0000275,atrial fibrillation,1.7995128897970418,0.0,0.0,0,1.7995
bupivacaine liposome,MONDO_0011377,long QT syndrome 3,1.697753131485748,0.0,0.0,0,1.6978
bupivacaine liposome,MONDO_0015263,Brugada syndrome,1.6972466443688696,0.0,0.0,0,1.6972
bupivacaine liposome,MONDO_0008195,paramyotonia congenita of Von Eulenburg,1.689541404919834,0.0,0.0,0,1.6895
bupivacaine liposome,MONDO_0008224,hyperkalemic periodic paralysis,1.672880494810728,0.0,0.0,0,1.6729
bupivacaine liposome,Orphanet_871,Familial progressive cardiac conduction defect,1.655498357539786,0.0,0.0,0,1.6555
bupivacaine liposome,MONDO_0007240,"progressive familial heart block, type 1A",1.654340201776926,0.0,0.0,0,1.6543
bupivacaine liposome,HP_0001250,Seizure,1.6228735991273575,0.0,0.0,0,1.6229
bupivacaine liposome,MONDO_0018959,potassium-aggravated myotonia,1.61963259300252,0.0,0.0,0,1.6196
bupivacaine liposome,MONDO_0011003,dilated cardiomyopathy 1E,1.6165491805654075,0.0,0.0,0,1.6165
bupivacaine liposome,MONDO_0013530,"atrial fibrillation, familial, 10",1.603730627659406,0.0,0.0,0,1.6037
bupivacaine liposome,MONDO_0024562,sick sinus syndrome 1,1.6000195407542703,0.0,0.0,0,1.6
bupivacaine liposome,EFO_0005303,sudden infant death syndrome,1.5956883018796106,0.0,0.0,0,1.5957
bupivacaine liposome,MONDO_0008223,hypokalemic periodic paralysis,1.5872469762431378,0.0,0.0,0,1.5872
bupivacaine liposome,MONDO_0011376,"ventricular fibrillation, paroxysmal familial, type 1",1.56378649793265,0.0,0.0,0,1.5638
bupivacaine liposome,EFO_0004138,bundle branch block,1.558825027820817,0.0,0.0,0,1.5588
bupivacaine liposome,HP_0012531,Pain,1.5397149192143809,0.0,0.0,0,1.5397
bupivacaine liposome,Orphanet_101016,Romano-Ward syndrome,1.5237792701247734,0.0,0.0,0,1.5238
bupivacaine liposome,Orphanet_590,Congenital myasthenic syndromes,1.5212353445653788,0.0,0.0,0,1.5212
bupivacaine liposome,EFO_0000319,cardiovascular disease,1.484529074353656,0.0,0.0,0,1.4845
bupivacaine liposome,EFO_0000474,epilepsy,1.4814346564666525,0.0,0.0,0,1.4814
bupivacaine liposome,MONDO_0957265,"congenital myopathy 22B, severe fetal",1.4763881113055324,0.0,0.0,0,1.4764
bupivacaine liposome,HP_0001657,Prolonged QT interval,1.4500107336829962,0.0,0.0,0,1.45
bupivacaine liposome,MONDO_0004985,bipolar disorder,1.4419133207489212,0.0,0.0,0,1.4419
bupivacaine liposome,MONDO_0005277,migraine disorder,1.4308315328628844,0.0,0.0,0,1.4308
bupivacaine liposome,MONDO_0019171,familial long QT syndrome,1.4099520013797475,0.0,0.0,0,1.41
bupivacaine liposome,EFO_0000407,dilated cardiomyopathy,1.4063712108217985,0.0,0.0,0,1.4064
bupivacaine liposome,MONDO_0042979,"hypokalemic periodic paralysis, type 1",1.389574834455016,0.0,0.0,0,1.3896
bupivacaine liposome,MONDO_0013620,congenital myasthenic syndrome 16,1.38144927037614,0.0,0.0,0,1.3814
bupivacaine liposome,EFO_0004263,partial epilepsy,1.3648669703721972,0.0,0.0,0,1.3649
bupivacaine liposome,EFO_0003913,angina pectoris,1.3307974413117614,0.0,0.0,0,1.3308
bupivacaine liposome,HP_0007359,Focal-onset seizure,1.3190421919001754,0.0,0.0,0,1.319
bupivacaine liposome,EFO_0009552,hemorrhoid,1.3123389702540798,0.0,0.0,0,1.3123
bupivacaine liposome,HP_0000989,Pruritus,1.308971067116417,0.0,0.0,0,1.309
bupivacaine liposome,EFO_0005762,neuropathic pain,1.3085707223223548,0.0,0.0,0,1.3086
bupivacaine liposome,MONDO_0005178,osteoarthritis,1.297894925123912,0.0,0.0,0,1.2979
bupivacaine liposome,HP_0004308,Ventricular arrhythmia,1.2918155830077251,0.0,0.0,0,1.2918
bupivacaine liposome,MONDO_0004976,amyotrophic lateral sclerosis,1.2881801193834774,0.0,0.0,0,1.2882
bupivacaine liposome,EFO_0003911,atrial flutter,1.2880344505723291,0.0,0.0,0,1.288
bupivacaine liposome,MONDO_0957247,"congenital myopathy 22A, classic",1.2878274961170093,0.0,0.0,0,1.2878
bupivacaine liposome,Orphanet_98913,Postsynaptic congenital myasthenic syndromes,1.2853389932936234,0.0,0.0,0,1.2853
bupivacaine liposome,Orphanet_228140,"Idiopathic ventricular fibrillation, not Brugada type",1.27919985744686,0.0,0.0,0,1.2792
bupivacaine liposome,EFO_0000537,hypertension,1.2729484996565597,0.0,0.0,0,1.2729
bupivacaine liposome,MONDO_0016532,Lennox-Gastaut syndrome,1.2651172762351308,0.0,0.0,0,1.2651
bupivacaine liposome,EFO_0000508,genetic disorder,1.2594829345938088,0.0,0.0,0,1.2595
bupivacaine liposome,MONDO_0002050,depressive disorder,1.2589379038221786,0.0,0.0,0,1.2589
bupivacaine liposome,EFO_1001219,trigeminal neuralgia,1.2516373885340482,0.0,0.0,0,1.2516
bupivacaine liposome,EFO_0009963,bipolar I disorder,1.2516182499715267,0.0,0.0,0,1.2516
canakinumab (acz885),EFO_0004274,gout,8.045187443478783,0.0,0.0,0,8.0452
canakinumab (acz885),MONDO_0016168,cryopyrin-associated periodic syndrome,7.7603892416716675,0.0,0.0,0,7.7604
canakinumab (acz885),EFO_0002609,juvenile idiopathic arthritis,7.528527341576587,0.0,0.0,0,7.5285
canakinumab (acz885),MONDO_0008633,Muckle-Wells syndrome,7.122296850763094,0.0,0.0,0,7.1223
canakinumab (acz885),EFO_0000540,immune system disease,6.6706650185870995,0.0,0.0,0,6.6707
canakinumab (acz885),EFO_1001982,Antisynthetase syndrome,6.519680536841211,0.0,0.0,0,6.5197
canakinumab (acz885),EFO_0007427,pericarditis,6.423383774962796,0.0,0.0,0,6.4234
canakinumab (acz885),Orphanet_47045,Familial cold urticaria,6.234012009732794,0.0,0.0,0,6.234
canakinumab (acz885),MONDO_0018088,familial Mediterranean fever,5.976685032155372,0.0,0.0,0,5.9767
canakinumab (acz885),EFO_0005854,allergic rhinitis,5.830742491256941,0.0,0.0,0,5.8307
canakinumab (acz885),EFO_1001999,systemic juvenile idiopathic arthritis,5.795296018857455,0.0,0.0,0,5.7953
canakinumab (acz885),MONDO_0017708,mevalonate kinase deficiency,5.573937399738753,0.0,0.0,0,5.5739
canakinumab (acz885),HP_0000964,Eczematoid dermatitis,5.4635687443122665,0.0,0.0,0,5.4636
canakinumab (acz885),EFO_1001231,uveitis,5.427591647309556,0.0,0.0,0,5.4276
canakinumab (acz885),EFO_0003060,non-small cell lung carcinoma,5.283662442933737,0.0,0.0,0,5.2837
canakinumab (acz885),HP_0001945,Fever,5.205134689402737,0.0,0.0,0,5.2051
canakinumab (acz885),HP_0000999,Pyoderma,5.1560869814937,0.0,0.0,0,5.1561
canakinumab (acz885),EFO_0005772,neurodegenerative disease,5.044935217261816,0.0,0.0,0,5.0449
canakinumab (acz885),EFO_0000684,respiratory system disease,5.012388666010973,0.0,0.0,0,5.0124
canakinumab (acz885),MONDO_0100096,COVID-19,4.9031385052724845,0.0,0.0,0,4.9031
canakinumab (acz885),MONDO_0004979,asthma,4.712558191779437,0.0,0.0,0,4.7126
canakinumab (acz885),EFO_0003914,atherosclerosis,4.371510645910084,0.0,0.0,0,4.3715
canakinumab (acz885),EFO_0007135,adult-onset Still's disease,4.3181921293998435,0.0,0.0,0,4.3182
canakinumab (acz885),EFO_0003780,Behcet's syndrome,4.2636207724128825,0.0,0.0,0,4.2636
canakinumab (acz885),MONDO_0008903,lung cancer,4.115315964306312,0.0,0.0,0,4.1153
canakinumab (acz885),EFO_0002618,pancreatic carcinoma,4.115148389063007,0.0,0.0,0,4.1151
canakinumab (acz885),EFO_1000710,hidradenitis suppurativa,4.100272420012057,0.0,0.0,0,4.1003
canakinumab (acz885),EFO_1001478,systemic inflammatory response syndrome,3.91651859781241,0.0,0.0,0,3.9165
canakinumab (acz885),EFO_0003106,pneumonia,3.895829057139267,0.0,0.0,0,3.8958
canakinumab (acz885),EFO_1000044,pancreatic adenocarcinoma,3.829744409749518,0.0,0.0,0,3.8297
canakinumab (acz885),HP_0001943,Hypoglycemia,3.815793631494588,0.0,0.0,0,3.8158
canakinumab (acz885),MONDO_0011776,CINCA syndrome,3.794228621675953,0.0,0.0,0,3.7942
canakinumab (acz885),EFO_0000729,ulcerative colitis,3.7408504862305367,0.0,0.0,0,3.7409
canakinumab (acz885),MONDO_0005178,osteoarthritis,3.5996843364730293,0.0,0.0,0,3.5997
canakinumab (acz885),EFO_0000685,rheumatoid arthritis,3.5716410414753565,0.0,0.0,0,3.5716
canakinumab (acz885),EFO_0000537,hypertension,3.1832285011186654,0.0,0.0,0,3.1832
canakinumab (acz885),EFO_0007328,influenza,3.182608878332219,0.0,0.0,0,3.1826
canakinumab (acz885),EFO_0001645,coronary artery disease,3.128141355827293,0.0,0.0,0,3.1281
canakinumab (acz885),EFO_0001065,endometriosis,3.090369548788771,0.0,0.0,0,3.0904
canakinumab (acz885),MONDO_0005271,allergic disease,3.087130135893718,0.0,0.0,0,3.0871
canakinumab (acz885),MONDO_0005148,type 2 diabetes mellitus,3.001398063298683,0.0,0.0,0,3.0014
canakinumab (acz885),HP_0001977,Abnormal thrombosis,2.968007879733468,0.0,0.0,0,2.968
canakinumab (acz885),EFO_0000319,cardiovascular disease,2.959013970223371,0.0,0.0,0,2.959
canakinumab (acz885),MONDO_0004992,cancer,2.9504675762277324,0.0,0.0,0,2.9505
canakinumab (acz885),EFO_0000616,neoplasm,2.878141288375141,0.0,0.0,0,2.8781
canakinumab (acz885),EFO_0000275,atrial fibrillation,2.8599891210765014,0.0,0.0,0,2.86
canakinumab (acz885),HP_0100806,Sepsis,2.8403853918399156,0.0,0.0,0,2.8404
canakinumab (acz885),MONDO_0007254,breast cancer,2.8333991484308285,0.0,0.0,0,2.8334
canakinumab (acz885),EFO_0000341,chronic obstructive pulmonary disease,2.8145317993130226,0.0,0.0,0,2.8145
canakinumab (acz885),MONDO_0004975,Alzheimer disease,2.7552604226966304,0.0,0.0,0,2.7553
cangrelor,MONDO_0012354,platelet-type bleeding disorder 8,1.7194684294023383,1.0,0.0,0,1.2036
cangrelor,Orphanet_36355,P2Y12 defect,1.6023435254816034,1.0,0.0,0,1.1216
cangrelor,EFO_0000612,myocardial infarction,1.499999502316808,1.0,0.0,0,1.05
cangrelor,EFO_0001645,coronary artery disease,1.488104565294434,1.0,0.0,0,1.0417
cangrelor,EFO_0005672,acute coronary syndrome,1.4597556147353623,1.0,0.0,0,1.0218
cangrelor,EFO_0008583,acute myocardial infarction,1.425978263976451,1.0,0.0,0,0.9982
cangrelor,EFO_0000712,stroke,1.4160623664361789,1.0,0.0,0,0.9912
cangrelor,EFO_0004265,peripheral arterial disease,1.3431350978152992,1.0,0.0,0,0.9402
cangrelor,HP_0004419,Recurrent thrombophlebitis,1.32206549944891,1.0,0.0,0,0.9254
cangrelor,MONDO_0000831,thrombotic disease,1.2950060458128914,1.0,0.0,0,0.9065
cangrelor,MONDO_0030030,Nizon-Isidor syndrome,1.1834680998443794,1.0,0.0,0,0.8284
cangrelor,EFO_0000556,ischemia,1.1313115877073967,1.0,0.0,0,0.7919
cangrelor,EFO_0000508,genetic disorder,1.1214267344520552,1.0,0.0,0,0.785
cangrelor,MP_0001914,hemorrhage,1.1131936560117404,1.0,0.0,0,0.7792
cangrelor,MONDO_0005148,type 2 diabetes mellitus,1.0950218999031285,1.0,0.0,0,0.7665
cangrelor,HP_0001249,Intellectual disability,1.011550814273387,1.0,0.0,0,0.7081
cangrelor,HP_0002140,Ischemic stroke,1.00522261735663,1.0,0.0,0,0.7037
cangrelor,EFO_0000275,atrial fibrillation,0.9940877376684802,1.0,0.0,0,0.6959
cangrelor,EFO_0003884,chronic kidney disease,0.9830770900901408,1.0,0.0,0,0.6882
cangrelor,HP_0001873,Thrombocytopenia,0.95948865206519,1.0,0.0,0,0.6716
cangrelor,MONDO_0100096,COVID-19,0.9570458391205484,1.0,0.0,0,0.6699
cangrelor,HP_0001892,Abnormal bleeding,0.953577362865437,1.0,0.0,0,0.6675
cangrelor,EFO_0008585,ST Elevation Myocardial Infarction,0.9500770150638485,1.0,0.0,0,0.6651
cangrelor,EFO_0003875,peripheral vascular disease,0.9354034733108256,1.0,0.0,0,0.6548
cangrelor,EFO_1000985,intermediate coronary syndrome,0.8829420026531825,1.0,0.0,0,0.6181
cangrelor,EFO_0000266,aortic stenosis,0.8820835868172695,1.0,0.0,0,0.6175
cangrelor,MONDO_0011382,sickle cell disease,0.8695766833086198,1.0,0.0,0,0.6087
cangrelor,EFO_0007328,influenza,0.8598431686956941,1.0,0.0,0,0.6019
cangrelor,EFO_0003106,pneumonia,0.8522842942277244,1.0,0.0,0,0.5966
cangrelor,EFO_0003914,atherosclerosis,0.841839671704794,1.0,0.0,0,0.5893
cangrelor,EFO_0000341,chronic obstructive pulmonary disease,0.839281695698565,1.0,0.0,0,0.5875
cangrelor,EFO_0002615,internal carotid artery stenosis,0.8092163454316417,1.0,0.0,0,0.5665
cangrelor,MONDO_0024327,chronic renal failure syndrome,0.7823847190176809,1.0,0.0,0,0.5477
cangrelor,EFO_0003870,brain aneurysm,0.7816444113397121,1.0,0.0,0,0.5472
cangrelor,HP_0002239,Gastrointestinal hemorrhage,0.7725742523215346,1.0,0.0,0,0.5408
cangrelor,HP_0030680,Abnormal cardiovascular system morphology,0.7725742523215346,1.0,0.0,0,0.5408
cangrelor,EFO_0003913,angina pectoris,0.7481169656613191,1.0,0.0,0,0.5237
cangrelor,HP_0004866,Impaired ADP-induced platelet aggregation,0.7377470955502146,1.0,0.0,0,0.5164
cangrelor,EFO_0002618,pancreatic carcinoma,0.7166733156564862,1.0,0.0,0,0.5017
cangrelor,EFO_0003764,transient ischemic attack,0.7021465675503611,1.0,0.0,0,0.4915
cangrelor,GO_0070527,platelet aggregation,0.6793012402079219,1.0,0.0,0,0.4755
cangrelor,MONDO_0004992,cancer,0.657005707677732,1.0,0.0,0,0.4599
cangrelor,EFO_0009959,diverticular disease,0.6511849190966823,1.0,0.0,0,0.4558
cangrelor,EFO_0003144,heart failure,0.6361434177182461,1.0,0.0,0,0.4453
cangrelor,HP_0011869,Abnormal platelet function,0.6357182419102911,1.0,0.0,0,0.445
cangrelor,EFO_0009086,arteriosclerosis,0.6303085518272392,1.0,0.0,0,0.4412
cangrelor,EFO_0001365,age-related macular degeneration,0.6294093955478851,1.0,0.0,0,0.4406
cangrelor,EFO_0020925,angina unstable,0.6278642200270136,1.0,0.0,0,0.4395
cangrelor,EFO_1001375,Myocardial Ischemia,0.6267197521198498,1.0,0.0,0,0.4387
cangrelor,EFO_1000044,pancreatic adenocarcinoma,0.6251229378784529,1.0,0.0,0,0.4376
cellgram-cli,MONDO_0002009,major depressive disorder,8.0789739496768,0.0,0.0,0,8.079
cellgram-cli,MONDO_0005148,type 2 diabetes mellitus,7.416452353530491,0.0,0.0,0,7.4165
cellgram-cli,HP_0100806,Sepsis,6.36131925422262,0.0,0.0,0,6.3613
cellgram-cli,EFO_0000729,ulcerative colitis,6.276678304197179,0.0,0.0,0,6.2767
cellgram-cli,MONDO_0003778,inborn error of immunity,5.900995717732101,0.0,0.0,0,5.901
cellgram-cli,EFO_0000676,psoriasis,5.798813283212193,0.0,0.0,0,5.7988
cellgram-cli,EFO_0000649,periodontitis,5.724090521511243,0.0,0.0,0,5.7241
cellgram-cli,EFO_0005423,adolescent idiopathic scoliosis,5.661547497705439,0.0,0.0,0,5.6615
cellgram-cli,EFO_0000384,Crohn's disease,5.653447962971424,0.0,0.0,0,5.6534
cellgram-cli,EFO_0003898,ankylosing spondylitis,5.627408820350402,0.0,0.0,0,5.6274
cellgram-cli,EFO_0004268,sclerosing cholangitis,5.609879879516417,0.0,0.0,0,5.6099
cellgram-cli,EFO_1000897,diabetic ketoacidosis,5.0743265517112,0.0,0.0,0,5.0743
cellgram-cli,EFO_0004616,"osteoarthritis, knee",4.862696327964578,0.0,0.0,0,4.8627
cellgram-cli,EFO_0001061,cervical carcinoma,4.826382335398982,0.0,0.0,0,4.8264
cellgram-cli,EFO_0000341,chronic obstructive pulmonary disease,4.761260282684226,0.0,0.0,0,4.7613
cellgram-cli,MONDO_0100096,COVID-19,4.506116798030392,0.0,0.0,0,4.5061
cellgram-cli,EFO_0004698,insomnia,4.500876374928694,0.0,0.0,0,4.5009
cellgram-cli,EFO_0004289,lymphoid leukemia,4.396335361378345,0.0,0.0,0,4.3963
cellgram-cli,EFO_0007328,influenza,4.318284602788265,0.0,0.0,0,4.3183
cellgram-cli,EFO_0000400,diabetes mellitus,4.293346264771853,0.0,0.0,0,4.2933
cellgram-cli,EFO_0005670,smoking initiation,4.273766085345647,0.0,0.0,0,4.2738
cellgram-cli,EFO_0003106,pneumonia,4.212650233523716,0.0,0.0,0,4.2127
cellgram-cli,EFO_0020975,total knee arthroplasty,4.020588695558051,0.0,0.0,0,4.0206
cellgram-cli,EFO_0001073,obesity,3.97699289104423,0.0,0.0,0,3.977
cellgram-cli,EFO_0004318,smoking behavior,3.953068824621539,0.0,0.0,0,3.9531
cellgram-cli,MONDO_0005178,osteoarthritis,3.709637936136158,0.0,0.0,0,3.7096
cellgram-cli,EFO_0000555,irritable bowel syndrome,3.694428738586375,0.0,0.0,0,3.6944
cellgram-cli,EFO_0000373,congestive heart failure,3.6544076389452727,0.0,0.0,0,3.6544
cellgram-cli,EFO_1001754,Abruptio Placentae,3.508827497077913,0.0,0.0,0,3.5088
cellgram-cli,EFO_0000195,metabolic syndrome,3.472442473798545,0.0,0.0,0,3.4724
cellgram-cli,EFO_0000668,preeclampsia,3.4618745126980737,0.0,0.0,0,3.4619
cellgram-cli,EFO_0003834,cutaneous lupus erythematosus,3.39386600237726,0.0,0.0,0,3.3939
cellgram-cli,EFO_0000783,myositis,3.357292922642978,0.0,0.0,0,3.3573
cellgram-cli,MONDO_0004736,inborn disorder of amino acid metabolism,3.3533109428534056,0.0,0.0,0,3.3533
cellgram-cli,EFO_0004247,mood disorder,3.3089841758127516,0.0,0.0,0,3.309
cellgram-cli,HP_0003326,Myalgia,3.294393115420635,0.0,0.0,0,3.2944
cellgram-cli,MONDO_0000812,vertebral column disorder,3.294393115420635,0.0,0.0,0,3.2944
cellgram-cli,EFO_1000786,"osteoarthritis, hip",3.2716832588526445,0.0,0.0,0,3.2717
cellgram-cli,EFO_0001421,liver disease,3.262151890858477,0.0,0.0,0,3.2622
cellgram-cli,EFO_0004257,neurotic disorder,3.25303098635838,0.0,0.0,0,3.253
cellgram-cli,EFO_0009727,shortness of breath,3.1154264736594213,0.0,0.0,0,3.1154
cellgram-cli,EFO_1001375,Myocardial Ischemia,3.110870225077566,0.0,0.0,0,3.1109
cellgram-cli,EFO_0003832,gallbladder disease,3.0766561862008492,0.0,0.0,0,3.0767
cellgram-cli,EFO_1001231,uveitis,3.0766561862008492,0.0,0.0,0,3.0767
cellgram-cli,EFO_0001074,morbid obesity,2.9882141875122867,0.0,0.0,0,2.9882
cellgram-cli,EFO_0000571,lung adenocarcinoma,2.9105541645071846,0.0,0.0,0,2.9106
cellgram-cli,HP_0000924,Abnormality of the skeletal system,2.812672849381592,0.0,0.0,0,2.8127
cellgram-cli,HP_0100749,Chest pain,2.5661829567106147,0.0,0.0,0,2.5662
cellgram-cli,EFO_0001645,coronary artery disease,2.5084538074963207,0.0,0.0,0,2.5085
cellgram-cli,EFO_0000684,respiratory system disease,2.415965753486163,0.0,0.0,0,2.416
cholecalciferol,Orphanet_93160,Hypocalcemic vitamin D-resistant rickets,3.930347498216506,1.0,0.0,0,2.7512
cholecalciferol,MONDO_0005148,type 2 diabetes mellitus,3.677773170254279,1.0,0.0,0,2.5744
cholecalciferol,EFO_0000537,hypertension,3.3001576781882784,1.0,0.0,0,2.3101
cholecalciferol,EFO_0003884,chronic kidney disease,3.137624543359656,1.0,0.0,0,2.1963
cholecalciferol,EFO_0000341,chronic obstructive pulmonary disease,3.1093554567045087,1.0,0.0,0,2.1765
cholecalciferol,EFO_0000676,psoriasis,3.1057597788465263,1.0,0.0,0,2.174
cholecalciferol,EFO_1001494,psoriasis vulgaris,2.9693655321989296,1.0,0.0,0,2.0786
cholecalciferol,MONDO_0005301,multiple sclerosis,2.9514036041629255,1.0,0.0,0,2.066
cholecalciferol,EFO_0003882,osteoporosis,2.9247508809746083,1.0,0.0,0,2.0473
cholecalciferol,EFO_1001173,secondary hyperparathyroidism,2.8685119688723555,1.0,0.0,0,2.008
cholecalciferol,EFO_0000400,diabetes mellitus,2.851000974669271,1.0,0.0,0,1.9957
cholecalciferol,HP_0002901,Hypocalcemia,2.836819561414222,1.0,0.0,0,1.9858
cholecalciferol,EFO_0000729,ulcerative colitis,2.793185345964889,1.0,0.0,0,1.9552
cholecalciferol,EFO_0000544,infection,2.7803906399030307,1.0,0.0,0,1.9463
cholecalciferol,EFO_0009451,hypoparathyroidism,2.7720099307116146,1.0,0.0,0,1.9404
cholecalciferol,MONDO_0004979,asthma,2.7425952156345166,1.0,0.0,0,1.9198
cholecalciferol,EFO_0001073,obesity,2.7399713301131094,1.0,0.0,0,1.918
cholecalciferol,MONDO_0011448,PPARG-related familial partial lipodystrophy,2.7333795678810473,1.0,0.0,0,1.9134
cholecalciferol,EFO_0000384,Crohn's disease,2.7203282151120773,1.0,0.0,0,1.9042
cholecalciferol,EFO_0000319,cardiovascular disease,2.689242513521384,1.0,0.0,0,1.8825
cholecalciferol,EFO_0003144,heart failure,2.680741551909408,1.0,0.0,0,1.8765
cholecalciferol,EFO_0000612,myocardial infarction,2.643105437241195,1.0,0.0,0,1.8502
cholecalciferol,MONDO_0014421,glucocorticoid resistance,2.5737579116229576,1.0,0.0,0,1.8016
cholecalciferol,EFO_0000574,lymphoma,2.572036596340314,1.0,0.0,0,1.8004
cholecalciferol,EFO_0000565,leukemia,2.540790253698812,1.0,0.0,0,1.7786
cholecalciferol,EFO_1000049,pulmonary tuberculosis,2.488957141536419,1.0,0.0,0,1.7423
cholecalciferol,MONDO_0008329,autosomal dominant pseudohypoaldosteronism type 1,2.4749316499235845,1.0,0.0,0,1.7325
cholecalciferol,EFO_0002609,juvenile idiopathic arthritis,2.4572560624052824,1.0,0.0,0,1.7201
cholecalciferol,MP_0001845,inflammation,2.4563120069692124,1.0,0.0,0,1.7194
cholecalciferol,MONDO_0007915,systemic lupus erythematosus,2.4209372116993517,1.0,0.0,0,1.6947
cholecalciferol,EFO_0004272,anemia (phenotype),2.4035643405558855,1.0,0.0,0,1.6825
cholecalciferol,EFO_0005754,parathyroid disease,2.4035643405558855,1.0,0.0,0,1.6825
cholecalciferol,MONDO_0004992,cancer,2.382024614992046,1.0,0.0,0,1.6674
cholecalciferol,EFO_0001645,coronary artery disease,2.3640154798978332,1.0,0.0,0,1.6548
cholecalciferol,Orphanet_171871,Renal pseudohypoaldosteronism type 1,2.3307762736407676,1.0,0.0,0,1.6315
cholecalciferol,HP_0012531,Pain,2.3225384607480226,1.0,0.0,0,1.6258
cholecalciferol,MONDO_0008315,prostate cancer,2.251189449102685,1.0,0.0,0,1.5758
cholecalciferol,MONDO_0100096,COVID-19,2.235539911725839,1.0,0.0,0,1.5649
cholecalciferol,EFO_0000274,atopic eczema,2.220247463040913,1.0,0.0,0,1.5542
cholecalciferol,EFO_0000616,neoplasm,2.2127985459143997,1.0,0.0,0,1.549
cholecalciferol,EFO_0005854,allergic rhinitis,2.208592956328655,1.0,0.0,0,1.546
cholecalciferol,EFO_0000701,skin disease,2.1912895503715637,1.0,0.0,0,1.5339
cholecalciferol,EFO_0000685,rheumatoid arthritis,2.1877901603657004,1.0,0.0,0,1.5315
cholecalciferol,MONDO_0007254,breast cancer,2.1650416703482396,1.0,0.0,0,1.5155
cholecalciferol,EFO_0003894,acne,2.1538171370657673,1.0,0.0,0,1.5077
cholecalciferol,MONDO_0011517,pseudohyperaldosteronism type 2,2.153578525452247,1.0,0.0,0,1.5075
cholecalciferol,EFO_0000275,atrial fibrillation,2.1055043898388197,1.0,0.0,0,1.4739
cholecalciferol,EFO_0003095,non-alcoholic fatty liver disease,2.0777217701015824,1.0,0.0,0,1.4544
cholecalciferol,EFO_1000941,frozen shoulder,2.058425647235976,1.0,0.0,0,1.4409
cholecalciferol,MONDO_0019338,sarcoidosis,2.057643808524575,1.0,0.0,0,1.4404
cilostazol,EFO_0000537,hypertension,1.5791613657434134,1.0,0.0,0,1.1054
cilostazol,MONDO_0019200,retinitis pigmentosa,1.556369626340392,1.0,0.0,0,1.0895
cilostazol,EFO_0000319,cardiovascular disease,1.546855860642903,1.0,0.0,0,1.0828
cilostazol,EFO_0001645,coronary artery disease,1.4430304047823457,1.0,0.0,0,1.0101
cilostazol,MONDO_0018852,achromatopsia,1.4306619453288874,1.0,0.0,0,1.0015
cilostazol,EFO_0000712,stroke,1.3885457739885985,1.0,0.0,0,0.972
cilostazol,Orphanet_1872,Cone rod dystrophy,1.3336572725604836,1.0,0.0,0,0.9336
cilostazol,MONDO_0004979,asthma,1.29385793995227,1.0,0.0,0,0.9057
cilostazol,EFO_0003913,angina pectoris,1.2926834317608282,1.0,0.0,0,0.9049
cilostazol,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,1.2823759951301383,1.0,0.0,0,0.8977
cilostazol,EFO_0000341,chronic obstructive pulmonary disease,1.2583578032560725,1.0,0.0,0,0.8809
cilostazol,EFO_0001361,pulmonary arterial hypertension,1.240655745766478,1.0,0.0,0,0.8685
cilostazol,EFO_0000676,psoriasis,1.2386421513156345,1.0,0.0,0,0.867
cilostazol,MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,1.2110423777158303,1.0,0.0,0,0.8477
cilostazol,EFO_0000612,myocardial infarction,1.1920683342916516,1.0,0.0,0,0.8344
cilostazol,Orphanet_1276,Brachydactyly - arterial hypertension,1.1895599638523269,1.0,0.0,0,0.8327
cilostazol,EFO_0003144,heart failure,1.1747090342831998,1.0,0.0,0,0.8223
cilostazol,MONDO_0005041,glaucoma,1.1456348841935742,1.0,0.0,0,0.8019
cilostazol,MONDO_0016293,congenital stationary night blindness,1.1393938299890096,1.0,0.0,0,0.7976
cilostazol,MONDO_0005277,migraine disorder,1.1389805713031529,1.0,0.0,0,0.7973
cilostazol,EFO_0000274,atopic eczema,1.1385902761338402,1.0,0.0,0,0.797
cilostazol,HP_0004419,Recurrent thrombophlebitis,1.1255530380326395,1.0,0.0,0,0.7879
cilostazol,MONDO_0013437,retinitis pigmentosa 43,1.1227328916707495,1.0,0.0,0,0.7859
cilostazol,HP_0006536,Airway obstruction,1.119374753690431,1.0,0.0,0,0.7836
cilostazol,MONDO_0005149,pulmonary hypertension,1.1163325322334368,1.0,0.0,0,0.7814
cilostazol,MONDO_0014835,"striatal degeneration, autosomal dominant 2",1.1151901705079166,1.0,0.0,0,0.7806
cilostazol,HP_0012531,Pain,1.1146136880566135,1.0,0.0,0,0.7802
cilostazol,MONDO_0007211,brachydactyly-arterial hypertension syndrome,1.1120001898216738,1.0,0.0,0,0.7784
cilostazol,MONDO_0001134,essential hypertension,1.09990490954711,1.0,0.0,0,0.7699
cilostazol,MONDO_0030900,intellectual developmental disorder with paroxysmal dyskinesia or seizures,1.0893989193580678,1.0,0.0,0,0.7626
cilostazol,HP_0100806,Sepsis,1.0850994798692406,1.0,0.0,0,0.7596
cilostazol,EFO_0004190,open-angle glaucoma,1.084330600044849,1.0,0.0,0,0.759
cilostazol,HP_0000556,Retinal dystrophy,1.073875011489864,1.0,0.0,0,0.7517
cilostazol,Orphanet_2754,Joubert syndrome with orofaciodigital defect,1.0707563865225374,1.0,0.0,0,0.7495
cilostazol,EFO_0000373,congestive heart failure,1.069110912267493,1.0,0.0,0,0.7484
cilostazol,EFO_0003778,psoriatic arthritis,1.050875687351308,1.0,0.0,0,0.7356
cilostazol,MONDO_0019797,acrodysostosis,1.03386441620032,1.0,0.0,0,0.7237
cilostazol,EFO_0000275,atrial fibrillation,1.0247870327030362,1.0,0.0,0,0.7174
cilostazol,HP_0004308,Ventricular arrhythmia,1.0157004101527871,1.0,0.0,0,0.711
cilostazol,EFO_0006834,septic shock,1.0136491514726766,1.0,0.0,0,0.7096
cilostazol,EFO_0000284,benign prostatic hyperplasia,1.012492609176383,1.0,0.0,0,0.7087
cilostazol,MONDO_0005148,type 2 diabetes mellitus,0.9945832614369317,1.0,0.0,0,0.6962
cilostazol,EFO_0005772,neurodegenerative disease,0.992210178690278,1.0,0.0,0,0.6945
cilostazol,EFO_0004705,hypothyroidism,0.9913209500350638,1.0,0.0,0,0.6939
cilostazol,MONDO_0012205,autosomal dominant striatal neurodegeneration type 1,0.984524524711656,1.0,0.0,0,0.6892
cilostazol,EFO_0007486,sinusitis,0.9761547037104236,1.0,0.0,0,0.6833
cilostazol,EFO_1001494,psoriasis vulgaris,0.9748981703373976,1.0,0.0,0,0.6824
cilostazol,EFO_0004234,erectile dysfunction,0.9743863244822168,1.0,0.0,0,0.6821
cilostazol,MONDO_0005271,allergic disease,0.9736955381166544,1.0,0.0,0,0.6816
cilostazol,HP_0000924,Abnormality of the skeletal system,0.9670408755262028,1.0,0.0,0,0.6769
colchicine,EFO_0000616,neoplasm,8.344301499066509,1.0,0.0,0,5.841
colchicine,MONDO_0012703,lissencephaly due to TUBA1A mutation,8.288154731377205,1.0,0.0,0,5.8017
colchicine,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,8.283598225638386,1.0,0.0,0,5.7985
colchicine,MONDO_0007254,breast cancer,8.202302978684605,1.0,0.0,0,5.7416
colchicine,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,8.187787001463917,1.0,0.0,0,5.7315
colchicine,EFO_0003060,non-small cell lung carcinoma,8.124676882473253,1.0,0.0,0,5.6873
colchicine,MONDO_0014421,glucocorticoid resistance,8.119302224664306,1.0,0.0,0,5.6835
colchicine,MONDO_0008315,prostate cancer,8.095747851454894,1.0,0.0,0,5.667
colchicine,MONDO_0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",8.067329307927917,1.0,0.0,0,5.6471
colchicine,Orphanet_183506,Genetic central nervous system malformation,8.052600960724,1.0,0.0,0,5.6368
colchicine,MONDO_0004976,amyotrophic lateral sclerosis,8.021892564610788,1.0,0.0,0,5.6153
colchicine,MONDO_0004992,cancer,7.957621776363707,1.0,0.0,0,5.5703
colchicine,EFO_0000341,chronic obstructive pulmonary disease,7.95499335216053,1.0,0.0,0,5.5685
colchicine,EFO_0000565,leukemia,7.936310356441922,1.0,0.0,0,5.5554
colchicine,EFO_0000574,lymphoma,7.906646894686174,1.0,0.0,0,5.5347
colchicine,EFO_1001985,congenital fibrosis of the extraocular muscles,7.862852176168641,1.0,0.0,0,5.504
colchicine,MONDO_0015372,autosomal dominant macrothrombocytopenia,7.850278501511964,1.0,0.0,0,5.4952
colchicine,MONDO_0100153,tubulinopathy,7.835587782613472,1.0,0.0,0,5.4849
colchicine,MONDO_0008329,autosomal dominant pseudohypoaldosteronism type 1,7.807540079962438,1.0,0.0,0,5.4653
colchicine,EFO_0000537,hypertension,7.786130062036715,1.0,0.0,0,5.4503
colchicine,MONDO_0012905,hypomyelinating leukodystrophy 6,7.762627164934834,1.0,0.0,0,5.4338
colchicine,EFO_0003869,breast neoplasm,7.699421676099922,1.0,0.0,0,5.3896
colchicine,EFO_0000305,breast carcinoma,7.676067665187123,1.0,0.0,0,5.3732
colchicine,Orphanet_404469,Female infertility due to fertilization defect,7.656992889552664,1.0,0.0,0,5.3599
colchicine,Orphanet_300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,7.65529957224248,1.0,0.0,0,5.3587
colchicine,Orphanet_139441,Hypomyelination with atrophy of basal ganglia and cerebellum,7.628047848076842,1.0,0.0,0,5.3396
colchicine,MONDO_0014337,complex cortical dysplasia with other brain malformations 5,7.571776696119168,1.0,0.0,0,5.3002
colchicine,MONDO_0020738,multiple benign circumferential skin creases on limbs 1,7.571576593247232,1.0,0.0,0,5.3001
colchicine,MONDO_0013541,complex cortical dysplasia with other brain malformations 1,7.492660278398774,1.0,0.0,0,5.2449
colchicine,EFO_0003144,heart failure,7.482053804504583,1.0,0.0,0,5.2374
colchicine,EFO_0001378,multiple myeloma,7.478237025299797,1.0,0.0,0,5.2348
colchicine,Orphanet_98805,"Primary dystonia, DYT4 type",7.448520441375891,1.0,0.0,0,5.214
colchicine,EFO_0000612,myocardial infarction,7.445081898660403,1.0,0.0,0,5.2116
colchicine,EFO_0000275,atrial fibrillation,7.408988598919742,1.0,0.0,0,5.1863
colchicine,EFO_0004274,gout,7.368268023206871,1.0,0.0,0,5.1578
colchicine,Orphanet_171871,Renal pseudohypoaldosteronism type 1,7.352780499791845,1.0,0.0,0,5.1469
colchicine,MONDO_0005301,multiple sclerosis,7.318038889939676,1.0,0.0,0,5.1226
colchicine,MONDO_0007493,torsion dystonia 4,7.233008465446657,1.0,0.0,0,5.0631
colchicine,EFO_0000183,Hodgkins lymphoma,7.224119021642552,1.0,0.0,0,5.0569
colchicine,EFO_0000403,diffuse large B-cell lymphoma,7.157314212554268,1.0,0.0,0,5.0101
colchicine,EFO_0000729,ulcerative colitis,7.153316892811044,1.0,0.0,0,5.0073
colchicine,EFO_0000544,infection,7.130428612485296,1.0,0.0,0,4.9913
colchicine,MONDO_0018088,familial Mediterranean fever,7.12323113948202,1.0,0.0,0,4.9863
colchicine,MONDO_0008170,ovarian cancer,7.047316304663706,1.0,0.0,0,4.9331
colchicine,EFO_0000673,prostate adenocarcinoma,6.9329859804878495,1.0,0.0,0,4.8531
colchicine,EFO_0005952,non-Hodgkins lymphoma,6.870164616805525,1.0,0.0,0,4.8091
colchicine,MONDO_0007990,multiple benign circumferential skin creases on limbs,6.828316872483039,1.0,0.0,0,4.7798
colchicine,EFO_0007160,autoimmune thrombocytopenic purpura,6.823460230742159,1.0,0.0,0,4.7764
colchicine,EFO_0006859,head and neck malignant neoplasia,6.8045620123451025,1.0,0.0,0,4.7632
colchicine,MONDO_0011517,pseudohyperaldosteronism type 2,6.793783841801844,1.0,0.0,0,4.7556
dipyridamole,EFO_0000537,hypertension,15.8375797726562,1.0,0.0,0,11.0863
dipyridamole,MONDO_0019200,retinitis pigmentosa,15.62036509286508,1.0,0.0,0,10.9343
dipyridamole,EFO_0000319,cardiovascular disease,15.515097581963987,1.0,0.0,0,10.8606
dipyridamole,EFO_0001645,coronary artery disease,14.475188764177831,1.0,0.0,0,10.1326
dipyridamole,MONDO_0018852,achromatopsia,14.355278126521654,1.0,0.0,0,10.0487
dipyridamole,EFO_0000712,stroke,13.910066109533211,1.0,0.0,0,9.737
dipyridamole,Orphanet_1872,Cone rod dystrophy,13.391803830430009,1.0,0.0,0,9.3743
dipyridamole,EFO_0003913,angina pectoris,13.138779189653798,1.0,0.0,0,9.1971
dipyridamole,MONDO_0004979,asthma,12.962424374634168,1.0,0.0,0,9.0737
dipyridamole,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,12.823759951301383,1.0,0.0,0,8.9766
dipyridamole,EFO_0000341,chronic obstructive pulmonary disease,12.603874771175828,1.0,0.0,0,8.8227
dipyridamole,EFO_0000676,psoriasis,12.428803149489235,1.0,0.0,0,8.7002
dipyridamole,EFO_0001361,pulmonary arterial hypertension,12.40655745766478,1.0,0.0,0,8.6846
dipyridamole,MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,12.17714223482543,1.0,0.0,0,8.524
dipyridamole,EFO_0000612,myocardial infarction,11.936675182719782,1.0,0.0,0,8.3557
dipyridamole,EFO_0003144,heart failure,11.920077101771785,1.0,0.0,0,8.3441
dipyridamole,Orphanet_1276,Brachydactyly - arterial hypertension,11.895599638523269,1.0,0.0,0,8.3269
dipyridamole,MONDO_0016293,congenital stationary night blindness,11.50124639724121,1.0,0.0,0,8.0509
dipyridamole,MONDO_0005041,glaucoma,11.456348841935744,1.0,0.0,0,8.0194
dipyridamole,MONDO_0005277,migraine disorder,11.389805713031526,1.0,0.0,0,7.9729
dipyridamole,EFO_0000274,atopic eczema,11.385902761338402,1.0,0.0,0,7.9701
dipyridamole,MONDO_0013437,retinitis pigmentosa 43,11.289182249243812,1.0,0.0,0,7.9024
dipyridamole,HP_0004419,Recurrent thrombophlebitis,11.255530380326396,1.0,0.0,0,7.8789
dipyridamole,HP_0006536,Airway obstruction,11.193747536904311,1.0,0.0,0,7.8356
dipyridamole,MONDO_0005149,pulmonary hypertension,11.166378534887562,1.0,0.0,0,7.8165
dipyridamole,MONDO_0014835,"striatal degeneration, autosomal dominant 2",11.151901705079164,1.0,0.0,0,7.8063
dipyridamole,HP_0012531,Pain,11.146136880566136,1.0,0.0,0,7.8023
dipyridamole,MONDO_0007211,brachydactyly-arterial hypertension syndrome,11.12000189821674,1.0,0.0,0,7.784
dipyridamole,MONDO_0001134,essential hypertension,11.111746381539794,1.0,0.0,0,7.7782
dipyridamole,MONDO_0030900,intellectual developmental disorder with paroxysmal dyskinesia or seizures,10.996588770843443,1.0,0.0,0,7.6976
dipyridamole,HP_0100806,Sepsis,10.850994798692406,1.0,0.0,0,7.5957
dipyridamole,EFO_0004190,open-angle glaucoma,10.84330600044849,1.0,0.0,0,7.5903
dipyridamole,HP_0000556,Retinal dystrophy,10.78322278756278,1.0,0.0,0,7.5483
dipyridamole,Orphanet_2754,Joubert syndrome with orofaciodigital defect,10.707563865225374,1.0,0.0,0,7.4953
dipyridamole,EFO_0000373,congestive heart failure,10.69110912267493,1.0,0.0,0,7.4838
dipyridamole,EFO_0000275,atrial fibrillation,10.578764893673362,1.0,0.0,0,7.4051
dipyridamole,EFO_0003778,psoriatic arthritis,10.544498522227547,1.0,0.0,0,7.3811
dipyridamole,MONDO_0019797,acrodysostosis,10.3386441620032,1.0,0.0,0,7.2371
dipyridamole,HP_0004308,Ventricular arrhythmia,10.157004101527871,1.0,0.0,0,7.1099
dipyridamole,EFO_0006834,septic shock,10.136491514726767,1.0,0.0,0,7.0955
dipyridamole,EFO_0000284,benign prostatic hyperplasia,10.12492609176383,1.0,0.0,0,7.0874
dipyridamole,EFO_0000400,diabetes mellitus,10.068506130097282,1.0,0.0,0,7.048
dipyridamole,EFO_0005772,neurodegenerative disease,9.996007663345798,1.0,0.0,0,6.9972
dipyridamole,MONDO_0005148,type 2 diabetes mellitus,9.945832614369316,1.0,0.0,0,6.9621
dipyridamole,EFO_0004705,hypothyroidism,9.928579170755716,1.0,0.0,0,6.95
dipyridamole,MONDO_0012205,autosomal dominant striatal neurodegeneration type 1,9.881719153241216,1.0,0.0,0,6.9172
dipyridamole,EFO_0004234,erectile dysfunction,9.797543903680705,1.0,0.0,0,6.8583
dipyridamole,EFO_0007486,sinusitis,9.761547037104236,1.0,0.0,0,6.8331
dipyridamole,EFO_1001494,psoriasis vulgaris,9.748981703373977,1.0,0.0,0,6.8243
dipyridamole,HP_0000924,Abnormality of the skeletal system,9.742822042204594,1.0,0.0,0,6.82
dipyridamole + aspirin,EFO_0000729,ulcerative colitis,6.720469093450703,0.0,0.0,0,6.7205
dipyridamole + aspirin,MONDO_0005277,migraine disorder,6.711668805233021,0.0,0.0,0,6.7117
dipyridamole + aspirin,EFO_0004274,gout,6.681922972942671,0.0,0.0,0,6.6819
dipyridamole + aspirin,MP_0001914,hemorrhage,6.677234004794785,0.0,0.0,0,6.6772
dipyridamole + aspirin,MONDO_0005178,osteoarthritis,6.642928340406933,0.0,0.0,0,6.6429
dipyridamole + aspirin,EFO_0001645,coronary artery disease,6.58665522813714,0.0,0.0,0,6.5867
dipyridamole + aspirin,HP_0012531,Pain,6.584407103789333,0.0,0.0,0,6.5844
dipyridamole + aspirin,EFO_0000685,rheumatoid arthritis,6.539518023614357,0.0,0.0,0,6.5395
dipyridamole + aspirin,HP_0002315,Headache,6.512944258594928,0.0,0.0,0,6.5129
dipyridamole + aspirin,HP_0001945,Fever,6.49574158242965,0.0,0.0,0,6.4957
dipyridamole + aspirin,EFO_0002609,juvenile idiopathic arthritis,6.487623421804666,0.0,0.0,0,6.4876
dipyridamole + aspirin,HP_0100607,Dysmenorrhea,6.475457846133503,0.0,0.0,0,6.4755
dipyridamole + aspirin,EFO_0003898,ankylosing spondylitis,6.456511036812518,0.0,0.0,0,6.4565
dipyridamole + aspirin,HP_0001643,Patent ductus arteriosus,6.420848690605366,0.0,0.0,0,6.4208
dipyridamole + aspirin,MONDO_0002258,pharyngitis,6.416113194466542,0.0,0.0,0,6.4161
dipyridamole + aspirin,EFO_0000712,stroke,6.410643201606182,0.0,0.0,0,6.4106
dipyridamole + aspirin,EFO_0007214,common cold,6.401763788848964,0.0,0.0,0,6.4018
dipyridamole + aspirin,EFO_0005755,rheumatic disease,6.387309607435615,0.0,0.0,0,6.3873
dipyridamole + aspirin,EFO_0010072,toothache,6.382845164859952,0.0,0.0,0,6.3828
dipyridamole + aspirin,HP_0003418,Back pain,6.371341452010584,0.0,0.0,0,6.3713
dipyridamole + aspirin,MP_0001845,inflammation,6.351956424758907,0.0,0.0,0,6.352
dipyridamole + aspirin,MONDO_0005129,cataract,6.3183371807236846,0.0,0.0,0,6.3183
dipyridamole + aspirin,EFO_0005856,arthritis,6.297793354541399,0.0,0.0,0,6.2978
dipyridamole + aspirin,EFO_0000612,myocardial infarction,6.255979842231969,0.0,0.0,0,6.256
dipyridamole + aspirin,HP_0003326,Myalgia,6.245505300770125,0.0,0.0,0,6.2455
dipyridamole + aspirin,MONDO_0003937,spondylitis,6.225628940647523,0.0,0.0,0,6.2256
dipyridamole + aspirin,HP_0002829,Arthralgia,6.224500188582215,0.0,0.0,0,6.2245
dipyridamole + aspirin,EFO_0009846,muscle cramp,6.221710510054445,0.0,0.0,0,6.2217
dipyridamole + aspirin,EFO_0007328,influenza,6.1660979963537175,0.0,0.0,0,6.1661
dipyridamole + aspirin,EFO_0009582,sprain,6.137527841707515,0.0,0.0,0,6.1375
dipyridamole + aspirin,EFO_0002496,actinic keratosis,6.125657977586125,0.0,0.0,0,6.1257
dipyridamole + aspirin,EFO_0005752,eye inflammation,5.985097297702477,0.0,0.0,0,5.9851
dipyridamole + aspirin,EFO_0000319,cardiovascular disease,5.929424228770532,0.0,0.0,0,5.9294
dipyridamole + aspirin,HP_0002018,Nausea,5.921738854494638,0.0,0.0,0,5.9217
dipyridamole + aspirin,HP_0002014,Diarrhea,5.920705434483268,0.0,0.0,0,5.9207
dipyridamole + aspirin,MONDO_0002471,bursitis,5.913541512728093,0.0,0.0,0,5.9135
dipyridamole + aspirin,EFO_0009454,gastric ulcer,5.845281501255728,0.0,0.0,0,5.8453
dipyridamole + aspirin,HP_0200026,Ocular pain,5.843903848398338,0.0,0.0,0,5.8439
dipyridamole + aspirin,Orphanet_733,Familial adenomatous polyposis,5.736237970658315,0.0,0.0,0,5.7362
dipyridamole + aspirin,MONDO_0004857,tendinitis,5.726394647047349,0.0,0.0,0,5.7264
dipyridamole + aspirin,EFO_0005628,proctitis,5.717917597207352,0.0,0.0,0,5.7179
dipyridamole + aspirin,MONDO_0000831,thrombotic disease,5.559765537815707,0.0,0.0,0,5.5598
dipyridamole + aspirin,EFO_0004253,nephrolithiasis,5.50880887662027,0.0,0.0,0,5.5088
dipyridamole + aspirin,HP_0004398,Peptic ulcer,5.36552908176904,0.0,0.0,0,5.3655
dipyridamole + aspirin,EFO_0005757,vaginal inflammation,5.333419418355719,0.0,0.0,0,5.3334
dipyridamole + aspirin,EFO_0009364,non-allergic rhinitis,5.333419418355719,0.0,0.0,0,5.3334
dipyridamole + aspirin,EFO_0004607,duodenal ulcer,5.087248807313153,0.0,0.0,0,5.0872
dipyridamole + aspirin,EFO_0004142,colorectal neoplasm,5.070653229082636,0.0,0.0,0,5.0707
dipyridamole + aspirin,EFO_0008583,acute myocardial infarction,5.018846470885212,0.0,0.0,0,5.0188
dipyridamole + aspirin,HP_0004419,Recurrent thrombophlebitis,4.8980382413470895,0.0,0.0,0,4.898
evolocumab,EFO_0004911,familial hypercholesterolemia,2.9058569262750287,1.0,0.0,0,2.0341
evolocumab,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",2.70586465886561,1.0,0.0,0,1.8941
evolocumab,HP_0003124,Hypercholesterolemia,2.6539123081398346,1.0,0.0,0,1.8577
evolocumab,EFO_0001645,coronary artery disease,2.503624314117451,1.0,0.0,0,1.7525
evolocumab,EFO_0000319,cardiovascular disease,2.4722584043751024,1.0,0.0,0,1.7306
evolocumab,EFO_0000589,metabolic disease,2.3055488757387117,1.0,0.0,0,1.6139
evolocumab,Orphanet_309005,Disorder of lipid metabolism,2.2170512532759004,1.0,0.0,0,1.5519
evolocumab,MONDO_0018328,homozygous familial hypercholesterolemia,2.206284704788466,1.0,0.0,0,1.5444
evolocumab,MONDO_0021187,hyperlipidemia,2.203136859660998,1.0,0.0,0,1.5422
evolocumab,EFO_0000612,myocardial infarction,2.1383678544611064,1.0,0.0,0,1.4969
evolocumab,EFO_0003914,atherosclerosis,2.11003330899773,1.0,0.0,0,1.477
evolocumab,EFO_1001375,Myocardial Ischemia,1.8796123064811092,1.0,0.0,0,1.3157
evolocumab,MONDO_0007750,"hypercholesterolemia, familial, 1",1.7836214902334102,1.0,0.0,0,1.2485
evolocumab,HP_0003077,Hyperlipidemia,1.773337140058782,1.0,0.0,0,1.2413
evolocumab,MONDO_0021661,coronary atherosclerosis,1.763336321760802,1.0,0.0,0,1.2343
evolocumab,MONDO_0001336,familial hyperlipidemia,1.7621089943612105,1.0,0.0,0,1.2335
evolocumab,EFO_0003913,angina pectoris,1.733713012728092,1.0,0.0,0,1.2136
evolocumab,EFO_0003777,heart disease,1.720350777630642,1.0,0.0,0,1.2042
evolocumab,GO_0036273,response to statin,1.6929627454314395,1.0,0.0,0,1.1851
evolocumab,EFO_0000195,metabolic syndrome,1.6508188367808607,1.0,0.0,0,1.1556
evolocumab,HP_0001626,Abnormality of the cardiovascular system,1.544989115822175,1.0,0.0,0,1.0815
evolocumab,HP_0003146,Hypocholesterolemia,1.519787603332834,1.0,0.0,0,1.0639
evolocumab,MONDO_0009387,familial lipoprotein lipase deficiency,1.477404180953503,1.0,0.0,0,1.0342
evolocumab,HP_0003119,Abnormal circulating lipid concentration,1.4715700044219706,1.0,0.0,0,1.0301
evolocumab,EFO_0000400,diabetes mellitus,1.4497025252387634,1.0,0.0,0,1.0148
evolocumab,EFO_0004214,Abdominal Aortic Aneurysm,1.4288552428438437,1.0,0.0,0,1.0002
evolocumab,MONDO_0008692,abetalipoproteinemia,1.3915521393970829,1.0,0.0,0,0.9741
evolocumab,MONDO_0013144,hereditary antithrombin deficiency,1.3529384233905548,1.0,0.0,0,0.9471
evolocumab,HP_0001976,Reduced antithrombin III activity,1.259039852698564,1.0,0.0,0,0.8813
evolocumab,EFO_0000712,stroke,1.2359095786396606,1.0,0.0,0,0.8651
evolocumab,EFO_0004286,venous thromboembolism,1.2276020375212808,1.0,0.0,0,0.8593
evolocumab,EFO_0000275,atrial fibrillation,1.2246559981045952,1.0,0.0,0,0.8573
evolocumab,EFO_1000985,intermediate coronary syndrome,1.2118467948374598,1.0,0.0,0,0.8483
evolocumab,EFO_0008583,acute myocardial infarction,1.2064338630397655,1.0,0.0,0,0.8445
evolocumab,EFO_0004264,vascular disease,1.195063853700586,1.0,0.0,0,0.8365
evolocumab,EFO_0005672,acute coronary syndrome,1.1946395370223528,1.0,0.0,0,0.8362
evolocumab,EFO_0003144,heart failure,1.1943910450436237,1.0,0.0,0,0.8361
evolocumab,HP_0011428,Short fetal femur length,1.187066470233723,1.0,0.0,0,0.8309
evolocumab,MONDO_0016085,Cole-Carpenter syndrome,1.1861271155659427,1.0,0.0,0,0.8303
evolocumab,HP_0004936,Venous thrombosis,1.160990275789953,1.0,0.0,0,0.8127
evolocumab,EFO_0004329,alcohol drinking,1.153512135309475,1.0,0.0,0,0.8075
evolocumab,MONDO_0100096,COVID-19,1.1527810225729451,1.0,0.0,0,0.8069
evolocumab,Orphanet_79211,Combined hyperlipidemia,1.1360479736028382,1.0,0.0,0,0.7952
evolocumab,EFO_0003776,coronary artery bypass,1.1279602973638454,1.0,0.0,0,0.7896
evolocumab,EFO_0003940,physical activity,1.1225894210654916,1.0,0.0,0,0.7858
evolocumab,EFO_0003951,percutaneous transluminal coronary angioplasty,1.1225894210654916,1.0,0.0,0,0.7858
evolocumab,EFO_0003907,deep vein thrombosis,1.101982647890135,1.0,0.0,0,0.7714
evolocumab,EFO_0003884,chronic kidney disease,1.0458297478468073,1.0,0.0,0,0.7321
evolocumab,EFO_0003086,kidney disease,1.0396200487798937,1.0,0.0,0,0.7277
evolocumab,EFO_0009578,placental retention,0.9852322328973993,1.0,0.0,0,0.6897
ezetimibe,HP_0003124,Hypercholesterolemia,1.1542297813935771,1.0,0.1,0,0.7849
ezetimibe,MONDO_0021187,hyperlipidemia,1.101764190881846,1.0,0.1,0,0.7492
ezetimibe,EFO_0004911,familial hypercholesterolemia,0.9811824336261872,1.0,0.1,0,0.6672
ezetimibe,EFO_0000319,cardiovascular disease,0.8306891947084494,1.0,0.1,0,0.5649
ezetimibe,Orphanet_309005,Disorder of lipid metabolism,0.7597204497794091,1.0,0.1,0,0.5166
ezetimibe,EFO_0000589,metabolic disease,0.7567782745272026,1.0,0.1,0,0.5146
ezetimibe,EFO_0001645,coronary artery disease,0.6510540466490428,1.0,0.1,0,0.4427
ezetimibe,EFO_0003914,atherosclerosis,0.5701983144655997,1.0,0.1,0,0.3877
ezetimibe,EFO_0004211,Hypertriglyceridemia,0.561669656826669,1.0,0.1,0,0.3819
ezetimibe,MONDO_0005148,type 2 diabetes mellitus,0.5400146586842938,1.0,0.1,0,0.3672
ezetimibe,GO_0036273,response to statin,0.5365245823298466,1.0,0.1,0,0.3648
ezetimibe,HP_0001650,Aortic valve stenosis,0.5150495015476898,1.0,0.1,0,0.3502
ezetimibe,MONDO_0001336,familial hyperlipidemia,0.5076893443384163,1.0,0.1,0,0.3452
ezetimibe,EFO_0000195,metabolic syndrome,0.426721400669677,1.0,0.1,0,0.2902
ezetimibe,EFO_0000400,diabetes mellitus,0.4153346238873279,1.0,0.1,0,0.2824
ezetimibe,EFO_0000612,myocardial infarction,0.4126282292399205,1.0,0.1,0,0.2806
ezetimibe,EFO_0000537,hypertension,0.4120396012381517,1.0,0.1,0,0.2802
ezetimibe,MONDO_0019052,inborn errors of metabolism,0.4120396012381517,1.0,0.1,0,0.2802
ezetimibe,EFO_0003913,angina pectoris,0.4097018129698564,1.0,0.1,0,0.2786
ezetimibe,EFO_0003776,coronary artery bypass,0.237488359962275,1.0,0.1,0,0.1615
ezetimibe,EFO_0000616,neoplasm,0.1604550422350072,1.0,0.1,0,0.1091
ezetimibe,EFO_0007304,hepatitis D virus infection,0.1471570004421969,1.0,0.1,0,0.1001
ezetimibe,EFO_0000182,hepatocellular carcinoma,0.1448920988848256,1.0,0.1,0,0.0985
ezetimibe,EFO_0008527,steatosis,0.1430460678595945,1.0,0.1,0,0.0973
ezetimibe,EFO_0003095,non-alcoholic fatty liver disease,0.1407433713945828,1.0,0.1,0,0.0957
ezetimibe,MONDO_0018328,homozygous familial hypercholesterolemia,0.1354330022169672,1.0,0.1,0,0.0921
ezetimibe,EFO_1001951,colorectal carcinoma,0.1332403482651239,1.0,0.1,0,0.0906
ezetimibe,EFO_0004220,chronic hepatitis C virus infection,0.1324413003979773,1.0,0.1,0,0.0901
ezetimibe,EFO_1000044,pancreatic adenocarcinoma,0.1177256003537575,1.0,0.1,0,0.0801
ezetimibe,MONDO_0859149,hypertriglyceridemia 2,0.0941304469028556,1.0,0.1,0,0.064
ezetimibe,MONDO_0004992,cancer,0.0920413897228009,1.0,0.1,0,0.0626
ezetimibe,MONDO_0009294,glycogen storage disease VI,0.0883824944655834,1.0,0.1,0,0.0601
ezetimibe,MONDO_0013700,pancreatic triacylglycerol lipase deficiency,0.0836057782312298,1.0,0.1,0,0.0569
ezetimibe,Orphanet_79211,Combined hyperlipidemia,0.0796001646791932,1.0,0.1,0,0.0541
ezetimibe,MONDO_0011601,neonatal intrahepatic cholestasis due to citrin deficiency,0.0758388317478905,1.0,0.1,0,0.0516
ezetimibe,MONDO_0008863,sitosterolemia,0.0741519169941481,1.0,0.1,0,0.0504
ezetimibe,EFO_1001979,Adrenocorticotropic hormone deficiency,0.073793349441744,1.0,0.1,0,0.0502
ezetimibe,MONDO_0009528,chylomicron retention disease,0.0732223802800283,1.0,0.1,0,0.0498
ezetimibe,Orphanet_411,Hyperlipoproteinemia type 1,0.0727661935786575,1.0,0.1,0,0.0495
ezetimibe,MONDO_0020748,sitosterolemia 2,0.0699407791701673,1.0,0.1,0,0.0476
ezetimibe,EFO_0005537,triple-negative breast cancer,0.0682808482051794,1.0,0.1,0,0.0464
ezetimibe,MONDO_0007254,breast cancer,0.0673045218103332,1.0,0.1,0,0.0458
ezetimibe,MONDO_0018305,chronic granulomatous disease,0.0668504821608811,1.0,0.1,0,0.0455
ezetimibe,EFO_0005546,congenital disorder of glycosylation type II,0.0665473387399702,1.0,0.1,0,0.0453
ezetimibe,MONDO_0001056,gastric cancer,0.0662206501989886,1.0,0.1,0,0.045
ezetimibe,MONDO_0021661,coronary atherosclerosis,0.0661879873498455,1.0,0.1,0,0.045
ezetimibe,MONDO_0008315,prostate cancer,0.0653050066406816,1.0,0.1,0,0.0444
ezetimibe,MONDO_0010939,gallbladder disease 1,0.0645724917940359,1.0,0.1,0,0.0439
ezetimibe,MONDO_0015762,progressive familial intrahepatic cholestasis,0.0643723582734345,1.0,0.1,0,0.0438
ezetimibe,MONDO_0011906,congenital bile acid synthesis defect 1,0.0615704889850152,1.0,0.1,0,0.0419
fentanyl,EFO_0010702,opioid use disorder,7.002267594670959,1.0,0.0,0,4.9016
fentanyl,HP_0012531,Pain,6.822850335585274,1.0,0.0,0,4.776
fentanyl,EFO_0005611,opioid dependence,6.628745440215823,1.0,0.0,0,4.6401
fentanyl,MONDO_0004992,cancer,6.233115881809948,1.0,0.0,0,4.3632
fentanyl,HP_0012532,Chronic pain,5.946467785371659,1.0,0.0,0,4.1625
fentanyl,MONDO_0007079,alcohol dependence,5.918031358432361,1.0,0.0,0,4.1426
fentanyl,EFO_0003890,drug dependence,5.892207549950015,1.0,0.0,0,4.1245
fentanyl,HP_0002014,Diarrhea,5.836776608821151,1.0,0.0,0,4.0857
fentanyl,HP_0002019,Constipation,5.746297578522295,1.0,0.0,0,4.0224
fentanyl,EFO_0005762,neuropathic pain,5.5709639812287906,1.0,0.0,0,3.8997
fentanyl,EFO_0000555,irritable bowel syndrome,5.472027545095557,1.0,0.0,0,3.8304
fentanyl,EFO_0022041,response to tramadol,5.2217151658732845,1.0,0.0,0,3.6552
fentanyl,EFO_0801084,cancer pain,5.016904778616746,1.0,0.0,0,3.5118
fentanyl,MONDO_0005277,migraine disorder,4.8622779140894234,1.0,0.0,0,3.4036
fentanyl,EFO_0006834,septic shock,4.80606898105521,1.0,0.0,0,3.3642
fentanyl,HP_0000924,Abnormality of the skeletal system,4.566519677634116,1.0,0.0,0,3.1966
fentanyl,HP_0012735,Cough,4.499962968855424,1.0,0.0,0,3.15
fentanyl,MONDO_0005178,osteoarthritis,4.45411707253661,1.0,0.0,0,3.1179
fentanyl,EFO_0020911,overdose,4.427880564805489,1.0,0.0,0,3.0995
fentanyl,MONDO_0002203,constipation disorder,4.414710013265912,1.0,0.0,0,3.0903
fentanyl,MONDO_0002046,alcohol abuse,4.3340440675088505,1.0,0.0,0,3.0338
fentanyl,EFO_0000712,stroke,4.276759220874101,1.0,0.0,0,2.9937
fentanyl,EFO_0001645,coronary artery disease,4.254885487528973,1.0,0.0,0,2.9784
fentanyl,HP_0003418,Back pain,4.241072920864486,1.0,0.0,0,2.9688
fentanyl,EFO_0001073,obesity,4.2114549731280935,1.0,0.0,0,2.948
fentanyl,HP_0003419,Low back pain,4.091649849938992,1.0,0.0,0,2.8642
fentanyl,EFO_0004616,"osteoarthritis, knee",4.048714742710546,1.0,0.0,0,2.8341
fentanyl,MONDO_0005090,schizophrenia,4.04770896767641,1.0,0.0,0,2.8334
fentanyl,EFO_0000616,neoplasm,4.0187352663578455,1.0,0.0,0,2.8131
fentanyl,EFO_0010072,toothache,3.957849395366877,1.0,0.0,0,2.7705
fentanyl,EFO_0004240,heroin dependence,3.9449113262244335,1.0,0.0,0,2.7614
fentanyl,EFO_0000546,injury,3.9211726611115383,1.0,0.0,0,2.7448
fentanyl,EFO_0000764,HIV infection,3.919249052007727,1.0,0.0,0,2.7435
fentanyl,EFO_0004329,alcohol drinking,3.8769086827947854,1.0,0.0,0,2.7138
fentanyl,MONDO_0004567,ileus,3.8734114962433894,1.0,0.0,0,2.7114
fentanyl,EFO_1000786,"osteoarthritis, hip",3.822712718692463,1.0,0.0,0,2.6759
fentanyl,EFO_1000783,diabetic neuropathy,3.8201786107528575,1.0,0.0,0,2.6741
fentanyl,EFO_0003884,chronic kidney disease,3.7878517183832376,1.0,0.0,0,2.6515
fentanyl,EFO_0002610,cocaine dependence,3.770823266824613,1.0,0.0,0,2.6396
fentanyl,EFO_0004253,nephrolithiasis,3.737185891578381,1.0,0.0,0,2.616
fentanyl,HP_0000989,Pruritus,3.7334228615347578,1.0,0.0,0,2.6134
fentanyl,EFO_0003918,obstructive sleep apnea,3.7097877821505687,1.0,0.0,0,2.5969
fentanyl,EFO_0002950,pregnancy,3.7059058179987834,1.0,0.0,0,2.5941
fentanyl,EFO_0005799,neonatal abstinence syndrome,3.681307033605641,1.0,0.0,0,2.5769
fentanyl,EFO_0008583,acute myocardial infarction,3.624260470921767,1.0,0.0,0,2.537
fentanyl,MONDO_0100096,COVID-19,3.612123811072872,1.0,0.0,0,2.5285
fentanyl,EFO_0009601,testicular disease,3.60969273078922,1.0,0.0,0,2.5268
fentanyl,MONDO_0004880,bowel dysfunction,3.601391791580448,1.0,0.0,0,2.521
fentanyl,EFO_0005800,substance withdrawal syndrome,3.578055264055153,1.0,0.0,0,2.5046
fentanyl,EFO_0002618,pancreatic carcinoma,3.5544708807307006,1.0,0.0,0,2.4881
gemfibrozil,MONDO_0005148,type 2 diabetes mellitus,7.837992335340784,1.0,0.0,0,5.4866
gemfibrozil,EFO_0000400,diabetes mellitus,6.803715946129082,1.0,0.0,0,4.7626
gemfibrozil,HP_0003124,Hypercholesterolemia,6.423956816306698,1.0,0.0,0,4.4968
gemfibrozil,EFO_0000319,cardiovascular disease,6.2704419081008735,1.0,0.0,0,4.3893
gemfibrozil,EFO_0001645,coronary artery disease,6.071841149152083,1.0,0.0,0,4.2503
gemfibrozil,HP_0003119,Abnormal circulating lipid concentration,5.503534078363644,1.0,0.0,0,3.8525
gemfibrozil,MONDO_0021187,hyperlipidemia,4.86137110822923,1.0,0.0,0,3.403
gemfibrozil,EFO_0000537,hypertension,4.792973778444817,1.0,0.0,0,3.3551
gemfibrozil,Orphanet_309005,Disorder of lipid metabolism,4.592936956841971,1.0,0.0,0,3.2151
gemfibrozil,MONDO_0011448,PPARG-related familial partial lipodystrophy,4.591598549494713,1.0,0.0,0,3.2141
gemfibrozil,EFO_1001486,primary biliary cirrhosis,4.437461186046076,1.0,0.0,0,3.1062
gemfibrozil,Orphanet_79211,Combined hyperlipidemia,4.359780940524052,1.0,0.0,0,3.0518
gemfibrozil,EFO_0000729,ulcerative colitis,4.282324746257909,1.0,0.0,0,2.9976
gemfibrozil,EFO_0000612,myocardial infarction,4.2822343211435125,1.0,0.0,0,2.9976
gemfibrozil,EFO_0003770,diabetic retinopathy,4.180956798289074,1.0,0.0,0,2.9267
gemfibrozil,EFO_0004211,Hypertriglyceridemia,4.122533474358606,1.0,0.0,0,2.8858
gemfibrozil,EFO_0001073,obesity,4.113635364154506,1.0,0.0,0,2.8795
gemfibrozil,EFO_0003914,atherosclerosis,4.100104553534541,1.0,0.0,0,2.8701
gemfibrozil,EFO_0004705,hypothyroidism,4.0350371122340265,1.0,0.0,0,2.8245
gemfibrozil,EFO_0000589,metabolic disease,4.0142682782789105,1.0,0.0,0,2.81
gemfibrozil,EFO_1000727,lipodystrophy,3.852092884139857,1.0,0.0,0,2.6965
gemfibrozil,HP_0002027,Abdominal pain,3.71382920101241,1.0,0.0,0,2.5997
gemfibrozil,EFO_0000195,metabolic syndrome,3.63821133271639,1.0,0.0,0,2.5467
gemfibrozil,EFO_0001074,morbid obesity,3.5475227811069536,1.0,0.0,0,2.4833
gemfibrozil,MONDO_0004975,Alzheimer disease,3.472067524174794,1.0,0.0,0,2.4304
gemfibrozil,EFO_1001249,non-alcoholic steatohepatitis,3.420159042923246,1.0,0.0,0,2.3941
gemfibrozil,HP_0001397,Hepatic steatosis,3.254286511047467,1.0,0.0,0,2.278
gemfibrozil,MONDO_0018473,hyperlipoproteinemia type 3,3.24376271713937,1.0,0.0,0,2.2706
gemfibrozil,EFO_0009321,diabetic macular edema,3.197156002742531,1.0,0.0,0,2.238
gemfibrozil,EFO_1001375,Myocardial Ischemia,3.168624607999939,1.0,0.0,0,2.218
gemfibrozil,EFO_0000341,chronic obstructive pulmonary disease,3.073657286118092,1.0,0.0,0,2.1516
gemfibrozil,EFO_0004268,sclerosing cholangitis,3.0444839405389423,1.0,0.0,0,2.1311
gemfibrozil,EFO_0003095,non-alcoholic fatty liver disease,3.0067386780125336,1.0,0.0,0,2.1047
gemfibrozil,EFO_0000384,Crohn's disease,2.993107770956096,1.0,0.0,0,2.0952
gemfibrozil,MONDO_0005301,multiple sclerosis,2.9516808661785343,1.0,0.0,0,2.0662
gemfibrozil,MONDO_0002009,major depressive disorder,2.9479932319360547,1.0,0.0,0,2.0636
gemfibrozil,MONDO_0015515,carnitine palmitoyltransferase II deficiency,2.9452508932403907,1.0,0.0,0,2.0617
gemfibrozil,EFO_0000616,neoplasm,2.941449194334525,1.0,0.0,0,2.059
gemfibrozil,EFO_0005422,skin aging,2.902942752307782,1.0,0.0,0,2.0321
gemfibrozil,MONDO_0005180,Parkinson disease,2.8496558571521673,1.0,0.0,0,1.9948
gemfibrozil,MONDO_0004992,cancer,2.8006087437085863,1.0,0.0,0,1.9604
gemfibrozil,MONDO_0004979,asthma,2.727969072159747,1.0,0.0,0,1.9096
gemfibrozil,EFO_0003777,heart disease,2.7113919414723693,1.0,0.0,0,1.898
gemfibrozil,EFO_0000275,atrial fibrillation,2.709518033505665,1.0,0.0,0,1.8967
gemfibrozil,EFO_0003144,heart failure,2.6962248920364735,1.0,0.0,0,1.8874
gemfibrozil,EFO_0005628,proctitis,2.6710169099448007,1.0,0.0,0,1.8697
gemfibrozil,EFO_0000182,hepatocellular carcinoma,2.6667970962337613,1.0,0.0,0,1.8668
gemfibrozil,MONDO_0100096,COVID-19,2.6533927466597227,1.0,0.0,0,1.8574
gemfibrozil,EFO_1001950,colon carcinoma,2.6458590447168007,1.0,0.0,0,1.8521
gemfibrozil,EFO_0000373,congestive heart failure,2.6266739934880183,1.0,0.0,0,1.8387
heparin,MONDO_0013144,hereditary antithrombin deficiency,5.411753693562219,1.0,0.0,0,3.7882
heparin,HP_0001976,Reduced antithrombin III activity,5.036159410794256,1.0,0.0,0,3.5253
heparin,HP_0004936,Venous thrombosis,4.522718569467626,1.0,0.0,0,3.1659
heparin,EFO_0004286,venous thromboembolism,4.339286468358595,1.0,0.0,0,3.0375
heparin,EFO_0003907,deep vein thrombosis,4.292850240672918,1.0,0.0,0,3.005
heparin,EFO_0000612,myocardial infarction,4.0945712517385555,1.0,0.0,0,2.8662
heparin,EFO_0000275,atrial fibrillation,4.078640086493252,1.0,0.0,0,2.855
heparin,EFO_0003827,pulmonary embolism,3.8402593823434983,1.0,0.0,0,2.6882
heparin,EFO_0001645,coronary artery disease,3.7043457348590145,1.0,0.0,0,2.593
heparin,HP_0004419,Recurrent thrombophlebitis,3.4918721127150674,1.0,0.0,0,2.4443
heparin,HP_0001907,Thromboembolism,3.4916864634032017,1.0,0.0,0,2.4442
heparin,EFO_0000319,cardiovascular disease,3.3944244354103943,1.0,0.0,0,2.3761
heparin,EFO_0004911,familial hypercholesterolemia,2.9697614252457183,1.0,0.0,0,2.0788
heparin,EFO_1001375,Myocardial Ischemia,2.8262940562959193,1.0,0.0,0,1.9784
heparin,MONDO_0008692,abetalipoproteinemia,2.7831042787941653,1.0,0.0,0,1.9482
heparin,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",2.741653613949166,1.0,0.0,0,1.9192
heparin,HP_0003124,Hypercholesterolemia,2.6890141186019783,1.0,0.0,0,1.8823
heparin,MONDO_0100096,COVID-19,2.6383708731210636,1.0,0.0,0,1.8469
heparin,EFO_0003777,heart disease,2.6265296152047712,1.0,0.0,0,1.8386
heparin,EFO_0003913,angina pectoris,2.6196014650970807,1.0,0.0,0,1.8337
heparin,EFO_1000985,intermediate coronary syndrome,2.5427569386867344,1.0,0.0,0,1.7799
heparin,EFO_0000544,infection,2.49040379977033,1.0,0.0,0,1.7433
heparin,EFO_0005672,acute coronary syndrome,2.4645497828644016,1.0,0.0,0,1.7252
heparin,MONDO_0000831,thrombotic disease,2.394982460246459,1.0,0.0,0,1.6765
heparin,MONDO_0005575,colorectal cancer,2.3921009194653973,1.0,0.0,0,1.6745
heparin,MONDO_0016085,Cole-Carpenter syndrome,2.3722542311318855,1.0,0.0,0,1.6606
heparin,HP_0100806,Sepsis,2.372128678699053,1.0,0.0,0,1.6605
heparin,MONDO_0018660,hemophilia,2.36055031929459,1.0,0.0,0,1.6524
heparin,EFO_0004875,mathematical ability,2.344212270435009,1.0,0.0,0,1.6409
heparin,EFO_0000712,stroke,2.34244928375826,1.0,0.0,0,1.6397
heparin,EFO_0008583,acute myocardial infarction,2.340050452552444,1.0,0.0,0,1.638
heparin,MONDO_0005148,type 2 diabetes mellitus,2.331071324005502,1.0,0.0,0,1.6317
heparin,EFO_0003884,chronic kidney disease,2.330556218454592,1.0,0.0,0,1.6314
heparin,EFO_0009315,thrombophilia,2.3142550984180867,1.0,0.0,0,1.62
heparin,MONDO_0021187,hyperlipidemia,2.302216883540242,1.0,0.0,0,1.6116
heparin,EFO_0000589,metabolic disease,2.2742260954083156,1.0,0.0,0,1.592
heparin,MP_0001914,hemorrhage,2.2741175216091283,1.0,0.0,0,1.5919
heparin,EFO_0009314,blood coagulation disease,2.2549256815981487,1.0,0.0,0,1.5784
heparin,MONDO_0004992,cancer,2.2506352879252702,1.0,0.0,0,1.5754
heparin,MONDO_0008903,lung cancer,2.245552395256097,1.0,0.0,0,1.5719
heparin,Orphanet_309005,Disorder of lipid metabolism,2.2170512532759004,1.0,0.0,0,1.5519
heparin,MONDO_0018328,homozygous familial hypercholesterolemia,2.214682730684774,1.0,0.0,0,1.5503
heparin,MONDO_0010602,hemophilia A,2.171017376293748,1.0,0.0,0,1.5197
heparin,EFO_0003914,atherosclerosis,2.1564363580273382,1.0,0.0,0,1.5095
heparin,MONDO_0010604,hemophilia B,2.1562058494037,1.0,0.0,0,1.5093
heparin,MONDO_0024327,chronic renal failure syndrome,2.1419518953253123,1.0,0.0,0,1.4994
heparin,HP_0000083,Renal insufficiency,2.1143642089446355,1.0,0.0,0,1.4801
heparin,EFO_0002950,pregnancy,2.1125204952368732,1.0,0.0,0,1.4788
heparin,EFO_1000954,habitual abortion,2.1125204952368732,1.0,0.0,0,1.4788
heparin,EFO_0000546,injury,2.073920559989772,1.0,0.0,0,1.4517
jardiance,MONDO_0009297,familial renal glucosuria,2.3140916382472043,0.0,0.0,0,2.3141
jardiance,MONDO_0005148,type 2 diabetes mellitus,2.022101849765444,0.0,0.0,0,2.0221
jardiance,EFO_0000400,diabetes mellitus,2.0068965622288326,0.0,0.0,0,2.0069
jardiance,EFO_0003144,heart failure,1.985098971500723,0.0,0.0,0,1.9851
jardiance,Orphanet_69076,Renal glucosuria,1.9824489793541893,0.0,0.0,0,1.9824
jardiance,EFO_0003884,chronic kidney disease,1.911341490139564,0.0,0.0,0,1.9113
jardiance,Orphanet_79161,Disorder of carbohydrate metabolism,1.814580585462054,0.0,0.0,0,1.8146
jardiance,MONDO_0005147,type 1 diabetes mellitus,1.7724402484276884,0.0,0.0,0,1.7724
jardiance,MONDO_0037792,carbohydrate metabolism disease,1.6543456943153243,0.0,0.0,0,1.6543
jardiance,HP_0003076,Glycosuria,1.2681771465222074,0.0,0.0,0,1.2682
jardiance,EFO_0000401,diabetic nephropathy,1.229615275206217,0.0,0.0,0,1.2296
jardiance,EFO_0004252,nasopharyngeal neoplasm,1.1772560035375763,0.0,0.0,0,1.1773
jardiance,EFO_1000647,renal tubular transport disease,1.1772560035375763,0.0,0.0,0,1.1773
jardiance,HP_0000855,Insulin resistance,1.1539204013135362,0.0,0.0,0,1.1539
jardiance,EFO_0000275,atrial fibrillation,1.1489732111582296,0.0,0.0,0,1.149
jardiance,EFO_0000612,myocardial infarction,1.1288817068864183,0.0,0.0,0,1.1289
jardiance,EFO_0000660,polycystic ovary syndrome,1.1281259600451865,0.0,0.0,0,1.1281
jardiance,HP_0012664,Reduced left ventricular ejection fraction,1.0594875641459125,0.0,0.0,0,1.0595
jardiance,EFO_0008585,ST Elevation Myocardial Infarction,1.057936202345695,0.0,0.0,0,1.0579
jardiance,EFO_0004593,gestational diabetes,1.0364671678015611,0.0,0.0,0,1.0365
jardiance,EFO_0000407,dilated cardiomyopathy,1.0300990030953796,0.0,0.0,0,1.0301
jardiance,EFO_0003095,non-alcoholic fatty liver disease,0.9951077690069184,0.0,0.0,0,0.9951
jardiance,EFO_1001249,non-alcoholic steatohepatitis,0.9719916296912632,0.0,0.0,0,0.972
jardiance,HP_0001943,Hypoglycemia,0.9466830333911628,0.0,0.0,0,0.9467
jardiance,HP_0001919,Acute kidney injury,0.9413066161549296,0.0,0.0,0,0.9413
jardiance,MONDO_0100096,COVID-19,0.9341420742803124,0.0,0.0,0,0.9341
jardiance,EFO_0000195,metabolic syndrome,0.9298855363464574,0.0,0.0,0,0.9299
jardiance,EFO_0008583,acute myocardial infarction,0.9048916753783904,0.0,0.0,0,0.9049
jardiance,EFO_0001645,coronary artery disease,0.8903189143857508,0.0,0.0,0,0.8903
jardiance,MONDO_0024327,chronic renal failure syndrome,0.8829420026531822,0.0,0.0,0,0.8829
jardiance,EFO_0000538,hypertrophic cardiomyopathy,0.8499966388226707,0.0,0.0,0,0.85
jardiance,HP_0001397,Hepatic steatosis,0.8494899532315877,0.0,0.0,0,0.8495
jardiance,EFO_0003770,diabetic retinopathy,0.846531548326213,0.0,0.0,0,0.8465
jardiance,EFO_0004194,IGA glomerulonephritis,0.8461375117486516,0.0,0.0,0,0.8461
jardiance,EFO_1002048,kidney failure,0.8424332649106879,0.0,0.0,0,0.8424
jardiance,HP_0001653,Mitral regurgitation,0.8274638134864739,0.0,0.0,0,0.8275
jardiance,EFO_0000694,severe acute respiratory syndrome,0.8258450864816099,0.0,0.0,0,0.8258
jardiance,HP_0031273,Shock,0.825256458479841,0.0,0.0,0,0.8253
jardiance,EFO_1001482,cardiotoxicity,0.8240792024763034,0.0,0.0,0,0.8241
jardiance,EFO_0000508,genetic disorder,0.6194352281385914,0.0,0.0,0,0.6194
jardiance,MONDO_0008315,prostate cancer,0.4476029205335426,0.0,0.0,0,0.4476
jardiance,EFO_0001073,obesity,0.3882727245773457,0.0,0.0,0,0.3883
jardiance,MONDO_0007254,breast cancer,0.3749525064397286,0.0,0.0,0,0.375
jardiance,EFO_0003086,kidney disease,0.3686870643489662,0.0,0.0,0,0.3687
jardiance,Orphanet_1331,Familial prostate cancer,0.3531768010612728,0.0,0.0,0,0.3532
jardiance,MONDO_0009067,cystinuria,0.3312138367556458,0.0,0.0,0,0.3312
jardiance,MONDO_0004975,Alzheimer disease,0.3295138578215085,0.0,0.0,0,0.3295
jardiance,EFO_0004253,nephrolithiasis,0.3281882573797608,0.0,0.0,0,0.3282
jardiance,MONDO_0002492,acute kidney injury,0.3251551417687456,0.0,0.0,0,0.3252
jardiance,EFO_0001422,cirrhosis of liver,0.3231905794556913,0.0,0.0,0,0.3232
lomitapide,MONDO_0008692,abetalipoproteinemia,13.915521393970828,1.0,0.0,0,9.7409
lomitapide,MONDO_0016085,Cole-Carpenter syndrome,11.861271155659429,1.0,0.0,0,8.3029
lomitapide,EFO_0004911,familial hypercholesterolemia,9.683703212499037,1.0,0.0,0,6.7786
lomitapide,HP_0003124,Hypercholesterolemia,7.9134575329535775,1.0,0.0,0,5.5394
lomitapide,EFO_0000508,genetic disorder,7.036806789546288,1.0,0.0,0,4.9258
lomitapide,MONDO_0018328,homozygous familial hypercholesterolemia,6.903441521175042,1.0,0.0,0,4.8324
lomitapide,EFO_0000319,cardiovascular disease,6.181989207976521,1.0,0.0,0,4.3274
lomitapide,MONDO_0008146,osteogenesis imperfecta type 1,5.8862800176878824,1.0,0.0,0,4.1204
lomitapide,MONDO_0011565,metabolic syndrome X,5.754737009002353,1.0,0.0,0,4.0283
lomitapide,EFO_0001421,liver disease,5.6337833788116995,1.0,0.0,0,3.9436
lomitapide,HP_0001392,Abnormality of the liver,4.195993161030923,1.0,0.0,0,2.9372
lomitapide,MONDO_0021187,hyperlipidemia,3.664055896461697,1.0,0.0,0,2.5648
lomitapide,EFO_0001645,coronary artery disease,3.401208935567048,1.0,0.0,0,2.3808
lomitapide,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",3.1875040076089163,1.0,0.0,0,2.2313
lomitapide,EFO_0003907,deep vein thrombosis,3.179975925824228,1.0,0.0,0,2.226
lomitapide,HP_0004936,Venous thrombosis,2.78084878051433,1.0,0.0,0,1.9466
lomitapide,EFO_0001422,cirrhosis of liver,2.734359169529843,1.0,0.0,0,1.9141
lomitapide,MONDO_0013144,hereditary antithrombin deficiency,2.7058768467811096,1.0,0.0,0,1.8941
lomitapide,EFO_0000275,atrial fibrillation,2.6969125269955425,1.0,0.0,0,1.8878
lomitapide,MONDO_0004992,cancer,2.6359583021301187,1.0,0.0,0,1.8452
lomitapide,EFO_0004286,venous thromboembolism,2.6251027994013048,1.0,0.0,0,1.8376
lomitapide,HP_0001976,Reduced antithrombin III activity,2.518079705397128,1.0,0.0,0,1.7627
lomitapide,EFO_0003914,atherosclerosis,2.498371177918856,1.0,0.0,0,1.7489
lomitapide,MONDO_0007254,breast cancer,2.4590707159719414,1.0,0.0,0,1.7213
lomitapide,EFO_0000195,metabolic syndrome,2.434712281161295,1.0,0.0,0,1.7043
lomitapide,MONDO_0008903,lung cancer,2.434402916414204,1.0,0.0,0,1.7041
lomitapide,EFO_1001375,Myocardial Ischemia,2.3413585910851,1.0,0.0,0,1.639
lomitapide,MONDO_0005148,type 2 diabetes mellitus,2.30046085190068,1.0,0.0,0,1.6103
lomitapide,EFO_0000589,metabolic disease,2.2742260954083156,1.0,0.0,0,1.592
lomitapide,Orphanet_309005,Disorder of lipid metabolism,2.2170512532759004,1.0,0.0,0,1.5519
lomitapide,EFO_0000612,myocardial infarction,2.1956920351852913,1.0,0.0,0,1.537
lomitapide,MONDO_0001336,familial hyperlipidemia,2.1212291806149586,1.0,0.0,0,1.4849
lomitapide,EFO_0003060,non-small cell lung carcinoma,2.042382270885487,1.0,0.0,0,1.4297
lomitapide,EFO_0000400,diabetes mellitus,2.009286256286109,1.0,0.0,0,1.4065
lomitapide,EFO_0000544,infection,1.978167379837561,1.0,0.0,0,1.3847
lomitapide,MONDO_0019019,osteogenesis imperfecta,1.9763046095693773,1.0,0.0,0,1.3834
lomitapide,EFO_0000339,chronic myelogenous leukemia,1.9242873677268872,1.0,0.0,0,1.347
lomitapide,MONDO_0009387,familial lipoprotein lipase deficiency,1.9209670214784835,1.0,0.0,0,1.3447
lomitapide,EFO_0003827,pulmonary embolism,1.9201296911717491,1.0,0.0,0,1.3441
lomitapide,HP_0003077,Hyperlipidemia,1.9118595304069816,1.0,0.0,0,1.3383
lomitapide,EFO_0003777,heart disease,1.9060263769663728,1.0,0.0,0,1.3342
lomitapide,EFO_0003884,chronic kidney disease,1.8521376664953155,1.0,0.0,0,1.2965
lomitapide,EFO_0000182,hepatocellular carcinoma,1.8163603676678937,1.0,0.0,0,1.2715
lomitapide,EFO_0005543,glioma,1.804673680283681,1.0,0.0,0,1.2633
lomitapide,MONDO_0007750,"hypercholesterolemia, familial, 1",1.7836214902334102,1.0,0.0,0,1.2485
lomitapide,EFO_0003913,angina pectoris,1.780189430645692,1.0,0.0,0,1.2461
lomitapide,HP_0100806,Sepsis,1.7695852740294913,1.0,0.0,0,1.2387
lomitapide,MONDO_0021661,coronary atherosclerosis,1.763336321760802,1.0,0.0,0,1.2343
lomitapide,EFO_0000220,acute lymphoblastic leukemia,1.7490124059842422,1.0,0.0,0,1.2243
lomitapide,HP_0004419,Recurrent thrombophlebitis,1.7459360563575337,1.0,0.0,0,1.2222
metoprolol,EFO_0000537,hypertension,1.744427605531155,1.0,0.0,0,1.2211
metoprolol,EFO_0000319,cardiovascular disease,1.6969473135783075,1.0,0.0,0,1.1879
metoprolol,EFO_0000712,stroke,1.4546209952027782,1.0,0.0,0,1.0182
metoprolol,EFO_0003913,angina pectoris,1.4228032756528322,1.0,0.0,0,0.996
metoprolol,MONDO_0004979,asthma,1.414901379019638,1.0,0.0,0,0.9904
metoprolol,EFO_0000612,myocardial infarction,1.3766000614618483,1.0,0.0,0,0.9636
metoprolol,EFO_0003144,heart failure,1.3493245953774002,1.0,0.0,0,0.9445
metoprolol,MONDO_0005041,glaucoma,1.3310610788556705,1.0,0.0,0,0.9317
metoprolol,MONDO_0005277,migraine disorder,1.3233297352861153,1.0,0.0,0,0.9263
metoprolol,EFO_0001645,coronary artery disease,1.3014675617462002,1.0,0.0,0,0.911
metoprolol,MONDO_0001134,essential hypertension,1.2977909698563912,1.0,0.0,0,0.9085
metoprolol,EFO_0004190,open-angle glaucoma,1.292528560885883,1.0,0.0,0,0.9048
metoprolol,HP_0012531,Pain,1.287155465291934,1.0,0.0,0,0.901
metoprolol,EFO_0000373,congestive heart failure,1.2743866020227976,1.0,0.0,0,0.8921
metoprolol,HP_0100806,Sepsis,1.2696598295568553,1.0,0.0,0,0.8888
metoprolol,HP_0006536,Airway obstruction,1.2498070058370807,1.0,0.0,0,0.8749
metoprolol,HP_0004308,Ventricular arrhythmia,1.226512204235,1.0,0.0,0,0.8586
metoprolol,EFO_1001069,ocular hypertension,1.2105772449750505,1.0,0.0,0,0.8474
metoprolol,EFO_0000275,atrial fibrillation,1.2091584877237636,1.0,0.0,0,0.8464
metoprolol,EFO_0006834,septic shock,1.208275851425742,1.0,0.0,0,0.8458
metoprolol,EFO_0007486,sinusitis,1.1996115709452,1.0,0.0,0,0.8397
metoprolol,EFO_0004278,sudden cardiac arrest,1.1857381005850631,1.0,0.0,0,0.83
metoprolol,MONDO_0005271,allergic disease,1.175789089747041,1.0,0.0,0,0.8231
metoprolol,EFO_0005251,hypotension,1.158852639401009,1.0,0.0,0,0.8112
metoprolol,EFO_0005531,urticaria,1.1383128268604843,1.0,0.0,0,0.7968
metoprolol,MP_0001914,hemorrhage,1.1259933666840871,1.0,0.0,0,0.7882
metoprolol,EFO_0004269,cardiac arrhythmia,1.1193095523820762,1.0,0.0,0,0.7835
metoprolol,MONDO_0005148,type 2 diabetes mellitus,1.1107552613732945,1.0,0.0,0,0.7775
metoprolol,HP_0001742,Nasal congestion,1.0871203366741324,1.0,0.0,0,0.761
metoprolol,EFO_0000400,diabetes mellitus,1.078578704060288,1.0,0.0,0,0.755
metoprolol,MONDO_0021661,coronary atherosclerosis,1.0739203502986738,1.0,0.0,0,0.7517
metoprolol,EFO_0003956,seasonal allergic rhinitis,1.0701641953029886,1.0,0.0,0,0.7491
metoprolol,EFO_0009492,cardiac arrest,1.055418766332203,1.0,0.0,0,0.7388
metoprolol,EFO_1000635,hemangioma,1.043471756362372,1.0,0.0,0,0.7304
metoprolol,EFO_0004329,alcohol drinking,1.0293192925434016,1.0,0.0,0,0.7205
metoprolol,EFO_0005252,orthostatic hypotension,1.0087670788778094,1.0,0.0,0,0.7061
metoprolol,EFO_0001073,obesity,0.9907953948481982,1.0,0.0,0,0.6936
metoprolol,MONDO_0019200,retinitis pigmentosa,0.9819599048130446,1.0,0.0,0,0.6874
metoprolol,EFO_0000341,chronic obstructive pulmonary disease,0.9658439828351147,1.0,0.0,0,0.6761
metoprolol,HP_0032263,Increased blood pressure,0.9559863250133662,1.0,0.0,0,0.6692
metoprolol,MONDO_0005180,Parkinson disease,0.9448988807951266,1.0,0.0,0,0.6614
metoprolol,EFO_0003777,heart disease,0.9427297695789414,1.0,0.0,0,0.6599
metoprolol,EFO_1002048,kidney failure,0.9284573002531024,1.0,0.0,0,0.6499
metoprolol,MONDO_0018852,achromatopsia,0.9026471886104168,1.0,0.0,0,0.6319
metoprolol,EFO_0001361,pulmonary arterial hypertension,0.8753235005864658,1.0,0.0,0,0.6127
metoprolol,Orphanet_1872,Cone rod dystrophy,0.841444054325368,1.0,0.0,0,0.589
metoprolol,EFO_1001375,Myocardial Ischemia,0.8412509128802588,1.0,0.0,0,0.5889
metoprolol,EFO_0003884,chronic kidney disease,0.837739806539916,1.0,0.0,0,0.5864
metoprolol,GO_0009410,response to xenobiotic stimulus,0.8357878754955463,1.0,0.0,0,0.5851
metoprolol,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,0.8090891705934107,1.0,0.0,0,0.5664
midazolam,MONDO_0016532,Lennox-Gastaut syndrome,15.22971294397271,1.0,0.0,0,10.6608
midazolam,EFO_0000474,epilepsy,15.200160259086031,1.0,0.0,0,10.6401
midazolam,MONDO_0100062,genetic developmental and epileptic encephalopathy,14.898953004772611,1.0,0.0,0,10.4293
midazolam,Orphanet_36387,Generalized epilepsy with febrile seizures-plus,14.520311055058633,1.0,0.0,0,10.1642
midazolam,HP_0001250,Seizure,14.508642989695836,1.0,0.0,0,10.1561
midazolam,MONDO_0007079,alcohol dependence,14.177366349747835,1.0,0.0,0,9.9242
midazolam,MONDO_0010826,childhood absence epilepsy,14.02095453473994,1.0,0.0,0,9.8147
midazolam,MONDO_0014921,"developmental and epileptic encephalopathy, 43",13.279716325996247,1.0,0.0,0,9.2958
midazolam,MONDO_0009696,juvenile myoclonic epilepsy,12.922926199698209,1.0,0.0,0,9.046
midazolam,MONDO_0005277,migraine disorder,12.567036549844124,1.0,0.0,0,8.7969
midazolam,EFO_0004698,insomnia,12.56391533905132,1.0,0.0,0,8.7947
midazolam,EFO_0004262,panic disorder,12.444180528313172,1.0,0.0,0,8.7109
midazolam,HP_0000739,Anxiety,12.340202787806628,1.0,0.0,0,8.6381
midazolam,MONDO_0014328,"developmental and epileptic encephalopathy, 19",12.31338650257852,1.0,0.0,0,8.6194
midazolam,EFO_0006788,anxiety disorder,12.029596652611092,1.0,0.0,0,8.4207
midazolam,MONDO_0002009,major depressive disorder,11.995864129513857,1.0,0.0,0,8.3971
midazolam,HP_0000713,Agitation,11.937043104062308,1.0,0.0,0,8.3559
midazolam,HP_0012531,Pain,11.882349968722943,1.0,0.0,0,8.3176
midazolam,HP_0001249,Intellectual disability,11.723328626181912,1.0,0.0,0,8.2063
midazolam,EFO_0007453,postpartum depression,11.441910656815812,1.0,0.0,0,8.0093
midazolam,EFO_1001892,generalized anxiety disorder,11.42009906686586,1.0,0.0,0,7.9941
midazolam,EFO_0008526,status epilepticus,11.268619982650163,1.0,0.0,0,7.888
midazolam,MONDO_0014942,"developmental and epileptic encephalopathy, 45",10.910061226530852,1.0,0.0,0,7.637
midazolam,MONDO_0002050,depressive disorder,10.813238755970067,1.0,0.0,0,7.5693
midazolam,EFO_0005917,generalised epilepsy,10.332999869911855,1.0,0.0,0,7.2331
midazolam,EFO_0000508,genetic disorder,10.25613822674406,1.0,0.0,0,7.1793
midazolam,MONDO_0005180,Parkinson disease,9.991453937447304,1.0,0.0,0,6.994
midazolam,HP_0200134,Epileptic encephalopathy,9.9728077635453,1.0,0.0,0,6.981
midazolam,EFO_0007498,Stiff-Person syndrome,9.958187599007694,1.0,0.0,0,6.9707
midazolam,MONDO_0005090,schizophrenia,9.909526163783053,1.0,0.0,0,6.9367
midazolam,MONDO_0004975,Alzheimer disease,9.863092041442052,1.0,0.0,0,6.9042
midazolam,MONDO_0005301,multiple sclerosis,9.80547481419865,1.0,0.0,0,6.8638
midazolam,EFO_1001454,amnesia,9.680749437463,1.0,0.0,0,6.7765
midazolam,Orphanet_1945,Rolandic epilepsy,9.646466837720313,1.0,0.0,0,6.7525
midazolam,EFO_0001073,obesity,9.627949549078208,1.0,0.0,0,6.7396
midazolam,MONDO_0007295,self-limited epilepsy with centrotemporal spikes,9.27409607548156,1.0,0.0,0,6.4919
midazolam,HP_0007359,Focal-onset seizure,8.961694883549978,1.0,0.0,0,6.2732
midazolam,EFO_0005772,neurodegenerative disease,8.899102825318057,1.0,0.0,0,6.2294
midazolam,MONDO_0018097,infantile spasms,8.779980860317327,1.0,0.0,0,6.146
midazolam,EFO_1000632,cerebral palsy,8.743774477177485,1.0,0.0,0,6.1206
midazolam,EFO_0004263,partial epilepsy,8.656119612440346,1.0,0.0,0,6.0593
midazolam,MONDO_0004985,bipolar disorder,8.60326258521306,1.0,0.0,0,6.0223
midazolam,HP_0000726,Dementia,8.385331639093557,1.0,0.0,0,5.8697
midazolam,MONDO_0002561,lysosomal storage disease,8.211376781031438,1.0,0.0,0,5.748
midazolam,MONDO_0018214,generalized epilepsy with febrile seizures plus,8.092763508322138,1.0,0.0,0,5.6649
midazolam,EFO_0008579,risk-taking behaviour,7.877887376858739,1.0,0.0,0,5.5145
midazolam,EFO_1000637,acute respiratory distress syndrome,7.865055175337393,1.0,0.0,0,5.5055
midazolam,HP_0002315,Headache,7.826445559952045,1.0,0.0,0,5.4785
midazolam,EFO_0008568,Sleep Disorder,7.815889215444841,1.0,0.0,0,5.4711
midazolam,MONDO_0004992,cancer,7.737897750690614,1.0,0.0,0,5.4165
mln1202,MONDO_0009060,cystic disease of lung,3.9526043303217593,0.0,0.0,0,3.9526
mln1202,MONDO_0100096,COVID-19,2.8048568550438784,0.0,0.0,0,2.8049
mln1202,EFO_0000180,HIV-1 infection,2.5773044386259927,0.0,0.0,0,2.5773
mln1202,EFO_0000685,rheumatoid arthritis,2.529982721267432,0.0,0.0,0,2.53
mln1202,HP_0012531,Pain,2.498224997334896,0.0,0.0,0,2.4982
mln1202,EFO_0000612,myocardial infarction,2.236499892658078,0.0,0.0,0,2.2365
mln1202,EFO_0001645,coronary artery disease,2.099465733535465,0.0,0.0,0,2.0995
mln1202,MONDO_0004992,cancer,2.0409540890399693,0.0,0.0,0,2.041
mln1202,EFO_0000712,stroke,1.9904015137601443,0.0,0.0,0,1.9904
mln1202,EFO_0001060,celiac disease,1.97037244314478,0.0,0.0,0,1.9704
mln1202,EFO_0004329,alcohol drinking,1.9631151700916347,0.0,0.0,0,1.9631
mln1202,EFO_0000616,neoplasm,1.9023176720276591,0.0,0.0,0,1.9023
mln1202,HP_0002014,Diarrhea,1.88399927157864,0.0,0.0,0,1.884
mln1202,MONDO_0005277,migraine disorder,1.859491161032664,0.0,0.0,0,1.8595
mln1202,EFO_0007328,influenza,1.8594006635186715,0.0,0.0,0,1.8594
mln1202,MONDO_0005148,type 2 diabetes mellitus,1.8373328492695744,0.0,0.0,0,1.8373
mln1202,EFO_0008583,acute myocardial infarction,1.8014796592398277,0.0,0.0,0,1.8015
mln1202,MP_0001914,hemorrhage,1.8004456546218153,0.0,0.0,0,1.8004
mln1202,MONDO_0005178,osteoarthritis,1.778601172387413,0.0,0.0,0,1.7786
mln1202,EFO_0000729,ulcerative colitis,1.7544759926653737,0.0,0.0,0,1.7545
mln1202,MONDO_0000831,thrombotic disease,1.74453935289923,0.0,0.0,0,1.7445
mln1202,EFO_0000319,cardiovascular disease,1.7240827622002888,0.0,0.0,0,1.7241
mln1202,HP_0002018,Nausea,1.715699540035712,0.0,0.0,0,1.7157
mln1202,EFO_0004616,"osteoarthritis, knee",1.7063990393037252,0.0,0.0,0,1.7064
mln1202,HP_0004419,Recurrent thrombophlebitis,1.6576976935959404,0.0,0.0,0,1.6577
mln1202,HP_0012532,Chronic pain,1.653990331421101,0.0,0.0,0,1.654
mln1202,HP_0003418,Back pain,1.6456449994630873,0.0,0.0,0,1.6456
mln1202,HP_0002140,Ischemic stroke,1.6207630711832273,0.0,0.0,0,1.6208
mln1202,EFO_0005672,acute coronary syndrome,1.6204253397741806,0.0,0.0,0,1.6204
mln1202,EFO_0010072,toothache,1.6158338062184927,0.0,0.0,0,1.6158
mln1202,EFO_0000764,HIV infection,1.5610046047367323,0.0,0.0,0,1.561
mln1202,HP_0000155,Oral ulcer,1.5583973936072413,0.0,0.0,0,1.5584
mln1202,EFO_0000555,irritable bowel syndrome,1.5560301777016288,0.0,0.0,0,1.556
mln1202,EFO_0004265,peripheral arterial disease,1.5509982085558716,0.0,0.0,0,1.551
mln1202,MONDO_0007254,breast cancer,1.5238647193133297,0.0,0.0,0,1.5239
mln1202,EFO_0003914,atherosclerosis,1.5139557538986987,0.0,0.0,0,1.514
mln1202,EFO_0001073,obesity,1.5008347209464603,0.0,0.0,0,1.5008
mln1202,MONDO_0008315,prostate cancer,1.4924096635710962,0.0,0.0,0,1.4924
mln1202,EFO_0000341,chronic obstructive pulmonary disease,1.4730961405923089,0.0,0.0,0,1.4731
mln1202,EFO_0005762,neuropathic pain,1.436437165203722,0.0,0.0,0,1.4364
mln1202,EFO_0004253,nephrolithiasis,1.4307344798926596,0.0,0.0,0,1.4307
mln1202,MONDO_0005301,multiple sclerosis,1.3924158650970462,0.0,0.0,0,1.3924
mln1202,HP_0003419,Low back pain,1.3741466644144025,0.0,0.0,0,1.3741
mln1202,EFO_0000275,atrial fibrillation,1.3537839511242606,0.0,0.0,0,1.3538
mln1202,EFO_0000546,injury,1.3489219630617608,0.0,0.0,0,1.3489
mln1202,EFO_0003060,non-small cell lung carcinoma,1.3459128072650774,0.0,0.0,0,1.3459
mln1202,HP_0001643,Patent ductus arteriosus,1.327640076782589,0.0,0.0,0,1.3276
mln1202,EFO_1000786,"osteoarthritis, hip",1.3017988940666665,0.0,0.0,0,1.3018
mln1202,EFO_0003918,obstructive sleep apnea,1.296813420703325,0.0,0.0,0,1.2968
mln1202,EFO_0000544,infection,1.2789244581891317,0.0,0.0,0,1.2789
montelukast sodium,MONDO_0004979,asthma,3.988642863859339,1.0,0.0,0,2.7921
montelukast sodium,EFO_0005854,allergic rhinitis,3.90366354999091,1.0,0.0,0,2.7326
montelukast sodium,EFO_0003956,seasonal allergic rhinitis,3.843928732175375,1.0,0.0,0,2.6908
montelukast sodium,HP_0006536,Airway obstruction,3.486499369549252,1.0,0.0,0,2.4405
montelukast sodium,EFO_1001417,"Rhinitis, Allergic, Perennial",3.4212056040308068,1.0,0.0,0,2.3948
montelukast sodium,EFO_0005772,neurodegenerative disease,2.9580818756543463,1.0,0.0,0,2.0707
montelukast sodium,EFO_0001378,multiple myeloma,2.835099432314964,1.0,0.0,0,1.9846
montelukast sodium,EFO_0000341,chronic obstructive pulmonary disease,2.8177670002878585,1.0,0.0,0,1.9724
montelukast sodium,MONDO_0005301,multiple sclerosis,2.802104658802175,1.0,0.0,0,1.9615
montelukast sodium,MONDO_0100096,COVID-19,2.716904693891192,1.0,0.0,0,1.9018
montelukast sodium,EFO_0000685,rheumatoid arthritis,2.5111067449056126,1.0,0.0,0,1.7578
montelukast sodium,MONDO_0004975,Alzheimer disease,2.3987557614204347,1.0,0.0,0,1.6791
montelukast sodium,EFO_0000401,diabetic nephropathy,2.279339804933725,1.0,0.0,0,1.5955
montelukast sodium,MONDO_0005180,Parkinson disease,2.2560132827410726,1.0,0.0,0,1.5792
montelukast sodium,HP_0012531,Pain,2.214068220850706,1.0,0.0,0,1.5498
montelukast sodium,HP_0011950,Bronchiolitis,2.1856411736788184,1.0,0.0,0,1.5299
montelukast sodium,EFO_0003894,acne,2.1173894297161433,1.0,0.0,0,1.4822
montelukast sodium,EFO_0003918,obstructive sleep apnea,2.108775127066618,1.0,0.0,0,1.4761
montelukast sodium,MONDO_0007254,breast cancer,2.063358244860647,1.0,0.0,0,1.4444
montelukast sodium,MONDO_0002561,lysosomal storage disease,2.050994234630195,1.0,0.0,0,1.4357
montelukast sodium,EFO_0000694,severe acute respiratory syndrome,2.0345392130577102,1.0,0.0,0,1.4242
montelukast sodium,EFO_0004232,eosinophilic esophagitis,1.9885612835067057,1.0,0.0,0,1.392
montelukast sodium,EFO_0007486,sinusitis,1.9215046885527272,1.0,0.0,0,1.3451
montelukast sodium,MONDO_0008315,prostate cancer,1.8443429280854315,1.0,0.0,0,1.291
montelukast sodium,EFO_0000616,neoplasm,1.8363227837688556,1.0,0.0,0,1.2854
montelukast sodium,EFO_0000612,myocardial infarction,1.7169390434702314,1.0,0.0,0,1.2019
montelukast sodium,EFO_0003144,heart failure,1.7019819254411073,1.0,0.0,0,1.1914
montelukast sodium,EFO_0003086,kidney disease,1.6887452327406154,1.0,0.0,0,1.1821
montelukast sodium,EFO_0000275,atrial fibrillation,1.6856910490746937,1.0,0.0,0,1.18
montelukast sodium,EFO_0003060,non-small cell lung carcinoma,1.6508123742537522,1.0,0.0,0,1.1556
montelukast sodium,HP_0030828,Wheezing,1.6481584049526068,1.0,0.0,0,1.1537
montelukast sodium,EFO_0004194,IGA glomerulonephritis,1.643646319989182,1.0,0.0,0,1.1506
montelukast sodium,EFO_0003884,chronic kidney disease,1.5617292697456873,1.0,0.0,0,1.0932
montelukast sodium,MONDO_0004992,cancer,1.554324986847149,1.0,0.0,0,1.088
montelukast sodium,MONDO_0008170,ovarian cancer,1.540561228169896,1.0,0.0,0,1.0784
montelukast sodium,EFO_0000676,psoriasis,1.485473428748475,1.0,0.0,0,1.0398
montelukast sodium,EFO_0000319,cardiovascular disease,1.4811341542095238,1.0,0.0,0,1.0368
montelukast sodium,MONDO_0005271,allergic disease,1.4226672487742336,1.0,0.0,0,0.9959
montelukast sodium,HP_0100806,Sepsis,1.4142281138973076,1.0,0.0,0,0.99
montelukast sodium,MONDO_0004976,amyotrophic lateral sclerosis,1.3863595761907148,1.0,0.0,0,0.9705
montelukast sodium,EFO_0004220,chronic hepatitis C virus infection,1.3818873365041773,1.0,0.0,0,0.9673
montelukast sodium,EFO_0000508,genetic disorder,1.3486010447145318,1.0,0.0,0,0.944
montelukast sodium,EFO_0003893,ovarian neoplasm,1.347473189647849,1.0,0.0,0,0.9432
montelukast sodium,EFO_0006834,septic shock,1.336310102482496,1.0,0.0,0,0.9354
montelukast sodium,MONDO_0012703,lissencephaly due to TUBA1A mutation,1.31364144494075,1.0,0.0,0,0.9195
montelukast sodium,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,1.312919255867715,1.0,0.0,0,0.919
montelukast sodium,EFO_0001645,coronary artery disease,1.3098364751150269,1.0,0.0,0,0.9169
montelukast sodium,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,1.297733536121243,1.0,0.0,0,0.9084
montelukast sodium,EFO_0000565,leukemia,1.2884672760732805,1.0,0.0,0,0.9019
montelukast sodium,MONDO_0014421,glucocorticoid resistance,1.2868789558114788,1.0,0.0,0,0.9008
mycophenolate mofetil,MONDO_0019200,retinitis pigmentosa,9.743822880188487,1.0,0.0,0,6.8207
mycophenolate mofetil,MONDO_0018998,Leber congenital amaurosis,8.611756382606888,1.0,0.0,0,6.0282
mycophenolate mofetil,EFO_0000616,neoplasm,8.210619271341015,1.0,0.0,0,5.7474
mycophenolate mofetil,EFO_0004220,chronic hepatitis C virus infection,7.824095106446953,1.0,0.0,0,5.4769
mycophenolate mofetil,EFO_0001422,cirrhosis of liver,7.736025065006619,1.0,0.0,0,5.4152
mycophenolate mofetil,EFO_0000574,lymphoma,7.482028207203293,1.0,0.0,0,5.2374
mycophenolate mofetil,EFO_0000565,leukemia,7.194702315715043,1.0,0.0,0,5.0363
mycophenolate mofetil,EFO_0000183,Hodgkins lymphoma,7.015458649781956,1.0,0.0,0,4.9108
mycophenolate mofetil,EFO_0000763,viral disease,6.995044246489466,1.0,0.0,0,4.8965
mycophenolate mofetil,EFO_0001378,multiple myeloma,6.8193232298783855,1.0,0.0,0,4.7735
mycophenolate mofetil,EFO_0000403,diffuse large B-cell lymphoma,6.612411530999507,1.0,0.0,0,4.6287
mycophenolate mofetil,MONDO_0005301,multiple sclerosis,6.608971186333205,1.0,0.0,0,4.6263
mycophenolate mofetil,EFO_0005952,non-Hodgkins lymphoma,6.436154934822608,1.0,0.0,0,4.5053
mycophenolate mofetil,MONDO_0004992,cancer,6.300846698602507,1.0,0.0,0,4.4106
mycophenolate mofetil,EFO_0000220,acute lymphoblastic leukemia,6.209249025025686,1.0,0.0,0,4.3465
mycophenolate mofetil,EFO_0006890,fibrosis,6.119512610803119,1.0,0.0,0,4.2837
mycophenolate mofetil,EFO_0004255,nephrotic syndrome,6.080823293795623,1.0,0.0,0,4.2566
mycophenolate mofetil,EFO_0000544,infection,6.046336109530092,1.0,0.0,0,4.2324
mycophenolate mofetil,EFO_0000222,acute myeloid leukemia,6.023566883056079,1.0,0.0,0,4.2165
mycophenolate mofetil,MONDO_0004976,amyotrophic lateral sclerosis,5.96752441644211,1.0,0.0,0,4.1773
mycophenolate mofetil,MONDO_0008379,retinitis pigmentosa 10,5.951885630732752,1.0,0.0,0,4.1663
mycophenolate mofetil,EFO_0007160,autoimmune thrombocytopenic purpura,5.916521574077368,1.0,0.0,0,4.1416
mycophenolate mofetil,EFO_0005772,neurodegenerative disease,5.899251094332402,1.0,0.0,0,4.1295
mycophenolate mofetil,MONDO_0013454,Leber congenital amaurosis 11,5.892482558083803,1.0,0.0,0,4.1247
mycophenolate mofetil,EFO_0003047,hepatitis C virus infection,5.790257815681435,1.0,0.0,0,4.0532
mycophenolate mofetil,EFO_0000198,myelodysplastic syndrome,5.714498819349205,1.0,0.0,0,4.0001
mycophenolate mofetil,MONDO_0007915,systemic lupus erythematosus,5.6779887114338665,1.0,0.0,0,3.9746
mycophenolate mofetil,EFO_0005761,lupus nephritis,5.596544479141036,1.0,0.0,0,3.9176
mycophenolate mofetil,HP_0001332,Dystonia,5.588169051533912,1.0,0.0,0,3.9117
mycophenolate mofetil,EFO_1001231,uveitis,5.571108091566431,1.0,0.0,0,3.8998
mycophenolate mofetil,EFO_0004599,acute graft vs. host disease,5.555429834341028,1.0,0.0,0,3.8888
mycophenolate mofetil,EFO_1001469,Mantle cell lymphoma,5.4662593133658115,1.0,0.0,0,3.8264
mycophenolate mofetil,MONDO_0013730,graft versus host disease,5.429814060575778,1.0,0.0,0,3.8009
mycophenolate mofetil,EFO_0003060,non-small cell lung carcinoma,5.427725143849036,1.0,0.0,0,3.7994
mycophenolate mofetil,EFO_0000508,genetic disorder,5.425028938965478,1.0,0.0,0,3.7975
mycophenolate mofetil,MONDO_0008315,prostate cancer,5.41737196733337,1.0,0.0,0,3.7922
mycophenolate mofetil,HP_0000556,Retinal dystrophy,5.395150822567877,1.0,0.0,0,3.7766
mycophenolate mofetil,MONDO_0100096,COVID-19,5.38368562881583,1.0,0.0,0,3.7686
mycophenolate mofetil,MONDO_0007254,breast cancer,5.381276219909969,1.0,0.0,0,3.7669
mycophenolate mofetil,EFO_0003833,brain neoplasm,5.275085302721218,1.0,0.0,0,3.6926
mycophenolate mofetil,MONDO_0005147,type 1 diabetes mellitus,5.261439973259123,1.0,0.0,0,3.683
mycophenolate mofetil,MONDO_0012703,lissencephaly due to TUBA1A mutation,5.254565779762999,1.0,0.0,0,3.6782
mycophenolate mofetil,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,5.25167702347086,1.0,0.0,0,3.6762
mycophenolate mofetil,EFO_0004719,pemphigus vulgaris,5.219310127283923,1.0,0.0,0,3.6535
mycophenolate mofetil,EFO_0004274,gout,5.215925536642896,1.0,0.0,0,3.6511
mycophenolate mofetil,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,5.190934144484972,1.0,0.0,0,3.6337
mycophenolate mofetil,EFO_1000158,Central Nervous System Neoplasm,5.184465566365744,1.0,0.0,0,3.6291
mycophenolate mofetil,EFO_0000685,rheumatoid arthritis,5.169127197101171,1.0,0.0,0,3.6184
mycophenolate mofetil,EFO_1001935,adult B acute lymphoblastic leukemia,5.151545989212893,1.0,0.0,0,3.6061
mycophenolate mofetil,EFO_0000540,immune system disease,5.1304685906197705,1.0,0.0,0,3.5913
nexlizet,EFO_0004911,familial hypercholesterolemia,2.4094996729070544,0.0,0.0,0,2.4095
nexlizet,EFO_0003914,atherosclerosis,2.308350512913208,0.0,0.0,0,2.3084
nexlizet,HP_0003124,Hypercholesterolemia,2.250676658103041,0.0,0.0,0,2.2507
nexlizet,EFO_0000319,cardiovascular disease,2.174478223400569,0.0,0.0,0,2.1745
nexlizet,EFO_0001645,coronary artery disease,1.952310150860574,0.0,0.0,0,1.9523
nexlizet,HP_0003119,Abnormal circulating lipid concentration,1.765884005306365,0.0,0.0,0,1.7659
nexlizet,EFO_0000616,neoplasm,1.6906198428356882,0.0,0.0,0,1.6906
nexlizet,MONDO_0004992,cancer,1.5779764748189296,0.0,0.0,0,1.578
nexlizet,MONDO_0007254,breast cancer,1.4718215314063527,0.0,0.0,0,1.4718
nexlizet,MONDO_0042490,"neutropenia, severe congenital, 1, autosomal dominant",1.444406828106269,0.0,0.0,0,1.4444
nexlizet,EFO_0003060,non-small cell lung carcinoma,1.4273586638710003,0.0,0.0,0,1.4274
nexlizet,MONDO_0008315,prostate cancer,1.391854196977534,0.0,0.0,0,1.3919
nexlizet,MONDO_0004976,amyotrophic lateral sclerosis,1.3489800099620737,0.0,0.0,0,1.349
nexlizet,MONDO_0021187,hyperlipidemia,1.3261788879850798,0.0,0.0,0,1.3262
nexlizet,MONDO_0008090,cyclic hematopoiesis,1.320513540780356,0.0,0.0,0,1.3205
nexlizet,Orphanet_2686,Cyclic neutropenia,1.3185250143717266,0.0,0.0,0,1.3185
nexlizet,MONDO_0012703,lissencephaly due to TUBA1A mutation,1.31364144494075,0.0,0.0,0,1.3136
nexlizet,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,1.312919255867715,0.0,0.0,0,1.3129
nexlizet,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,1.297733536121243,0.0,0.0,0,1.2977
nexlizet,MONDO_0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",1.2786414434034508,0.0,0.0,0,1.2786
nexlizet,EFO_0003869,breast neoplasm,1.2785871195246965,0.0,0.0,0,1.2786
nexlizet,Orphanet_183506,Genetic central nervous system malformation,1.2763070556018696,0.0,0.0,0,1.2763
nexlizet,MONDO_0008170,ovarian cancer,1.2486910281189842,0.0,0.0,0,1.2487
nexlizet,EFO_1001985,congenital fibrosis of the extraocular muscles,1.2462325847941036,0.0,0.0,0,1.2462
nexlizet,MONDO_0015372,autosomal dominant macrothrombocytopenia,1.244239704511393,0.0,0.0,0,1.2442
nexlizet,MONDO_0100153,tubulinopathy,1.241911280655119,0.0,0.0,0,1.2419
nexlizet,MONDO_0012905,hypomyelinating leukodystrophy 6,1.2303472963501092,0.0,0.0,0,1.2303
nexlizet,EFO_0000574,lymphoma,1.2249152658689484,0.0,0.0,0,1.2249
nexlizet,EFO_0000305,breast carcinoma,1.2240571698463765,0.0,0.0,0,1.2241
nexlizet,MONDO_0019200,retinitis pigmentosa,1.2179778600235611,0.0,0.0,0,1.218
nexlizet,Orphanet_404469,Female infertility due to fertilization defect,1.2136046598229504,0.0,0.0,0,1.2136
nexlizet,Orphanet_300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,1.213336275379104,0.0,0.0,0,1.2133
nexlizet,Orphanet_139441,Hypomyelination with atrophy of basal ganglia and cerebellum,1.2090169792908507,0.0,0.0,0,1.209
nexlizet,MONDO_0014337,complex cortical dysplasia with other brain malformations 5,1.200098212718321,0.0,0.0,0,1.2001
nexlizet,MONDO_0020738,multiple benign circumferential skin creases on limbs 1,1.200066497163491,0.0,0.0,0,1.2001
nexlizet,EFO_0000403,diffuse large B-cell lymphoma,1.197661631649812,0.0,0.0,0,1.1977
nexlizet,EFO_0001378,multiple myeloma,1.1887156580687472,0.0,0.0,0,1.1887
nexlizet,MONDO_0013541,complex cortical dysplasia with other brain malformations 1,1.1875585571904996,0.0,0.0,0,1.1876
nexlizet,MONDO_0008903,lung cancer,1.186688823733311,0.0,0.0,0,1.1867
nexlizet,Orphanet_98805,"Primary dystonia, DYT4 type",1.1805625585435782,0.0,0.0,0,1.1806
nexlizet,EFO_0004274,gout,1.1746332065396383,0.0,0.0,0,1.1746
nexlizet,MONDO_0002974,cervical cancer,1.1630498485968817,0.0,0.0,0,1.163
nexlizet,EFO_0000756,melanoma,1.156784982836449,0.0,0.0,0,1.1568
nexlizet,EFO_0000220,acute lymphoblastic leukemia,1.1542723382939477,0.0,0.0,0,1.1543
nexlizet,EFO_0000183,Hodgkins lymphoma,1.1498448496645723,0.0,0.0,0,1.1498
nexlizet,MONDO_0007493,torsion dystonia 4,1.1464047185131627,0.0,0.0,0,1.1464
nexlizet,MONDO_0018088,familial Mediterranean fever,1.1290054240048233,0.0,0.0,0,1.129
nexlizet,MONDO_0018998,Leber congenital amaurosis,1.105326947068426,0.0,0.0,0,1.1053
nexlizet,MONDO_0011136,Quebec platelet disorder,1.1034736948883288,0.0,0.0,0,1.1035
nexlizet,MONDO_0001475,neutropenia,1.0993475519975822,0.0,0.0,0,1.0993
niacin/laropiprant,EFO_0001361,pulmonary arterial hypertension,1.4267158488993,0.0,0.0,0,1.4267
niacin/laropiprant,MONDO_0005149,pulmonary hypertension,1.297016008518515,0.0,0.0,0,1.297
niacin/laropiprant,HP_0004419,Recurrent thrombophlebitis,1.2388497524505553,0.0,0.0,0,1.2388
niacin/laropiprant,EFO_0000537,hypertension,1.2186729440315014,0.0,0.0,0,1.2187
niacin/laropiprant,EFO_0005772,neurodegenerative disease,1.099118956491301,0.0,0.0,0,1.0991
niacin/laropiprant,EFO_0000319,cardiovascular disease,0.995809637356361,0.0,0.0,0,0.9958
niacin/laropiprant,MONDO_0019200,retinitis pigmentosa,0.9819599048130446,0.0,0.0,0,0.982
niacin/laropiprant,HP_0012531,Pain,0.9632109836038012,0.0,0.0,0,0.9632
niacin/laropiprant,EFO_0006834,septic shock,0.9263315532025312,0.0,0.0,0,0.9263
niacin/laropiprant,MONDO_0005148,type 2 diabetes mellitus,0.915401713405238,0.0,0.0,0,0.9154
niacin/laropiprant,EFO_0001645,coronary artery disease,0.9104508176854456,0.0,0.0,0,0.9105
niacin/laropiprant,MONDO_0004979,asthma,0.9093472174137404,0.0,0.0,0,0.9093
niacin/laropiprant,MONDO_0018852,achromatopsia,0.9026471886104168,0.0,0.0,0,0.9026
niacin/laropiprant,EFO_0000341,chronic obstructive pulmonary disease,0.8934655838378379,0.0,0.0,0,0.8935
niacin/laropiprant,EFO_0000712,stroke,0.8810885124266817,0.0,0.0,0,0.8811
niacin/laropiprant,Orphanet_1872,Cone rod dystrophy,0.841444054325368,0.0,0.0,0,0.8414
niacin/laropiprant,EFO_0000729,ulcerative colitis,0.8318939901709135,0.0,0.0,0,0.8319
niacin/laropiprant,EFO_0003913,angina pectoris,0.8155924390467653,0.0,0.0,0,0.8156
niacin/laropiprant,MONDO_0017147,idiopathic pulmonary arterial hypertension,0.8149267197558608,0.0,0.0,0,0.8149
niacin/laropiprant,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,0.8090891705934107,0.0,0.0,0,0.8091
niacin/laropiprant,EFO_0000612,myocardial infarction,0.7930589800926311,0.0,0.0,0,0.7931
niacin/laropiprant,EFO_0000676,psoriasis,0.7852100164938053,0.0,0.0,0,0.7852
niacin/laropiprant,HP_0003124,Hypercholesterolemia,0.7834245215494735,0.0,0.0,0,0.7834
niacin/laropiprant,MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,0.7640826689368406,0.0,0.0,0,0.7641
niacin/laropiprant,MONDO_0005277,migraine disorder,0.7621562204607338,0.0,0.0,0,0.7622
niacin/laropiprant,Orphanet_1276,Brachydactyly - arterial hypertension,0.7505287748518205,0.0,0.0,0,0.7505
niacin/laropiprant,EFO_0003144,heart failure,0.7411588815184639,0.0,0.0,0,0.7412
niacin/laropiprant,EFO_0000274,atopic eczema,0.7274884393114894,0.0,0.0,0,0.7275
niacin/laropiprant,MONDO_0005041,glaucoma,0.7228151351671169,0.0,0.0,0,0.7228
niacin/laropiprant,Orphanet_309005,Disorder of lipid metabolism,0.7199464230007054,0.0,0.0,0,0.7199
niacin/laropiprant,MONDO_0016293,congenital stationary night blindness,0.7188774683758049,0.0,0.0,0,0.7189
niacin/laropiprant,MONDO_0013437,retinitis pigmentosa 43,0.708365586668396,0.0,0.0,0,0.7084
niacin/laropiprant,MONDO_0021187,hyperlipidemia,0.7076907866373647,0.0,0.0,0,0.7077
niacin/laropiprant,Orphanet_79211,Combined hyperlipidemia,0.7076907866373647,0.0,0.0,0,0.7077
niacin/laropiprant,HP_0006536,Airway obstruction,0.7062468375000145,0.0,0.0,0,0.7062
niacin/laropiprant,MONDO_0014835,"striatal degeneration, autosomal dominant 2",0.7036066594638714,0.0,0.0,0,0.7036
niacin/laropiprant,MONDO_0007211,brachydactyly-arterial hypertension syndrome,0.7015940057356027,0.0,0.0,0,0.7016
niacin/laropiprant,EFO_0000768,idiopathic pulmonary fibrosis,0.6984274661045389,0.0,0.0,0,0.6984
niacin/laropiprant,HP_0100806,Sepsis,0.697738531530229,0.0,0.0,0,0.6977
niacin/laropiprant,MONDO_0001134,essential hypertension,0.6939627335325943,0.0,0.0,0,0.694
niacin/laropiprant,MONDO_0030900,intellectual developmental disorder with paroxysmal dyskinesia or seizures,0.6873341917315976,0.0,0.0,0,0.6873
niacin/laropiprant,EFO_0004190,open-angle glaucoma,0.6841364382762871,0.0,0.0,0,0.6841
niacin/laropiprant,HP_0000556,Retinal dystrophy,0.677539696365846,0.0,0.0,0,0.6775
niacin/laropiprant,Orphanet_2754,Joubert syndrome with orofaciodigital defect,0.6755720630837286,0.0,0.0,0,0.6756
niacin/laropiprant,EFO_0000373,congestive heart failure,0.6745338844174854,0.0,0.0,0,0.6745
niacin/laropiprant,EFO_1001145,Raynaud disease,0.6656602107025804,0.0,0.0,0,0.6657
niacin/laropiprant,EFO_0000275,atrial fibrillation,0.6637141414845589,0.0,0.0,0,0.6637
niacin/laropiprant,EFO_0003778,psoriatic arthritis,0.6630287384547967,0.0,0.0,0,0.663
niacin/laropiprant,MONDO_0019797,acrodysostosis,0.6522958213395667,0.0,0.0,0,0.6523
niacin/laropiprant,EFO_0003956,seasonal allergic rhinitis,0.6513267909665891,0.0,0.0,0,0.6513
niacin/laropiprant combination,EFO_0001361,pulmonary arterial hypertension,1.4267158488993,0.0,0.0,0,1.4267
niacin/laropiprant combination,MONDO_0005149,pulmonary hypertension,1.297016008518515,0.0,0.0,0,1.297
niacin/laropiprant combination,HP_0004419,Recurrent thrombophlebitis,1.2388497524505553,0.0,0.0,0,1.2388
niacin/laropiprant combination,EFO_0000537,hypertension,1.2186729440315014,0.0,0.0,0,1.2187
niacin/laropiprant combination,EFO_0005772,neurodegenerative disease,1.099118956491301,0.0,0.0,0,1.0991
niacin/laropiprant combination,EFO_0000319,cardiovascular disease,0.995809637356361,0.0,0.0,0,0.9958
niacin/laropiprant combination,MONDO_0019200,retinitis pigmentosa,0.9819599048130446,0.0,0.0,0,0.982
niacin/laropiprant combination,HP_0012531,Pain,0.9632109836038012,0.0,0.0,0,0.9632
niacin/laropiprant combination,EFO_0006834,septic shock,0.9263315532025312,0.0,0.0,0,0.9263
niacin/laropiprant combination,MONDO_0005148,type 2 diabetes mellitus,0.915401713405238,0.0,0.0,0,0.9154
niacin/laropiprant combination,EFO_0001645,coronary artery disease,0.9104508176854456,0.0,0.0,0,0.9105
niacin/laropiprant combination,MONDO_0004979,asthma,0.9093472174137404,0.0,0.0,0,0.9093
niacin/laropiprant combination,MONDO_0018852,achromatopsia,0.9026471886104168,0.0,0.0,0,0.9026
niacin/laropiprant combination,EFO_0000341,chronic obstructive pulmonary disease,0.8934655838378379,0.0,0.0,0,0.8935
niacin/laropiprant combination,EFO_0000712,stroke,0.8810885124266817,0.0,0.0,0,0.8811
niacin/laropiprant combination,Orphanet_1872,Cone rod dystrophy,0.841444054325368,0.0,0.0,0,0.8414
niacin/laropiprant combination,EFO_0000729,ulcerative colitis,0.8318939901709135,0.0,0.0,0,0.8319
niacin/laropiprant combination,EFO_0003913,angina pectoris,0.8155924390467653,0.0,0.0,0,0.8156
niacin/laropiprant combination,MONDO_0017147,idiopathic pulmonary arterial hypertension,0.8149267197558608,0.0,0.0,0,0.8149
niacin/laropiprant combination,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,0.8090891705934107,0.0,0.0,0,0.8091
niacin/laropiprant combination,EFO_0000612,myocardial infarction,0.7930589800926311,0.0,0.0,0,0.7931
niacin/laropiprant combination,EFO_0000676,psoriasis,0.7852100164938053,0.0,0.0,0,0.7852
niacin/laropiprant combination,HP_0003124,Hypercholesterolemia,0.7834245215494735,0.0,0.0,0,0.7834
niacin/laropiprant combination,MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,0.7640826689368406,0.0,0.0,0,0.7641
niacin/laropiprant combination,MONDO_0005277,migraine disorder,0.7621562204607338,0.0,0.0,0,0.7622
niacin/laropiprant combination,Orphanet_1276,Brachydactyly - arterial hypertension,0.7505287748518205,0.0,0.0,0,0.7505
niacin/laropiprant combination,EFO_0003144,heart failure,0.7411588815184639,0.0,0.0,0,0.7412
niacin/laropiprant combination,EFO_0000274,atopic eczema,0.7274884393114894,0.0,0.0,0,0.7275
niacin/laropiprant combination,MONDO_0005041,glaucoma,0.7228151351671169,0.0,0.0,0,0.7228
niacin/laropiprant combination,Orphanet_309005,Disorder of lipid metabolism,0.7199464230007054,0.0,0.0,0,0.7199
niacin/laropiprant combination,MONDO_0016293,congenital stationary night blindness,0.7188774683758049,0.0,0.0,0,0.7189
niacin/laropiprant combination,MONDO_0013437,retinitis pigmentosa 43,0.708365586668396,0.0,0.0,0,0.7084
niacin/laropiprant combination,MONDO_0021187,hyperlipidemia,0.7076907866373647,0.0,0.0,0,0.7077
niacin/laropiprant combination,Orphanet_79211,Combined hyperlipidemia,0.7076907866373647,0.0,0.0,0,0.7077
niacin/laropiprant combination,HP_0006536,Airway obstruction,0.7062468375000145,0.0,0.0,0,0.7062
niacin/laropiprant combination,MONDO_0014835,"striatal degeneration, autosomal dominant 2",0.7036066594638714,0.0,0.0,0,0.7036
niacin/laropiprant combination,MONDO_0007211,brachydactyly-arterial hypertension syndrome,0.7015940057356027,0.0,0.0,0,0.7016
niacin/laropiprant combination,EFO_0000768,idiopathic pulmonary fibrosis,0.6984274661045389,0.0,0.0,0,0.6984
niacin/laropiprant combination,HP_0100806,Sepsis,0.697738531530229,0.0,0.0,0,0.6977
niacin/laropiprant combination,MONDO_0001134,essential hypertension,0.6939627335325943,0.0,0.0,0,0.694
niacin/laropiprant combination,MONDO_0030900,intellectual developmental disorder with paroxysmal dyskinesia or seizures,0.6873341917315976,0.0,0.0,0,0.6873
niacin/laropiprant combination,EFO_0004190,open-angle glaucoma,0.6841364382762871,0.0,0.0,0,0.6841
niacin/laropiprant combination,HP_0000556,Retinal dystrophy,0.677539696365846,0.0,0.0,0,0.6775
niacin/laropiprant combination,Orphanet_2754,Joubert syndrome with orofaciodigital defect,0.6755720630837286,0.0,0.0,0,0.6756
niacin/laropiprant combination,EFO_0000373,congestive heart failure,0.6745338844174854,0.0,0.0,0,0.6745
niacin/laropiprant combination,EFO_1001145,Raynaud disease,0.6656602107025804,0.0,0.0,0,0.6657
niacin/laropiprant combination,EFO_0000275,atrial fibrillation,0.6637141414845589,0.0,0.0,0,0.6637
niacin/laropiprant combination,EFO_0003778,psoriatic arthritis,0.6630287384547967,0.0,0.0,0,0.663
niacin/laropiprant combination,MONDO_0019797,acrodysostosis,0.6522958213395667,0.0,0.0,0,0.6523
niacin/laropiprant combination,EFO_0003956,seasonal allergic rhinitis,0.6513267909665891,0.0,0.0,0,0.6513
nitroglycerin,EFO_0000537,hypertension,11.145297339214602,1.0,0.0,0,7.8017
nitroglycerin,EFO_0000319,cardiovascular disease,10.693672595148708,1.0,0.0,0,7.4856
nitroglycerin,EFO_0003913,angina pectoris,10.645484360734438,1.0,0.0,0,7.4518
nitroglycerin,EFO_0001645,coronary artery disease,10.488743226716466,1.0,0.0,0,7.3421
nitroglycerin,EFO_0003144,heart failure,9.521634612576564,1.0,0.0,0,6.6651
nitroglycerin,EFO_0001361,pulmonary arterial hypertension,8.957198451292456,1.0,0.0,0,6.27
nitroglycerin,EFO_0000612,myocardial infarction,8.781276206133551,1.0,0.0,0,6.1469
nitroglycerin,MONDO_0014331,Moyamoya disease with early-onset achalasia,8.571058148795336,1.0,0.0,0,5.9997
nitroglycerin,MONDO_0005149,pulmonary hypertension,8.32917525165744,1.0,0.0,0,5.8304
nitroglycerin,MONDO_0001134,essential hypertension,8.17462117557293,1.0,0.0,0,5.7222
nitroglycerin,EFO_0000400,diabetes mellitus,7.845965956086022,1.0,0.0,0,5.4922
nitroglycerin,EFO_1001375,Myocardial Ischemia,7.826064174515964,1.0,0.0,0,5.4782
nitroglycerin,HP_0012531,Pain,7.77781131039075,1.0,0.0,0,5.4445
nitroglycerin,EFO_0000712,stroke,7.500254468984219,1.0,0.0,0,5.2502
nitroglycerin,EFO_0000373,congestive heart failure,7.0791353097390495,1.0,0.0,0,4.9554
nitroglycerin,MONDO_0021661,coronary atherosclerosis,6.988898107307239,1.0,0.0,0,4.8922
nitroglycerin,EFO_0004329,alcohol drinking,6.949670924496786,1.0,0.0,0,4.8648
nitroglycerin,MONDO_0019200,retinitis pigmentosa,6.845162613725323,1.0,0.0,0,4.7916
nitroglycerin,MONDO_0005148,type 2 diabetes mellitus,6.673844903609761,1.0,0.0,0,4.6717
nitroglycerin,EFO_0009552,hemorrhoid,6.3872514947811805,1.0,0.0,0,4.4711
nitroglycerin,HP_0032263,Increased blood pressure,6.25475062756075,1.0,0.0,0,4.3783
nitroglycerin,MP_0001914,hemorrhage,6.163464908701409,1.0,0.0,0,4.3144
nitroglycerin,MONDO_0016820,Moyamoya disease,6.042879442551046,1.0,0.0,0,4.23
nitroglycerin,MONDO_0018852,achromatopsia,5.917282474246671,1.0,0.0,0,4.1421
nitroglycerin,HP_0002093,Respiratory insufficiency,5.8993606399494105,1.0,0.0,0,4.1296
nitroglycerin,HP_0100749,Chest pain,5.7886068004751605,1.0,0.0,0,4.052
nitroglycerin,Orphanet_1872,Cone rod dystrophy,5.773628411637926,1.0,0.0,0,4.0415
nitroglycerin,MONDO_0100096,COVID-19,5.766925599743349,1.0,0.0,0,4.0368
nitroglycerin,MONDO_0004979,asthma,5.741714061669979,1.0,0.0,0,4.0192
nitroglycerin,MONDO_0014917,"developmental and epileptic encephalopathy, 42",5.676318571900374,1.0,0.0,0,3.9734
nitroglycerin,MONDO_0002009,major depressive disorder,5.623683602357094,1.0,0.0,0,3.9366
nitroglycerin,EFO_0000474,epilepsy,5.609346618458622,1.0,0.0,0,3.9265
nitroglycerin,Orphanet_97,Familial paroxysmal ataxia,5.570972205824502,1.0,0.0,0,3.8997
nitroglycerin,MONDO_0010979,Timothy syndrome,5.568298191807099,1.0,0.0,0,3.8978
nitroglycerin,HP_0001250,Seizure,5.532703414267498,1.0,0.0,0,3.8729
nitroglycerin,EFO_0000668,preeclampsia,5.504338854676822,1.0,0.0,0,3.853
nitroglycerin,EFO_0005670,smoking initiation,5.4659405553105564,1.0,0.0,0,3.8262
nitroglycerin,EFO_0000275,atrial fibrillation,5.441562493440749,1.0,0.0,0,3.8091
nitroglycerin,EFO_0000341,chronic obstructive pulmonary disease,5.425677873401536,1.0,0.0,0,3.798
nitroglycerin,EFO_0005138,acquired long QT syndrome,5.422307621293342,1.0,0.0,0,3.7956
nitroglycerin,MONDO_0005090,schizophrenia,5.376326565413978,1.0,0.0,0,3.7634
nitroglycerin,MONDO_0100062,genetic developmental and epileptic encephalopathy,5.365086481529034,1.0,0.0,0,3.7556
nitroglycerin,EFO_1001145,Raynaud disease,5.349108569591144,1.0,0.0,0,3.7444
nitroglycerin,EFO_0000589,metabolic disease,5.334014737439832,1.0,0.0,0,3.7338
nitroglycerin,GO_0009410,response to xenobiotic stimulus,5.3215507353434734,1.0,0.0,0,3.7251
nitroglycerin,EFO_0003777,heart disease,5.307173474979343,1.0,0.0,0,3.715
nitroglycerin,MONDO_0007163,episodic ataxia type 2,5.269069623990863,1.0,0.0,0,3.6883
nitroglycerin,MONDO_0020756,"migraine, familial hemiplegic, 1",5.239606424053178,1.0,0.0,0,3.6677
nitroglycerin,EFO_0009686,respiratory failure,5.190200354176156,1.0,0.0,0,3.6331
nitroglycerin,EFO_0000676,psoriasis,5.184088116534394,1.0,0.0,0,3.6289
olmesartan medoxomil,MONDO_0017609,renal tubular dysgenesis,4.8070045513337725,1.0,0.0,0,3.3649
olmesartan medoxomil,EFO_0000537,hypertension,4.764211662581255,1.0,0.0,0,3.3349
olmesartan medoxomil,MONDO_0009970,renal tubular dysgenesis of genetic origin,4.603030194668649,1.0,0.0,0,3.2221
olmesartan medoxomil,MONDO_0007781,"essential hypertension, genetic",4.099940983287322,1.0,0.0,0,2.87
olmesartan medoxomil,EFO_0000612,myocardial infarction,4.006854785540133,1.0,0.0,0,2.8048
olmesartan medoxomil,EFO_0003086,kidney disease,3.9723875248795526,1.0,0.0,0,2.7807
olmesartan medoxomil,EFO_0003144,heart failure,3.959131572227173,1.0,0.0,0,2.7714
olmesartan medoxomil,MONDO_0001134,essential hypertension,3.906886789900324,1.0,0.0,0,2.7348
olmesartan medoxomil,EFO_0000712,stroke,3.8753344383828896,1.0,0.0,0,2.7127
olmesartan medoxomil,EFO_0000400,diabetes mellitus,3.849825329384962,1.0,0.0,0,2.6949
olmesartan medoxomil,EFO_0000401,diabetic nephropathy,3.8123095524465738,1.0,0.0,0,2.6686
olmesartan medoxomil,EFO_0000373,congestive heart failure,3.810514575802316,1.0,0.0,0,2.6674
olmesartan medoxomil,EFO_0000319,cardiovascular disease,3.80705616206431,1.0,0.0,0,2.6649
olmesartan medoxomil,EFO_0003884,chronic kidney disease,3.629328510815018,1.0,0.0,0,2.5405
olmesartan medoxomil,HP_0000093,Proteinuria,3.5734566920440636,1.0,0.0,0,2.5014
olmesartan medoxomil,MONDO_0005148,type 2 diabetes mellitus,3.569244055144846,1.0,0.0,0,2.4985
olmesartan medoxomil,EFO_0003913,angina pectoris,3.3714486340198695,1.0,0.0,0,2.36
olmesartan medoxomil,EFO_0004194,IGA glomerulonephritis,3.338193878991166,1.0,0.0,0,2.3367
olmesartan medoxomil,EFO_0006834,septic shock,2.930417242859929,1.0,0.0,0,2.0513
olmesartan medoxomil,EFO_0000275,atrial fibrillation,2.5899359389879475,1.0,0.0,0,1.813
olmesartan medoxomil,MONDO_0100096,COVID-19,2.5890865085429944,1.0,0.0,0,1.8124
olmesartan medoxomil,MONDO_0007947,Marfan syndrome,2.5334838058491904,1.0,0.0,0,1.7734
olmesartan medoxomil,HP_0003124,Hypercholesterolemia,2.492207378826713,1.0,0.0,0,1.7445
olmesartan medoxomil,EFO_0003914,atherosclerosis,2.485329280440919,1.0,0.0,0,1.7397
olmesartan medoxomil,EFO_0005251,hypotension,2.386940560477032,1.0,0.0,0,1.6709
olmesartan medoxomil,MONDO_0019719,congenital anomaly of kidney and urinary tract,2.362164171098147,1.0,0.0,0,1.6535
olmesartan medoxomil,HP_0031273,Shock,2.358632403087534,1.0,0.0,0,1.651
olmesartan medoxomil,EFO_0004236,focal segmental glomerulosclerosis,2.304651014947832,1.0,0.0,0,1.6133
olmesartan medoxomil,EFO_0003896,left ventricular hypertrophy,2.2791145131946595,1.0,0.0,0,1.5954
olmesartan medoxomil,EFO_0001645,coronary artery disease,2.2596560979532905,1.0,0.0,0,1.5818
olmesartan medoxomil,Orphanet_309005,Disorder of lipid metabolism,2.2474471138645407,1.0,0.0,0,1.5732
olmesartan medoxomil,MONDO_0005147,type 1 diabetes mellitus,2.191563407180455,1.0,0.0,0,1.5341
olmesartan medoxomil,EFO_0000195,metabolic syndrome,2.1795478877304366,1.0,0.0,0,1.5257
olmesartan medoxomil,EFO_0008583,acute myocardial infarction,2.1677905128449835,1.0,0.0,0,1.5175
olmesartan medoxomil,EFO_0005670,smoking initiation,2.132606653726835,1.0,0.0,0,1.4928
olmesartan medoxomil,EFO_0003777,heart disease,2.1015483742426624,1.0,0.0,0,1.4711
olmesartan medoxomil,MONDO_0005149,pulmonary hypertension,2.0930140811562308,1.0,0.0,0,1.4651
olmesartan medoxomil,EFO_0008585,ST Elevation Myocardial Infarction,2.075841776384434,1.0,0.0,0,1.4531
olmesartan medoxomil,EFO_0000266,aortic stenosis,2.0719759787209076,1.0,0.0,0,1.4504
olmesartan medoxomil,EFO_0008620,Polycystic Kidney Disease,2.0631411461996025,1.0,0.0,0,1.4442
olmesartan medoxomil,MONDO_0024327,chronic renal failure syndrome,2.060198006190759,1.0,0.0,0,1.4421
olmesartan medoxomil,MONDO_0005180,Parkinson disease,2.0156107609237104,1.0,0.0,0,1.4109
olmesartan medoxomil,EFO_0005423,adolescent idiopathic scoliosis,1.9817866224931855,1.0,0.0,0,1.3873
olmesartan medoxomil,MONDO_0003689,familial hemolytic anemia,1.9817866224931855,1.0,0.0,0,1.3873
olmesartan medoxomil,MONDO_0007254,breast cancer,1.95616896197251,1.0,0.0,0,1.3693
olmesartan medoxomil,MONDO_0004975,Alzheimer disease,1.9247673512646024,1.0,0.0,0,1.3473
olmesartan medoxomil,EFO_0005772,neurodegenerative disease,1.8782345851893436,1.0,0.0,0,1.3148
olmesartan medoxomil,EFO_1001249,non-alcoholic steatohepatitis,1.854293553276344,1.0,0.0,0,1.298
olmesartan medoxomil,HP_0012531,Pain,1.8231961268624737,1.0,0.0,0,1.2762
olmesartan medoxomil,EFO_1001461,endothelial dysfunction,1.7990406760443824,1.0,0.0,0,1.2593
pactimibe sulfate,EFO_0004911,familial hypercholesterolemia,2.9697614252457183,0.0,0.0,0,2.9698
pactimibe sulfate,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",2.741653613949166,0.0,0.0,0,2.7417
pactimibe sulfate,HP_0003124,Hypercholesterolemia,2.6890141186019783,0.0,0.0,0,2.689
pactimibe sulfate,EFO_0001645,coronary artery disease,2.522959374402546,0.0,0.0,0,2.523
pactimibe sulfate,EFO_0000319,cardiovascular disease,2.4913512311300523,0.0,0.0,0,2.4914
pactimibe sulfate,EFO_0000589,metabolic disease,2.3995172167298993,0.0,0.0,0,2.3995
pactimibe sulfate,MONDO_0018328,homozygous familial hypercholesterolemia,2.296730590323977,0.0,0.0,0,2.2967
pactimibe sulfate,Orphanet_309005,Disorder of lipid metabolism,2.2170512532759004,0.0,0.0,0,2.2171
pactimibe sulfate,EFO_0003914,atherosclerosis,2.1564363580273382,0.0,0.0,0,2.1564
pactimibe sulfate,MONDO_0021187,hyperlipidemia,2.1040568357817544,0.0,0.0,0,2.1041
pactimibe sulfate,EFO_0000612,myocardial infarction,2.0810436737369216,0.0,0.0,0,2.081
pactimibe sulfate,HP_0003077,Hyperlipidemia,1.7967920763748404,0.0,0.0,0,1.7968
pactimibe sulfate,MONDO_0007750,"hypercholesterolemia, familial, 1",1.7836214902334102,0.0,0.0,0,1.7836
pactimibe sulfate,EFO_1001375,Myocardial Ischemia,1.7694639103980672,0.0,0.0,0,1.7695
pactimibe sulfate,MONDO_0021661,coronary atherosclerosis,1.763336321760802,0.0,0.0,0,1.7633
pactimibe sulfate,MONDO_0001336,familial hyperlipidemia,1.7148713527001924,0.0,0.0,0,1.7149
pactimibe sulfate,GO_0036273,response to statin,1.6929627454314395,0.0,0.0,0,1.693
pactimibe sulfate,EFO_0003913,angina pectoris,1.687236594810492,0.0,0.0,0,1.6872
pactimibe sulfate,EFO_0003777,heart disease,1.642982730620368,0.0,0.0,0,1.643
pactimibe sulfate,EFO_0000195,metabolic syndrome,1.641838259890651,0.0,0.0,0,1.6418
pactimibe sulfate,HP_0001626,Abnormality of the cardiovascular system,1.544989115822175,0.0,0.0,0,1.545
pactimibe sulfate,MONDO_0009387,familial lipoprotein lipase deficiency,1.5379698591500608,0.0,0.0,0,1.538
pactimibe sulfate,HP_0003146,Hypocholesterolemia,1.519787603332834,0.0,0.0,0,1.5198
pactimibe sulfate,HP_0000924,Abnormality of the skeletal system,1.5023777048523923,0.0,0.0,0,1.5024
pactimibe sulfate,HP_0003119,Abnormal circulating lipid concentration,1.4715700044219706,0.0,0.0,0,1.4716
pactimibe sulfate,EFO_0000400,diabetes mellitus,1.4418160359973236,0.0,0.0,0,1.4418
pactimibe sulfate,EFO_0004214,Abdominal Aortic Aneurysm,1.4288552428438437,0.0,0.0,0,1.4289
pactimibe sulfate,MONDO_0021511,benign neoplasm of adrenal gland,1.3547010903713852,0.0,0.0,0,1.3547
pactimibe sulfate,EFO_0000712,stroke,1.20277799938547,0.0,0.0,0,1.2028
pactimibe sulfate,EFO_0008583,acute myocardial infarction,1.1998707733605194,0.0,0.0,0,1.1999
pactimibe sulfate,EFO_0005772,neurodegenerative disease,1.1945285932663348,0.0,0.0,0,1.1945
pactimibe sulfate,EFO_0003144,heart failure,1.1943910450436237,0.0,0.0,0,1.1944
pactimibe sulfate,HP_0011428,Short fetal femur length,1.187066470233723,0.0,0.0,0,1.1871
pactimibe sulfate,Orphanet_79211,Combined hyperlipidemia,1.1826198710376177,0.0,0.0,0,1.1826
pactimibe sulfate,EFO_0004264,vascular disease,1.1630272440108385,0.0,0.0,0,1.163
pactimibe sulfate,EFO_0005672,acute coronary syndrome,1.1541008061604114,0.0,0.0,0,1.1541
pactimibe sulfate,EFO_0003776,coronary artery bypass,1.1279602973638454,0.0,0.0,0,1.128
pactimibe sulfate,EFO_0003940,physical activity,1.1225894210654916,0.0,0.0,0,1.1226
pactimibe sulfate,EFO_0003951,percutaneous transluminal coronary angioplasty,1.1225894210654916,0.0,0.0,0,1.1226
pactimibe sulfate,EFO_0004329,alcohol drinking,1.1225894210654916,0.0,0.0,0,1.1226
pactimibe sulfate,EFO_1000985,intermediate coronary syndrome,1.118232710706178,0.0,0.0,0,1.1182
pactimibe sulfate,EFO_0003086,kidney disease,1.053370520411149,0.0,0.0,0,1.0534
pactimibe sulfate,EFO_0003769,endocrine neoplasm,0.9968458962306624,0.0,0.0,0,0.9968
pactimibe sulfate,EFO_0003894,acne,0.9955008356694512,0.0,0.0,0,0.9955
pactimibe sulfate,MONDO_0000627,benign endocrine neoplasm,0.9933934657064296,0.0,0.0,0,0.9934
pactimibe sulfate,HP_0003040,Arthropathy,0.9594178191147148,0.0,0.0,0,0.9594
pactimibe sulfate,EFO_0009578,placental retention,0.9588206730453008,0.0,0.0,0,0.9588
pactimibe sulfate,MONDO_0100096,COVID-19,0.9519017092954246,0.0,0.0,0,0.9519
pactimibe sulfate,EFO_0003884,chronic kidney disease,0.858094158148282,0.0,0.0,0,0.8581
pactimibe sulfate,EFO_0020092,neuroinflammatory disorder,0.8564903946660308,0.0,0.0,0,0.8565
placebo matching with bms-823778,Orphanet_168588,Hyperandrogenism due to cortisone reductase deficiency,1.1317646901471916,0.0,0.0,0,1.1318
placebo matching with bms-823778,EFO_0003948,gastroesophageal reflux disease,1.0109868380533782,0.0,0.0,0,1.011
placebo matching with bms-823778,HP_0004398,Peptic ulcer,1.0109868380533782,0.0,0.0,0,1.011
placebo matching with bms-823778,HP_0030839,Knee pain,0.6306784414620139,0.0,0.0,0,0.6307
placebo matching with bms-823778,MONDO_0005148,type 2 diabetes mellitus,0.263874102158652,0.0,0.0,0,0.2639
placebo matching with bms-823778,MONDO_0017919,exstrophy-epispadias complex,0.237685068864794,0.0,0.0,0,0.2377
placebo matching with bms-823778,EFO_0000537,hypertension,0.2036828992910804,0.0,0.0,0,0.2037
placebo matching with bms-823778,EFO_0000616,neoplasm,0.1976207380265295,0.0,0.0,0,0.1976
placebo matching with bms-823778,EFO_0000319,cardiovascular disease,0.1873221405556315,0.0,0.0,0,0.1873
placebo matching with bms-823778,Orphanet_309005,Disorder of lipid metabolism,0.1868056088109242,0.0,0.0,0,0.1868
placebo matching with bms-823778,EFO_0000756,melanoma,0.1858515673539529,0.0,0.0,0,0.1859
placebo matching with bms-823778,EFO_0000195,metabolic syndrome,0.1815993585536852,0.0,0.0,0,0.1816
placebo matching with bms-823778,HP_0001513,Obesity,0.1738834519039859,0.0,0.0,0,0.1739
placebo matching with bms-823778,MONDO_0007763,nonpapillary renal cell carcinoma,0.1547841481444171,0.0,0.0,0,0.1548
placebo matching with bms-823778,MONDO_0004975,Alzheimer disease,0.1534628088947827,0.0,0.0,0,0.1535
placebo matching with bms-823778,EFO_0003095,non-alcoholic fatty liver disease,0.1514829666324061,0.0,0.0,0,0.1515
placebo matching with bms-823778,MONDO_0011719,gastrointestinal stromal tumor,0.1503688178721023,0.0,0.0,0,0.1504
placebo matching with bms-823778,EFO_1001069,ocular hypertension,0.1496673168008001,0.0,0.0,0,0.1497
placebo matching with bms-823778,EFO_1001110,pituitary-dependent Cushing's disease,0.1485531680404963,0.0,0.0,0,0.1486
placebo matching with bms-823778,EFO_1001132,pseudotumor cerebri,0.1485531680404963,0.0,0.0,0,0.1486
placebo matching with bms-823778,MONDO_0013616,"pigmented nodular adrenocortical disease, primary, 3",0.1430158487017868,0.0,0.0,0,0.143
placebo matching with bms-823778,EFO_0000729,ulcerative colitis,0.1281496140417894,0.0,0.0,0,0.1281
placebo matching with bms-823778,MONDO_0013310,congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,0.1249109313468514,0.0,0.0,0,0.1249
placebo matching with bms-823778,MONDO_0018479,congenital adrenal hyperplasia,0.1131938002176571,0.0,0.0,0,0.1132
placebo matching with bms-823778,HP_0000855,Insulin resistance,0.1090347159755504,0.0,0.0,0,0.109
placebo matching with bms-823778,MONDO_0008725,congenital lipoid adrenal hyperplasia due to STAR deficency,0.1067874448459106,0.0,0.0,0,0.1068
placebo matching with bms-823778,MONDO_0958023,"lipodystrophy, congenital generalized, type 5",0.1022029290211055,0.0,0.0,0,0.1022
placebo matching with bms-823778,MONDO_0007080,glucocorticoid-remediable aldosteronism,0.0950628860583145,0.0,0.0,0,0.0951
placebo matching with bms-823778,EFO_0000384,Crohn's disease,0.0929413428395162,0.0,0.0,0,0.0929
placebo matching with bms-823778,MONDO_0008733,familial glucocorticoid deficiency,0.0909442494743917,0.0,0.0,0,0.0909
placebo matching with bms-823778,MONDO_0012923,congenital generalized lipodystrophy type 3,0.0899823677113296,0.0,0.0,0,0.09
placebo matching with bms-823778,Orphanet_228429,Generalized congenital lipodystrophy with myopathy,0.0899823677113296,0.0,0.0,0,0.09
placebo matching with bms-823778,Orphanet_411,Hyperlipoproteinemia type 1,0.0869036033036903,0.0,0.0,0,0.0869
placebo matching with bms-823778,MONDO_0012381,hyperinsulinism due to INSR deficiency,0.0810951744333069,0.0,0.0,0,0.0811
placebo matching with bms-823778,EFO_0000389,cutaneous melanoma,0.0799917545129171,0.0,0.0,0,0.08
placebo matching with bms-823778,HP_0040175,Platelet-activating factor acetylhydrolase deficiency,0.0798324725049626,0.0,0.0,0,0.0798
placebo matching with bms-823778,EFO_1001354,Kleine-Levin Syndrome,0.07963935338651,0.0,0.0,0,0.0796
placebo matching with bms-823778,EFO_0004246,mucocutaneous lymph node syndrome,0.078444325679162,0.0,0.0,0,0.0784
placebo matching with bms-823778,MONDO_0007762,hyperlipoproteinemia type V,0.0781835323397132,0.0,0.0,0,0.0782
placebo matching with bms-823778,Orphanet_70470,Hyperlipoproteinemia type 5,0.0781835323397132,0.0,0.0,0,0.0782
placebo matching with bms-823778,MONDO_0014098,CIDEC-related familial partial lipodystrophy,0.0770025346537912,0.0,0.0,0,0.077
placebo matching with bms-823778,MONDO_0007254,breast cancer,0.0765217564437655,0.0,0.0,0,0.0765
placebo matching with bms-823778,EFO_0001073,obesity,0.0749663632775876,0.0,0.0,0,0.075
placebo matching with bms-823778,EFO_0003875,peripheral vascular disease,0.074276584020248,0.0,0.0,0,0.0743
placebo matching with bms-823778,MONDO_0012396,exercise-induced hyperinsulinism,0.073934911733755,0.0,0.0,0,0.0739
placebo matching with bms-823778,MONDO_0859149,hypertriglyceridemia 2,0.0732218565271606,0.0,0.0,0,0.0732
placebo matching with bms-823778,MONDO_0009734,"hyperinsulinemic hypoglycemia, familial, 1",0.0723453928357216,0.0,0.0,0,0.0723
placebo matching with bms-823778,EFO_1001979,Adrenocorticotropic hormone deficiency,0.0711718228082017,0.0,0.0,0,0.0712
placebo matching with bms-823778,MONDO_0011236,hyperinsulinism due to glucokinase deficiency,0.0710678355905733,0.0,0.0,0,0.0711
placebo matching with bms-823778,EFO_0000478,esophageal adenocarcinoma,0.0698794102462494,0.0,0.0,0,0.0699
pregabalin,EFO_0000319,cardiovascular disease,15.301655223678926,1.0,0.0,0,10.7112
pregabalin,EFO_0000275,atrial fibrillation,15.230049427796231,1.0,0.0,0,10.661
pregabalin,EFO_0000537,hypertension,15.118964880586226,1.0,0.0,0,10.5833
pregabalin,EFO_0004269,cardiac arrhythmia,14.38027674166051,1.0,0.0,0,10.0662
pregabalin,MONDO_0014917,"developmental and epileptic encephalopathy, 42",14.190796429750936,1.0,0.0,0,9.9336
pregabalin,HP_0001250,Seizure,14.082269606114933,1.0,0.0,0,9.8576
pregabalin,Orphanet_97,Familial paroxysmal ataxia,13.927430514561255,1.0,0.0,0,9.7492
pregabalin,MONDO_0010979,Timothy syndrome,13.920745479517748,1.0,0.0,0,9.7445
pregabalin,EFO_0000400,diabetes mellitus,13.58021312798232,1.0,0.0,0,9.5061
pregabalin,EFO_0005138,acquired long QT syndrome,13.555769053233355,1.0,0.0,0,9.489
pregabalin,MONDO_0015263,Brugada syndrome,13.501553858389425,1.0,0.0,0,9.4511
pregabalin,EFO_0000474,epilepsy,13.434189345712566,1.0,0.0,0,9.4039
pregabalin,MONDO_0100062,genetic developmental and epileptic encephalopathy,13.412716203822583,1.0,0.0,0,9.3889
pregabalin,MONDO_0007163,episodic ataxia type 2,13.172674059977158,1.0,0.0,0,9.2209
pregabalin,MONDO_0020756,"migraine, familial hemiplegic, 1",13.099016060132945,1.0,0.0,0,9.1693
pregabalin,MONDO_0042979,"hypokalemic periodic paralysis, type 1",13.066457923114603,1.0,0.0,0,9.1465
pregabalin,MONDO_0011001,Brugada syndrome 1,13.026730219712258,1.0,0.0,0,9.1187
pregabalin,EFO_0001645,coronary artery disease,12.931979674474556,1.0,0.0,0,9.0524
pregabalin,MONDO_0013960,sinoatrial node dysfunction and deafness,12.90406885393879,1.0,0.0,0,9.0328
pregabalin,EFO_0003144,heart failure,12.84694025279319,1.0,0.0,0,8.9929
pregabalin,MONDO_0010241,congenital stationary night blindness 2A,12.823162524001887,1.0,0.0,0,8.9762
pregabalin,HP_0012531,Pain,12.568599581949345,1.0,0.0,0,8.798
pregabalin,MONDO_0008457,spinocerebellar ataxia type 6,12.493213730799672,1.0,0.0,0,8.7452
pregabalin,EFO_0003913,angina pectoris,12.474636304609966,1.0,0.0,0,8.7322
pregabalin,MONDO_0004985,bipolar disorder,12.434491867867086,1.0,0.0,0,8.7041
pregabalin,Orphanet_1872,Cone rod dystrophy,12.395686824926404,1.0,0.0,0,8.677
pregabalin,EFO_0009059,Spinocerebellar ataxia type 42,12.37540150094074,1.0,0.0,0,8.6628
pregabalin,MONDO_0013464,episodic ataxia type 5,12.328237228973803,1.0,0.0,0,8.6298
pregabalin,MONDO_0012742,Brugada syndrome 3,12.135806199592674,1.0,0.0,0,8.4951
pregabalin,MONDO_0859514,congenital myopathy 18,12.127841546608158,1.0,0.0,0,8.4895
pregabalin,MONDO_0014200,aldosterone-producing adenoma with seizures and neurological abnormalities,12.049779722981365,1.0,0.0,0,8.4348
pregabalin,HP_0001657,Prolonged QT interval,11.942134888095577,1.0,0.0,0,8.3595
pregabalin,Orphanet_871,Familial progressive cardiac conduction defect,11.93282065962897,1.0,0.0,0,8.353
pregabalin,EFO_0000712,stroke,11.930321787429572,1.0,0.0,0,8.3512
pregabalin,MONDO_0008223,hypokalemic periodic paralysis,11.81515371330024,1.0,0.0,0,8.2706
pregabalin,MONDO_0010371,Aland island eye disease,11.797338000505183,1.0,0.0,0,8.2581
pregabalin,MONDO_0016293,congenital stationary night blindness,11.7371710575553,1.0,0.0,0,8.216
pregabalin,MONDO_0859286,"neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures",11.734855711915673,1.0,0.0,0,8.2144
pregabalin,MONDO_0060551,"cerebellar atrophy, developmental delay, and seizures",11.693733980834493,1.0,0.0,0,8.1856
pregabalin,EFO_0000612,myocardial infarction,11.679093608646276,1.0,0.0,0,8.1754
pregabalin,Orphanet_101016,Romano-Ward syndrome,11.64899402994832,1.0,0.0,0,8.1543
pregabalin,MONDO_0060758,"spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits",11.64892685839759,1.0,0.0,0,8.1542
pregabalin,EFO_0005762,neuropathic pain,11.51967660247097,1.0,0.0,0,8.0638
pregabalin,MONDO_0001134,essential hypertension,11.49376781305492,1.0,0.0,0,8.0456
pregabalin,EFO_0000508,genetic disorder,11.386382589457048,1.0,0.0,0,7.9705
pregabalin,EFO_0010276,neurodevelopmental disorder with seizures and non-epileptic hyperkinetic movements,11.378964327659697,1.0,0.0,0,7.9653
pregabalin,MONDO_0011376,"ventricular fibrillation, paroxysmal familial, type 1",11.271608848304243,1.0,0.0,0,7.8901
pregabalin,EFO_0005687,fibromyalgia,11.145652082343526,1.0,0.0,0,7.802
pregabalin,MONDO_0005090,schizophrenia,11.071795213181844,1.0,0.0,0,7.7503
pregabalin,EFO_1001892,generalized anxiety disorder,11.006491920116632,1.0,0.0,0,7.7045
ranolazine,MONDO_0011001,Brugada syndrome 1,4.6589333260179835,1.0,0.0,0,3.2613
ranolazine,EFO_0004269,cardiac arrhythmia,4.652830275029573,1.0,0.0,0,3.257
ranolazine,EFO_0000275,atrial fibrillation,4.651673339689716,1.0,0.0,0,3.2562
ranolazine,MONDO_0011377,long QT syndrome 3,4.388628180372573,1.0,0.0,0,3.072
ranolazine,MONDO_0015263,Brugada syndrome,4.387318930168344,1.0,0.0,0,3.0711
ranolazine,MONDO_0008195,paramyotonia congenita of Von Eulenburg,4.36740117513351,1.0,0.0,0,3.0572
ranolazine,MONDO_0008224,hyperkalemic periodic paralysis,4.324333347273584,1.0,0.0,0,3.027
ranolazine,Orphanet_871,Familial progressive cardiac conduction defect,4.2794011742458125,1.0,0.0,0,2.9956
ranolazine,MONDO_0007240,"progressive familial heart block, type 1A",4.276407385028826,1.0,0.0,0,2.9935
ranolazine,HP_0001250,Seizure,4.195067397154598,1.0,0.0,0,2.9365
ranolazine,MONDO_0018959,potassium-aggravated myotonia,4.1866895178572845,1.0,0.0,0,2.9307
ranolazine,MONDO_0011003,dilated cardiomyopathy 1E,4.178719012333092,1.0,0.0,0,2.9251
ranolazine,MONDO_0013530,"atrial fibrillation, familial, 10",4.145583533757567,1.0,0.0,0,2.9019
ranolazine,MONDO_0024562,sick sinus syndrome 1,4.135990513270874,1.0,0.0,0,2.8952
ranolazine,EFO_0005303,sudden infant death syndrome,4.124794423198214,1.0,0.0,0,2.8874
ranolazine,MONDO_0008223,hypokalemic periodic paralysis,4.102973912971556,1.0,0.0,0,2.8721
ranolazine,MONDO_0011376,"ventricular fibrillation, paroxysmal familial, type 1",4.042329456289963,1.0,0.0,0,2.8296
ranolazine,EFO_0004138,bundle branch block,4.029504242102426,1.0,0.0,0,2.8207
ranolazine,HP_0012531,Pain,3.980105327970079,1.0,0.0,0,2.7861
ranolazine,Orphanet_101016,Romano-Ward syndrome,3.9389122726487926,1.0,0.0,0,2.7572
ranolazine,Orphanet_590,Congenital myasthenic syndromes,3.932336320473132,1.0,0.0,0,2.7526
ranolazine,EFO_0000319,cardiovascular disease,3.8374519884344904,1.0,0.0,0,2.6862
ranolazine,EFO_0000474,epilepsy,3.8294530342350246,1.0,0.0,0,2.6806
ranolazine,MONDO_0957265,"congenital myopathy 22B, severe fetal",3.8164079042353336,1.0,0.0,0,2.6715
ranolazine,HP_0001657,Prolonged QT interval,3.748223372213716,1.0,0.0,0,2.6238
ranolazine,MONDO_0004985,bipolar disorder,3.727291863426278,1.0,0.0,0,2.6091
ranolazine,MONDO_0005277,migraine disorder,3.698645857299927,1.0,0.0,0,2.5891
ranolazine,MONDO_0019171,familial long QT syndrome,3.644673051383392,1.0,0.0,0,2.5513
ranolazine,EFO_0000407,dilated cardiomyopathy,3.635416842068156,1.0,0.0,0,2.5448
ranolazine,MONDO_0042979,"hypokalemic periodic paralysis, type 1",3.5919988390120254,1.0,0.0,0,2.5144
ranolazine,MONDO_0013620,congenital myasthenic syndrome 16,3.5709945605709237,1.0,0.0,0,2.4997
ranolazine,EFO_0004263,partial epilepsy,3.528129936885023,1.0,0.0,0,2.4697
ranolazine,EFO_0003913,angina pectoris,3.4400614818465667,1.0,0.0,0,2.408
ranolazine,HP_0007359,Focal-onset seizure,3.409674602930993,1.0,0.0,0,2.3868
ranolazine,EFO_0009552,hemorrhoid,3.392347026341813,1.0,0.0,0,2.3746
ranolazine,HP_0000989,Pruritus,3.383641123024894,1.0,0.0,0,2.3685
ranolazine,EFO_0005762,neuropathic pain,3.382606246744884,1.0,0.0,0,2.3678
ranolazine,MONDO_0005178,osteoarthritis,3.3550097113216055,1.0,0.0,0,2.3485
ranolazine,HP_0004308,Ventricular arrhythmia,3.339294839922208,1.0,0.0,0,2.3375
ranolazine,MONDO_0004976,amyotrophic lateral sclerosis,3.329897302780791,1.0,0.0,0,2.3309
ranolazine,EFO_0003911,atrial flutter,3.3295207543664485,1.0,0.0,0,2.3307
ranolazine,MONDO_0957247,"congenital myopathy 22A, classic",3.3289857848600892,1.0,0.0,0,2.3303
ranolazine,Orphanet_98913,Postsynaptic congenital myasthenic syndromes,3.322553098378698,1.0,0.0,0,2.3258
ranolazine,Orphanet_228140,"Idiopathic ventricular fibrillation, not Brugada type",3.3066836624279814,1.0,0.0,0,2.3147
ranolazine,EFO_0000537,hypertension,3.2905241369614644,1.0,0.0,0,2.3034
ranolazine,MONDO_0016532,Lennox-Gastaut syndrome,3.2702807180823017,1.0,0.0,0,2.2892
ranolazine,EFO_0000508,genetic disorder,3.2557161562232326,1.0,0.0,0,2.279
ranolazine,MONDO_0002050,depressive disorder,3.25430727211683,1.0,0.0,0,2.278
ranolazine,EFO_1001219,trigeminal neuralgia,3.235435713861071,1.0,0.0,0,2.2648
ranolazine,EFO_0009963,bipolar I disorder,3.235386241394635,1.0,0.0,0,2.2648
remodulin (treprostinil sodium),EFO_0001361,pulmonary arterial hypertension,3.2286338772621814,0.0,0.0,0,3.2286
remodulin (treprostinil sodium),MONDO_0005149,pulmonary hypertension,2.9951109404403193,0.0,0.0,0,2.9951
remodulin (treprostinil sodium),HP_0004419,Recurrent thrombophlebitis,2.801507765290995,0.0,0.0,0,2.8015
remodulin (treprostinil sodium),EFO_0005772,neurodegenerative disease,2.4919144810506837,0.0,0.0,0,2.4919
remodulin (treprostinil sodium),HP_0012531,Pain,1.9386928905329168,0.0,0.0,0,1.9387
remodulin (treprostinil sodium),EFO_0000537,hypertension,1.9315509169333824,0.0,0.0,0,1.9316
remodulin (treprostinil sodium),EFO_0006834,septic shock,1.9227523986489163,0.0,0.0,0,1.9228
remodulin (treprostinil sodium),MONDO_0017147,idiopathic pulmonary arterial hypertension,1.8842295324294656,0.0,0.0,0,1.8842
remodulin (treprostinil sodium),EFO_0000729,ulcerative colitis,1.8201671846555445,0.0,0.0,0,1.8202
remodulin (treprostinil sodium),EFO_0000768,idiopathic pulmonary fibrosis,1.6220308447970804,0.0,0.0,0,1.622
remodulin (treprostinil sodium),EFO_0000319,cardiovascular disease,1.6081430524082758,0.0,0.0,0,1.6081
remodulin (treprostinil sodium),EFO_0000341,chronic obstructive pulmonary disease,1.5656240651649669,0.0,0.0,0,1.5656
remodulin (treprostinil sodium),MONDO_0019200,retinitis pigmentosa,1.556369626340392,0.0,0.0,0,1.5564
remodulin (treprostinil sodium),MONDO_0001999,primary pulmonary hypertension,1.5469143886483754,0.0,0.0,0,1.5469
remodulin (treprostinil sodium),EFO_1001145,Raynaud disease,1.475032551447764,0.0,0.0,0,1.475
remodulin (treprostinil sodium),EFO_0009658,adverse effect,1.4747478819106987,0.0,0.0,0,1.4747
remodulin (treprostinil sodium),MONDO_0004979,asthma,1.4738219567532151,0.0,0.0,0,1.4738
remodulin (treprostinil sodium),MONDO_0005148,type 2 diabetes mellitus,1.462649948878573,0.0,0.0,0,1.4626
remodulin (treprostinil sodium),EFO_0001645,coronary artery disease,1.4430304047823457,0.0,0.0,0,1.443
remodulin (treprostinil sodium),MONDO_0018852,achromatopsia,1.4306619453288874,0.0,0.0,0,1.4307
remodulin (treprostinil sodium),EFO_1001459,diabetic foot,1.407717320199678,0.0,0.0,0,1.4077
remodulin (treprostinil sodium),EFO_0000712,stroke,1.4044387300363554,0.0,0.0,0,1.4044
remodulin (treprostinil sodium),MONDO_0100130,adult acute respiratory distress syndrome,1.3903121526832112,0.0,0.0,0,1.3903
remodulin (treprostinil sodium),EFO_0000556,ischemia,1.370546723618402,0.0,0.0,0,1.3705
remodulin (treprostinil sodium),Orphanet_1872,Cone rod dystrophy,1.3336572725604836,0.0,0.0,0,1.3337
remodulin (treprostinil sodium),EFO_0000612,myocardial infarction,1.3184803704918246,0.0,0.0,0,1.3185
remodulin (treprostinil sodium),EFO_0003913,angina pectoris,1.2926834317608282,0.0,0.0,0,1.2927
remodulin (treprostinil sodium),EFO_0009448,pulmonary fibrosis,1.2892565607060134,0.0,0.0,0,1.2893
remodulin (treprostinil sodium),MONDO_0013822,acrodysostosis 2 with or without hormone resistance,1.2823759951301383,0.0,0.0,0,1.2824
remodulin (treprostinil sodium),MONDO_0005277,migraine disorder,1.2769974869401066,0.0,0.0,0,1.277
remodulin (treprostinil sodium),EFO_0004244,interstitial lung disease,1.270304327729045,0.0,0.0,0,1.2703
remodulin (treprostinil sodium),EFO_0000676,psoriasis,1.25041471135101,0.0,0.0,0,1.2504
remodulin (treprostinil sodium),HP_0003124,Hypercholesterolemia,1.241698488801329,0.0,0.0,0,1.2417
remodulin (treprostinil sodium),MONDO_0012833,Crouzon syndrome-acanthosis nigricans syndrome,1.236118803714455,0.0,0.0,0,1.2361
remodulin (treprostinil sodium),MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,1.2110423777158303,0.0,0.0,0,1.211
remodulin (treprostinil sodium),Orphanet_1276,Brachydactyly - arterial hypertension,1.1895599638523269,0.0,0.0,0,1.1896
remodulin (treprostinil sodium),EFO_0003144,heart failure,1.1747090342831998,0.0,0.0,0,1.1747
remodulin (treprostinil sodium),EFO_0000274,atopic eczema,1.164814456052245,0.0,0.0,0,1.1648
remodulin (treprostinil sodium),EFO_0009492,cardiac arrest,1.1493922399268044,0.0,0.0,0,1.1494
remodulin (treprostinil sodium),EFO_0000616,neoplasm,1.1461710594457224,0.0,0.0,0,1.1462
remodulin (treprostinil sodium),MONDO_0005041,glaucoma,1.1456348841935742,0.0,0.0,0,1.1456
remodulin (treprostinil sodium),Orphanet_309005,Disorder of lipid metabolism,1.1410880829844496,0.0,0.0,0,1.1411
remodulin (treprostinil sodium),MONDO_0016293,congenital stationary night blindness,1.1393938299890096,0.0,0.0,0,1.1394
remodulin (treprostinil sodium),HP_0100806,Sepsis,1.1266793356980775,0.0,0.0,0,1.1267
remodulin (treprostinil sodium),MONDO_0013437,retinitis pigmentosa 43,1.1227328916707495,0.0,0.0,0,1.1227
remodulin (treprostinil sodium),MONDO_0004992,cancer,1.1219445678004976,0.0,0.0,0,1.1219
remodulin (treprostinil sodium),MONDO_0021187,hyperlipidemia,1.12166335892608,0.0,0.0,0,1.1217
remodulin (treprostinil sodium),Orphanet_79211,Combined hyperlipidemia,1.12166335892608,0.0,0.0,0,1.1217
remodulin (treprostinil sodium),HP_0006536,Airway obstruction,1.119374753690431,0.0,0.0,0,1.1194
remodulin (treprostinil sodium),MONDO_0014835,"striatal degeneration, autosomal dominant 2",1.1151901705079166,0.0,0.0,0,1.1152
repatha,EFO_0004911,familial hypercholesterolemia,2.9058569262750287,0.0,0.0,0,2.9059
repatha,MONDO_0011369,"hypercholesterolemia, autosomal dominant, 3",2.70586465886561,0.0,0.0,0,2.7059
repatha,HP_0003124,Hypercholesterolemia,2.6539123081398346,0.0,0.0,0,2.6539
repatha,EFO_0001645,coronary artery disease,2.503624314117451,0.0,0.0,0,2.5036
repatha,EFO_0000319,cardiovascular disease,2.4722584043751024,0.0,0.0,0,2.4723
repatha,EFO_0000589,metabolic disease,2.3055488757387117,0.0,0.0,0,2.3055
repatha,Orphanet_309005,Disorder of lipid metabolism,2.2170512532759004,0.0,0.0,0,2.2171
repatha,MONDO_0018328,homozygous familial hypercholesterolemia,2.206284704788466,0.0,0.0,0,2.2063
repatha,MONDO_0021187,hyperlipidemia,2.203136859660998,0.0,0.0,0,2.2031
repatha,EFO_0000612,myocardial infarction,2.1383678544611064,0.0,0.0,0,2.1384
repatha,EFO_0003914,atherosclerosis,2.11003330899773,0.0,0.0,0,2.11
repatha,EFO_1001375,Myocardial Ischemia,1.8796123064811092,0.0,0.0,0,1.8796
repatha,MONDO_0007750,"hypercholesterolemia, familial, 1",1.7836214902334102,0.0,0.0,0,1.7836
repatha,HP_0003077,Hyperlipidemia,1.773337140058782,0.0,0.0,0,1.7733
repatha,MONDO_0021661,coronary atherosclerosis,1.763336321760802,0.0,0.0,0,1.7633
repatha,MONDO_0001336,familial hyperlipidemia,1.7621089943612105,0.0,0.0,0,1.7621
repatha,EFO_0003913,angina pectoris,1.733713012728092,0.0,0.0,0,1.7337
repatha,EFO_0003777,heart disease,1.720350777630642,0.0,0.0,0,1.7204
repatha,GO_0036273,response to statin,1.6929627454314395,0.0,0.0,0,1.693
repatha,EFO_0000195,metabolic syndrome,1.6508188367808607,0.0,0.0,0,1.6508
repatha,HP_0001626,Abnormality of the cardiovascular system,1.544989115822175,0.0,0.0,0,1.545
repatha,HP_0003146,Hypocholesterolemia,1.519787603332834,0.0,0.0,0,1.5198
repatha,MONDO_0009387,familial lipoprotein lipase deficiency,1.477404180953503,0.0,0.0,0,1.4774
repatha,HP_0003119,Abnormal circulating lipid concentration,1.4715700044219706,0.0,0.0,0,1.4716
repatha,EFO_0000400,diabetes mellitus,1.4497025252387634,0.0,0.0,0,1.4497
repatha,EFO_0004214,Abdominal Aortic Aneurysm,1.4288552428438437,0.0,0.0,0,1.4289
repatha,MONDO_0008692,abetalipoproteinemia,1.3915521393970829,0.0,0.0,0,1.3916
repatha,MONDO_0013144,hereditary antithrombin deficiency,1.3529384233905548,0.0,0.0,0,1.3529
repatha,HP_0001976,Reduced antithrombin III activity,1.259039852698564,0.0,0.0,0,1.259
repatha,EFO_0000712,stroke,1.2359095786396606,0.0,0.0,0,1.2359
repatha,EFO_0004286,venous thromboembolism,1.2276020375212808,0.0,0.0,0,1.2276
repatha,EFO_0000275,atrial fibrillation,1.2246559981045952,0.0,0.0,0,1.2247
repatha,EFO_1000985,intermediate coronary syndrome,1.2118467948374598,0.0,0.0,0,1.2118
repatha,EFO_0008583,acute myocardial infarction,1.2064338630397655,0.0,0.0,0,1.2064
repatha,EFO_0004264,vascular disease,1.195063853700586,0.0,0.0,0,1.1951
repatha,EFO_0005672,acute coronary syndrome,1.1946395370223528,0.0,0.0,0,1.1946
repatha,EFO_0003144,heart failure,1.1943910450436237,0.0,0.0,0,1.1944
repatha,HP_0011428,Short fetal femur length,1.187066470233723,0.0,0.0,0,1.1871
repatha,MONDO_0016085,Cole-Carpenter syndrome,1.1861271155659427,0.0,0.0,0,1.1861
repatha,HP_0004936,Venous thrombosis,1.160990275789953,0.0,0.0,0,1.161
repatha,EFO_0004329,alcohol drinking,1.153512135309475,0.0,0.0,0,1.1535
repatha,MONDO_0100096,COVID-19,1.1527810225729451,0.0,0.0,0,1.1528
repatha,Orphanet_79211,Combined hyperlipidemia,1.1360479736028382,0.0,0.0,0,1.136
repatha,EFO_0003776,coronary artery bypass,1.1279602973638454,0.0,0.0,0,1.128
repatha,EFO_0003940,physical activity,1.1225894210654916,0.0,0.0,0,1.1226
repatha,EFO_0003951,percutaneous transluminal coronary angioplasty,1.1225894210654916,0.0,0.0,0,1.1226
repatha,EFO_0003907,deep vein thrombosis,1.101982647890135,0.0,0.0,0,1.102
repatha,EFO_0003884,chronic kidney disease,1.0458297478468073,0.0,0.0,0,1.0458
repatha,EFO_0003086,kidney disease,1.0396200487798937,0.0,0.0,0,1.0396
repatha,EFO_0009578,placental retention,0.9852322328973993,0.0,0.0,0,0.9852
rimonabant,EFO_0001073,obesity,2.0028528271570245,0.0,0.0,0,2.0029
rimonabant,MONDO_0004992,cancer,1.8836584159151248,0.0,0.0,0,1.8837
rimonabant,HP_0012531,Pain,1.743318750296837,0.0,0.0,0,1.7433
rimonabant,EFO_0000474,epilepsy,1.692202673458652,0.0,0.0,0,1.6922
rimonabant,MONDO_0016532,Lennox-Gastaut syndrome,1.6900817993008064,0.0,0.0,0,1.6901
rimonabant,HP_0002017,Nausea and vomiting,1.602376227037257,0.0,0.0,0,1.6024
rimonabant,HP_0002018,Nausea,1.5204222775032776,0.0,0.0,0,1.5204
rimonabant,HP_0001250,Seizure,1.491305393259052,0.0,0.0,0,1.4913
rimonabant,MONDO_0005148,type 2 diabetes mellitus,1.412916877633804,0.0,0.0,0,1.4129
rimonabant,EFO_0010702,opioid use disorder,1.3990456127819952,0.0,0.0,0,1.399
rimonabant,EFO_0005611,opioid dependence,1.3225270886515077,0.0,0.0,0,1.3225
rimonabant,EFO_0004616,"osteoarthritis, knee",1.289629200330651,0.0,0.0,0,1.2896
rimonabant,EFO_0004319,smoking cessation,1.2460759006940505,0.0,0.0,0,1.2461
rimonabant,MONDO_0007079,alcohol dependence,1.2176576160625712,0.0,0.0,0,1.2177
rimonabant,HP_0012532,Chronic pain,1.1959524121990142,0.0,0.0,0,1.196
rimonabant,HP_0002039,Anorexia,1.1889177770424944,0.0,0.0,0,1.1889
rimonabant,EFO_1000634,hamartoma,1.1772560035375763,0.0,0.0,0,1.1773
rimonabant,EFO_0005762,neuropathic pain,1.1652867312011783,0.0,0.0,0,1.1653
rimonabant,MONDO_0012354,platelet-type bleeding disorder 8,1.1463122862682256,0.0,0.0,0,1.1463
rimonabant,EFO_0003890,drug dependence,1.1029516947082771,0.0,0.0,0,1.103
rimonabant,EFO_1000783,diabetic neuropathy,1.101741454968901,0.0,0.0,0,1.1017
rimonabant,EFO_0000555,irritable bowel syndrome,1.098760742239176,0.0,0.0,0,1.0988
rimonabant,MONDO_0004985,bipolar disorder,1.088466822293406,0.0,0.0,0,1.0885
rimonabant,HP_0001397,Hepatic steatosis,1.0858811574787106,0.0,0.0,0,1.0859
rimonabant,Orphanet_36355,P2Y12 defect,1.0682290169877355,0.0,0.0,0,1.0682
rimonabant,MONDO_0005180,Parkinson disease,1.0644649374714663,0.0,0.0,0,1.0645
rimonabant,EFO_0000612,myocardial infarction,1.0608752198699016,0.0,0.0,0,1.0609
rimonabant,EFO_0000195,metabolic syndrome,1.0556211372509705,0.0,0.0,0,1.0556
rimonabant,MONDO_0010726,Rett syndrome,1.0300990030953796,0.0,0.0,0,1.0301
rimonabant,MONDO_0018097,infantile spasms,1.0300990030953796,0.0,0.0,0,1.0301
rimonabant,Orphanet_309005,Disorder of lipid metabolism,1.0300990030953796,0.0,0.0,0,1.0301
rimonabant,EFO_0001645,coronary artery disease,1.027849236307808,0.0,0.0,0,1.0278
rimonabant,EFO_0005772,neurodegenerative disease,1.0204644264740146,0.0,0.0,0,1.0205
rimonabant,EFO_0005687,fibromyalgia,1.006727144689814,0.0,0.0,0,1.0067
rimonabant,EFO_0009521,dislocation,1.0020311730750098,0.0,0.0,0,1.002
rimonabant,EFO_0009866,pulmonary vascular congestion,1.0020311730750098,0.0,0.0,0,1.002
rimonabant,MONDO_0009060,cystic disease of lung,0.9881510825804398,0.0,0.0,0,0.9882
rimonabant,EFO_0008583,acute myocardial infarction,0.984937956513647,0.0,0.0,0,0.9849
rimonabant,EFO_0000712,stroke,0.9780889433785664,0.0,0.0,0,0.9781
rimonabant,EFO_0005672,acute coronary syndrome,0.9731704098235748,0.0,0.0,0,0.9732
rimonabant,HP_0002014,Diarrhea,0.957762425825498,0.0,0.0,0,0.9578
rimonabant,HP_0002019,Constipation,0.9577162630870492,0.0,0.0,0,0.9577
rimonabant,MONDO_0002462,glomerulonephritis,0.9393083814102824,0.0,0.0,0,0.9393
rimonabant,MONDO_0008300,Prader-Willi syndrome,0.9363109414802192,0.0,0.0,0,0.9363
rimonabant,MONDO_0005277,migraine disorder,0.9352075658594664,0.0,0.0,0,0.9352
rimonabant,MONDO_0021661,coronary atherosclerosis,0.9325499675949253,0.0,0.0,0,0.9325
rimonabant,MONDO_0010383,fragile X syndrome,0.913543354470815,0.0,0.0,0,0.9135
rimonabant,MONDO_0005090,schizophrenia,0.9132958184855778,0.0,0.0,0,0.9133
rimonabant,EFO_0004698,insomnia,0.911066867565702,0.0,0.0,0,0.9111
rimonabant,MONDO_0007254,breast cancer,0.909414707559958,0.0,0.0,0,0.9094
rosiglitazone,MONDO_0005148,type 2 diabetes mellitus,11.392484754012074,0.0,0.0,0,11.3925
rosiglitazone,MONDO_0011448,PPARG-related familial partial lipodystrophy,10.719432586702112,0.0,0.0,0,10.7194
rosiglitazone,EFO_0000400,diabetes mellitus,10.04596734349902,0.0,0.0,0,10.046
rosiglitazone,EFO_0000729,ulcerative colitis,8.550656730099506,0.0,0.0,0,8.5507
rosiglitazone,EFO_0001073,obesity,8.117190128209684,0.0,0.0,0,8.1172
rosiglitazone,EFO_0001074,morbid obesity,7.807404420911833,0.0,0.0,0,7.8074
rosiglitazone,HP_0003124,Hypercholesterolemia,7.364449728224574,0.0,0.0,0,7.3644
rosiglitazone,EFO_0000319,cardiovascular disease,7.303115954140583,0.0,0.0,0,7.3031
rosiglitazone,EFO_0001645,coronary artery disease,7.302039499347698,0.0,0.0,0,7.302
rosiglitazone,EFO_0005628,proctitis,6.773538625687371,0.0,0.0,0,6.7735
rosiglitazone,EFO_1001950,colon carcinoma,6.7097397889120485,0.0,0.0,0,6.7097
rosiglitazone,MONDO_0019182,inherited obesity,6.445900431529504,0.0,0.0,0,6.4459
rosiglitazone,EFO_0000537,hypertension,6.365177354548177,0.0,0.0,0,6.3652
rosiglitazone,HP_0000924,Abnormality of the skeletal system,6.134713846684055,0.0,0.0,0,6.1347
rosiglitazone,EFO_1000727,lipodystrophy,6.123156979901725,0.0,0.0,0,6.1232
rosiglitazone,HP_0009125,Lipodystrophy,5.945319124702832,0.0,0.0,0,5.9453
rosiglitazone,EFO_0000195,metabolic syndrome,5.943990497934736,0.0,0.0,0,5.944
rosiglitazone,EFO_0000384,Crohn's disease,5.928811580388484,0.0,0.0,0,5.9288
rosiglitazone,MONDO_0004975,Alzheimer disease,5.846153514029663,0.0,0.0,0,5.8462
rosiglitazone,HP_0000855,Insulin resistance,5.783674498429141,0.0,0.0,0,5.7837
rosiglitazone,EFO_0004274,gout,5.728458046726883,0.0,0.0,0,5.7285
rosiglitazone,EFO_0003095,non-alcoholic fatty liver disease,5.627513481544331,0.0,0.0,0,5.6275
rosiglitazone,EFO_1000783,diabetic neuropathy,5.596503202136758,0.0,0.0,0,5.5965
rosiglitazone,EFO_0003914,atherosclerosis,5.595051142595219,0.0,0.0,0,5.5951
rosiglitazone,MONDO_0020088,familial partial lipodystrophy,5.59323604965712,0.0,0.0,0,5.5932
rosiglitazone,EFO_0003770,diabetic retinopathy,5.530676739471858,0.0,0.0,0,5.5307
rosiglitazone,EFO_1001486,primary biliary cirrhosis,5.445515545795706,0.0,0.0,0,5.4455
rosiglitazone,MONDO_0004979,asthma,5.406840859893012,0.0,0.0,0,5.4068
rosiglitazone,EFO_0000616,neoplasm,5.271840364013161,0.0,0.0,0,5.2718
rosiglitazone,HP_0001513,Obesity,5.269490438865254,0.0,0.0,0,5.2695
rosiglitazone,MONDO_0011962,endometrial cancer,5.2548100302061265,0.0,0.0,0,5.2548
rosiglitazone,EFO_0004705,hypothyroidism,5.249193605684485,0.0,0.0,0,5.2492
rosiglitazone,Orphanet_309005,Disorder of lipid metabolism,5.13527969146932,0.0,0.0,0,5.1353
rosiglitazone,EFO_1000941,frozen shoulder,5.074153567457077,0.0,0.0,0,5.0742
rosiglitazone,MONDO_0018883,Berardinelli-Seip congenital lipodystrophy,5.068388507131118,0.0,0.0,0,5.0684
rosiglitazone,EFO_0000641,papillary thyroid carcinoma,5.040434817760611,0.0,0.0,0,5.0404
rosiglitazone,EFO_0000685,rheumatoid arthritis,4.939341108399458,0.0,0.0,0,4.9393
rosiglitazone,EFO_0003767,inflammatory bowel disease,4.910333606046287,0.0,0.0,0,4.9103
rosiglitazone,EFO_0005140,autoimmune disease,4.891271727926962,0.0,0.0,0,4.8913
rosiglitazone,EFO_1000681,congenital generalized lipodystrophy,4.884282769428058,0.0,0.0,0,4.8843
rosiglitazone,EFO_0003841,thyroid neoplasm,4.8589677570801015,0.0,0.0,0,4.859
rosiglitazone,EFO_0001642,lymphoid neoplasm,4.856181014592503,0.0,0.0,0,4.8562
rosiglitazone,EFO_0000673,prostate adenocarcinoma,4.845648898182869,0.0,0.0,0,4.8456
rosiglitazone,EFO_0000501,follicular thyroid carcinoma,4.822967468248123,0.0,0.0,0,4.823
rosiglitazone,MONDO_0001583,diabetic polyneuropathy,4.814919085689502,0.0,0.0,0,4.8149
rosiglitazone,Orphanet_79211,Combined hyperlipidemia,4.777492315708812,0.0,0.0,0,4.7775
rosiglitazone,EFO_1000261,Follicular Variant Thyroid Gland Papillary Carcinoma,4.739588196126593,0.0,0.0,0,4.7396
rosiglitazone,MONDO_0021187,hyperlipidemia,4.723463864284527,0.0,0.0,0,4.7235
rosiglitazone,MONDO_0004483,thyroid gland oncocytic adenoma,4.717853434176837,0.0,0.0,0,4.7179
rosiglitazone,EFO_1000122,Benign Thyroid Gland Neoplasm,4.709024014150306,0.0,0.0,0,4.709
rosuvastatin,HP_0003124,Hypercholesterolemia,4.933217740180516,1.0,0.0,0,3.4533
rosuvastatin,MONDO_0021187,hyperlipidemia,4.845499374382493,1.0,0.0,0,3.3918
rosuvastatin,EFO_0001645,coronary artery disease,4.790190738379875,1.0,0.0,0,3.3531
rosuvastatin,EFO_0004911,familial hypercholesterolemia,4.503957057819439,1.0,0.0,0,3.1528
rosuvastatin,EFO_0000319,cardiovascular disease,4.462884304617532,1.0,0.0,0,3.124
rosuvastatin,EFO_0000712,stroke,4.363053505116997,1.0,0.0,0,3.0541
rosuvastatin,MONDO_0957270,"muscular dystrophy, limb-girdle, autosomal recessive 28",4.139181387657921,1.0,0.0,0,2.8974
rosuvastatin,MONDO_0005148,type 2 diabetes mellitus,4.112784979850193,1.0,0.0,0,2.8789
rosuvastatin,EFO_0000612,myocardial infarction,4.0349585125306335,1.0,0.0,0,2.8245
rosuvastatin,HP_0003119,Abnormal circulating lipid concentration,3.9327261105025513,1.0,0.0,0,2.7529
rosuvastatin,EFO_0003914,atherosclerosis,3.873268201585155,1.0,0.0,0,2.7113
rosuvastatin,MONDO_0004975,Alzheimer disease,3.868476294930664,1.0,0.0,0,2.7079
rosuvastatin,EFO_0003913,angina pectoris,3.863629413422242,1.0,0.0,0,2.7045
rosuvastatin,EFO_0000373,congestive heart failure,3.8369037769256056,1.0,0.0,0,2.6858
rosuvastatin,EFO_0000537,hypertension,3.827293118600767,1.0,0.0,0,2.6791
rosuvastatin,MONDO_0005301,multiple sclerosis,3.6886049872558786,1.0,0.0,0,2.582
rosuvastatin,EFO_0005772,neurodegenerative disease,3.682190813719466,1.0,0.0,0,2.5775
rosuvastatin,EFO_0000589,metabolic disease,3.649567887688011,1.0,0.0,0,2.5547
rosuvastatin,EFO_0000400,diabetes mellitus,3.6416669282093506,1.0,0.0,0,2.5492
rosuvastatin,EFO_0000195,metabolic syndrome,3.5536216770031643,1.0,0.0,0,2.4875
rosuvastatin,Orphanet_309005,Disorder of lipid metabolism,3.451584924544929,1.0,0.0,0,2.4161
rosuvastatin,MONDO_0005180,Parkinson disease,3.445586101873285,1.0,0.0,0,2.4119
rosuvastatin,MONDO_0018473,hyperlipoproteinemia type 3,3.3908130177989007,1.0,0.0,0,2.3736
rosuvastatin,MONDO_0021661,coronary atherosclerosis,3.267835882400563,1.0,0.0,0,2.2875
rosuvastatin,MONDO_0002561,lysosomal storage disease,3.1221168810178797,1.0,0.0,0,2.1855
rosuvastatin,EFO_0008583,acute myocardial infarction,3.0371903135417453,1.0,0.0,0,2.126
rosuvastatin,EFO_0003144,heart failure,3.03366373053073,1.0,0.0,0,2.1236
rosuvastatin,Orphanet_79211,Combined hyperlipidemia,2.818124869401234,1.0,0.0,0,1.9727
rosuvastatin,MONDO_0001336,familial hyperlipidemia,2.7727416637700424,1.0,0.0,0,1.9409
rosuvastatin,MONDO_0100096,COVID-19,2.712483131831161,1.0,0.0,0,1.8987
rosuvastatin,EFO_0004211,Hypertriglyceridemia,2.6531207653257143,1.0,0.0,0,1.8572
rosuvastatin,EFO_1001375,Myocardial Ischemia,2.6170798235550556,1.0,0.0,0,1.832
rosuvastatin,HP_0003077,Hyperlipidemia,2.6096540692120263,1.0,0.0,0,1.8268
rosuvastatin,MONDO_0005147,type 1 diabetes mellitus,2.5963853546596805,1.0,0.0,0,1.8175
rosuvastatin,HP_0002140,Ischemic stroke,2.54837978994417,1.0,0.0,0,1.7839
rosuvastatin,EFO_0005672,acute coronary syndrome,2.5099170764918135,1.0,0.0,0,1.7569
rosuvastatin,MONDO_0016971,limb-girdle muscular dystrophy,2.4969739995092692,1.0,0.0,0,1.7479
rosuvastatin,EFO_0003884,chronic kidney disease,2.477294596111572,1.0,0.0,0,1.7341
rosuvastatin,EFO_0001073,obesity,2.392857400626029,1.0,0.0,0,1.675
rosuvastatin,EFO_0003929,relapsing-remitting multiple sclerosis,2.3900258965152026,1.0,0.0,0,1.673
rosuvastatin,MONDO_0008315,prostate cancer,2.3850703244687725,1.0,0.0,0,1.6695
rosuvastatin,EFO_1000727,lipodystrophy,2.379320341589604,1.0,0.0,0,1.6655
rosuvastatin,EFO_0000275,atrial fibrillation,2.3659595467973276,1.0,0.0,0,1.6562
rosuvastatin,GO_0036273,response to statin,2.3637690965826086,1.0,0.0,0,1.6546
rosuvastatin,EFO_0008585,ST Elevation Myocardial Infarction,2.3486911301687723,1.0,0.0,0,1.6441
rosuvastatin,EFO_0000341,chronic obstructive pulmonary disease,2.3163513320411333,1.0,0.0,0,1.6214
rosuvastatin,MONDO_0004992,cancer,2.288730660905142,1.0,0.0,0,1.6021
rosuvastatin,EFO_0000764,HIV infection,2.2523892301700803,1.0,0.0,0,1.5767
rosuvastatin,MONDO_0005575,colorectal cancer,2.2498931727742955,1.0,0.0,0,1.5749
rosuvastatin,MONDO_0008903,lung cancer,2.229148188765344,1.0,0.0,0,1.5604
serine proteinase-1 (serp-1),MONDO_0042490,"neutropenia, severe congenital, 1, autosomal dominant",10.684977764053016,0.0,0.0,0,10.685
serine proteinase-1 (serp-1),MONDO_0008090,cyclic hematopoiesis,10.564108326242849,0.0,0.0,0,10.5641
serine proteinase-1 (serp-1),Orphanet_2686,Cyclic neutropenia,10.548200114973811,0.0,0.0,0,10.5482
serine proteinase-1 (serp-1),MONDO_0001475,neutropenia,7.061207416418718,0.0,0.0,0,7.0612
serine proteinase-1 (serp-1),MONDO_0018542,severe congenital neutropenia,6.857353726922563,0.0,0.0,0,6.8574
serine proteinase-1 (serp-1),HP_0001875,Decreased total neutrophil count,6.786226829281052,0.0,0.0,0,6.7862
serine proteinase-1 (serp-1),MONDO_0019751,autoinflammatory syndrome,5.91911488585729,0.0,0.0,0,5.9191
serine proteinase-1 (serp-1),EFO_0003026,minimally differentiated acute myeloblastic leukemia,5.8862800176878824,0.0,0.0,0,5.8863
serine proteinase-1 (serp-1),EFO_0000508,genetic disorder,5.818215227799257,0.0,0.0,0,5.8182
serine proteinase-1 (serp-1),MONDO_0008742,autosomal dominant severe congenital neutropenia,5.55664833669736,0.0,0.0,0,5.5566
serine proteinase-1 (serp-1),EFO_0005772,neurodegenerative disease,5.363254764698948,0.0,0.0,0,5.3633
serine proteinase-1 (serp-1),EFO_0003818,lung disease,4.757309054783094,0.0,0.0,0,4.7573
serine proteinase-1 (serp-1),MP_0001914,hemorrhage,4.7160875501715305,0.0,0.0,0,4.7161
serine proteinase-1 (serp-1),MONDO_0017953,hereditary periodic fever syndrome,4.709024014150306,0.0,0.0,0,4.709
serine proteinase-1 (serp-1),Orphanet_60,Alpha-1-antitrypsin deficiency,4.633847935671903,0.0,0.0,0,4.6338
serine proteinase-1 (serp-1),MONDO_0010294,X-linked severe congenital neutropenia,4.566597016351963,0.0,0.0,0,4.5666
serine proteinase-1 (serp-1),EFO_0000341,chronic obstructive pulmonary disease,4.039608409568944,0.0,0.0,0,4.0396
serine proteinase-1 (serp-1),EFO_0000694,severe acute respiratory syndrome,3.6317758197915775,0.0,0.0,0,3.6318
serine proteinase-1 (serp-1),HP_0100806,Sepsis,3.5623991368315737,0.0,0.0,0,3.5624
serine proteinase-1 (serp-1),EFO_0003777,heart disease,3.335122694647107,0.0,0.0,0,3.3351
serine proteinase-1 (serp-1),EFO_0000616,neoplasm,2.4837856836367367,0.0,0.0,0,2.4838
serine proteinase-1 (serp-1),MONDO_0100096,COVID-19,2.3455382541224647,0.0,0.0,0,2.3455
serine proteinase-1 (serp-1),EFO_0003060,non-small cell lung carcinoma,2.179872408534648,0.0,0.0,0,2.1799
serine proteinase-1 (serp-1),EFO_0004274,gout,2.012455110095758,0.0,0.0,0,2.0125
serine proteinase-1 (serp-1),MONDO_0001056,gastric cancer,1.9758334561666735,0.0,0.0,0,1.9758
serine proteinase-1 (serp-1),MONDO_0005147,type 1 diabetes mellitus,1.9082806232803349,0.0,0.0,0,1.9083
serine proteinase-1 (serp-1),MONDO_0004992,cancer,1.9068283801523516,0.0,0.0,0,1.9068
serine proteinase-1 (serp-1),MONDO_0013730,graft versus host disease,1.804944721550444,0.0,0.0,0,1.8049
serine proteinase-1 (serp-1),MONDO_0007254,breast cancer,1.8010980385283606,0.0,0.0,0,1.8011
serine proteinase-1 (serp-1),MONDO_0018088,familial Mediterranean fever,1.7930815386887535,0.0,0.0,0,1.7931
serine proteinase-1 (serp-1),EFO_0000756,melanoma,1.7744315731444988,0.0,0.0,0,1.7744
serine proteinase-1 (serp-1),MONDO_0008903,lung cancer,1.6998227521326168,0.0,0.0,0,1.6998
serine proteinase-1 (serp-1),EFO_0002618,pancreatic carcinoma,1.6375069629875647,0.0,0.0,0,1.6375
serine proteinase-1 (serp-1),MONDO_0022096,pyogenic granuloma,1.6270536489512302,0.0,0.0,0,1.6271
serine proteinase-1 (serp-1),EFO_0000222,acute myeloid leukemia,1.6157826076676374,0.0,0.0,0,1.6158
serine proteinase-1 (serp-1),EFO_0003884,chronic kidney disease,1.542508190854745,0.0,0.0,0,1.5425
serine proteinase-1 (serp-1),MONDO_0008315,prostate cancer,1.536592193834057,0.0,0.0,0,1.5366
serine proteinase-1 (serp-1),EFO_0000546,injury,1.5360995733543352,0.0,0.0,0,1.5361
serine proteinase-1 (serp-1),EFO_0003914,atherosclerosis,1.5354791251074824,0.0,0.0,0,1.5355
serine proteinase-1 (serp-1),EFO_0000544,infection,1.525158884963625,0.0,0.0,0,1.5252
serine proteinase-1 (serp-1),EFO_0000305,breast carcinoma,1.5235179000620072,0.0,0.0,0,1.5235
serine proteinase-1 (serp-1),EFO_0001378,multiple myeloma,1.4859727989619853,0.0,0.0,0,1.486
serine proteinase-1 (serp-1),EFO_0000571,lung adenocarcinoma,1.4634520506602615,0.0,0.0,0,1.4635
serine proteinase-1 (serp-1),EFO_0000403,diffuse large B-cell lymphoma,1.440176368378553,0.0,0.0,0,1.4402
serine proteinase-1 (serp-1),EFO_0000565,leukemia,1.4140983511850729,0.0,0.0,0,1.4141
serine proteinase-1 (serp-1),MONDO_0009061,cystic fibrosis,1.3982402049485712,0.0,0.0,0,1.3982
serine proteinase-1 (serp-1),EFO_0007427,pericarditis,1.3971831885541568,0.0,0.0,0,1.3972
serine proteinase-1 (serp-1),EFO_0000540,immune system disease,1.385894047016698,0.0,0.0,0,1.3859
serine proteinase-1 (serp-1),EFO_0000673,prostate adenocarcinoma,1.379623784321623,0.0,0.0,0,1.3796
serine proteinase-1 (serp-1),EFO_0000339,chronic myelogenous leukemia,1.3545243471742434,0.0,0.0,0,1.3545
sildenafil,MONDO_0019200,retinitis pigmentosa,4.725777708482338,1.0,0.0,0,3.308
sildenafil,EFO_0000319,cardiovascular disease,4.372235778373601,1.0,0.0,0,3.0606
sildenafil,EFO_0001645,coronary artery disease,4.362058045703796,1.0,0.0,0,3.0534
sildenafil,MONDO_0018852,achromatopsia,4.340644509219443,1.0,0.0,0,3.0385
sildenafil,EFO_0000712,stroke,4.167848590304611,1.0,0.0,0,2.9175
sildenafil,Orphanet_1872,Cone rod dystrophy,4.056202922506624,1.0,0.0,0,2.8393
sildenafil,MONDO_0013822,acrodysostosis 2 with or without hormone resistance,3.847127985390415,1.0,0.0,0,2.693
sildenafil,EFO_0000537,hypertension,3.843465479832964,1.0,0.0,0,2.6904
sildenafil,MONDO_0004979,asthma,3.81450786264374,1.0,0.0,0,2.6702
sildenafil,EFO_0000341,chronic obstructive pulmonary disease,3.747358255262998,1.0,0.0,0,2.6232
sildenafil,EFO_0000676,psoriasis,3.7322604540137534,1.0,0.0,0,2.6126
sildenafil,MONDO_0044637,infantile-onset generalized dyskinesia with orofacial involvement,3.6998455908146175,1.0,0.0,0,2.5899
sildenafil,EFO_0001361,pulmonary arterial hypertension,3.634958795805789,1.0,0.0,0,2.5445
sildenafil,Orphanet_1276,Brachydactyly - arterial hypertension,3.5686798915569806,1.0,0.0,0,2.4981
sildenafil,MONDO_0016293,congenital stationary night blindness,3.525489587318144,1.0,0.0,0,2.4678
sildenafil,MONDO_0013437,retinitis pigmentosa 43,3.4300520075485625,1.0,0.0,0,2.401
sildenafil,MONDO_0030900,intellectual developmental disorder with paroxysmal dyskinesia or seizures,3.3707963353369683,1.0,0.0,0,2.3596
sildenafil,MONDO_0014835,"striatal degeneration, autosomal dominant 2",3.34557051152375,1.0,0.0,0,2.3419
sildenafil,EFO_0003144,heart failure,3.341256378108474,1.0,0.0,0,2.3389
sildenafil,MONDO_0007211,brachydactyly-arterial hypertension syndrome,3.336000569465021,1.0,0.0,0,2.3352
sildenafil,HP_0006536,Airway obstruction,3.3261958695309306,1.0,0.0,0,2.3283
sildenafil,EFO_0000274,atopic eczema,3.2968888578538333,1.0,0.0,0,2.3078
sildenafil,HP_0000556,Retinal dystrophy,3.266097707133731,1.0,0.0,0,2.2863
sildenafil,HP_0004419,Recurrent thrombophlebitis,3.215083916596696,1.0,0.0,0,2.2506
sildenafil,Orphanet_2754,Joubert syndrome with orofaciodigital defect,3.212269159567612,1.0,0.0,0,2.2486
sildenafil,MONDO_0005149,pulmonary hypertension,3.1913998550806744,1.0,0.0,0,2.234
sildenafil,EFO_0003778,psoriatic arthritis,3.1883687107683913,1.0,0.0,0,2.2319
sildenafil,MONDO_0019797,acrodysostosis,3.1015932486009605,1.0,0.0,0,2.1711
sildenafil,EFO_0000400,diabetes mellitus,3.0958002851383757,1.0,0.0,0,2.1671
sildenafil,EFO_0005772,neurodegenerative disease,3.0347330888127853,1.0,0.0,0,2.1243
sildenafil,EFO_0000508,genetic disorder,3.0210094217265855,1.0,0.0,0,2.1147
sildenafil,MONDO_0012205,autosomal dominant striatal neurodegeneration type 1,2.990047480259625,1.0,0.0,0,2.093
sildenafil,EFO_0004705,hypothyroidism,2.989332520510268,1.0,0.0,0,2.0925
sildenafil,EFO_0004234,erectile dysfunction,2.976839632305186,1.0,0.0,0,2.0838
sildenafil,MONDO_0005090,schizophrenia,2.9762394178798286,1.0,0.0,0,2.0834
sildenafil,HP_0000924,Abnormality of the skeletal system,2.9735359135211747,1.0,0.0,0,2.0815
sildenafil,EFO_0000284,benign prostatic hyperplasia,2.9317429459879305,1.0,0.0,0,2.0522
sildenafil,EFO_1001494,psoriasis vulgaris,2.924694511012193,1.0,0.0,0,2.0473
sildenafil,EFO_0000479,essential thrombocythemia,2.9207537746371144,1.0,0.0,0,2.0445
sildenafil,HP_0000802,Impotence,2.8648705917018074,1.0,0.0,0,2.0054
sildenafil,MONDO_0005148,type 2 diabetes mellitus,2.8347357717148904,1.0,0.0,0,1.9843
sildenafil,MONDO_0029137,"hearing loss, autosomal dominant 74",2.8322091186813347,1.0,0.0,0,1.9825
sildenafil,EFO_0006505,chronic bronchitis,2.8002428770381407,1.0,0.0,0,1.9602
sildenafil,HP_0002140,Ischemic stroke,2.7871975826371096,1.0,0.0,0,1.951
sildenafil,MONDO_0001134,essential hypertension,2.7742432189475776,1.0,0.0,0,1.942
sildenafil,EFO_0000275,atrial fibrillation,2.760712853504035,1.0,0.0,0,1.9325
sildenafil,EFO_0005670,smoking initiation,2.7030330438124026,1.0,0.0,0,1.8921
sildenafil,Orphanet_228169,Autosomal dominant striatal neurodegeneration,2.702389167976414,1.0,0.0,0,1.8917
sildenafil,MONDO_0002009,major depressive disorder,2.6757582860665137,1.0,0.0,0,1.873
sildenafil,EFO_0020026,autosomal recessive retinitis pigmentosa,2.636302016554362,1.0,0.0,0,1.8454
spironolactone,EFO_0000537,hypertension,3.864579948014754,1.0,0.0,0,2.7052
spironolactone,MONDO_0014421,glucocorticoid resistance,3.8606368674344367,1.0,0.0,0,2.7024
spironolactone,MONDO_0005148,type 2 diabetes mellitus,3.8017844638651064,1.0,0.0,0,2.6612
spironolactone,EFO_0000341,chronic obstructive pulmonary disease,3.782509846998157,1.0,0.0,0,2.6478
spironolactone,MONDO_0008329,autosomal dominant pseudohypoaldosteronism type 1,3.712397474885377,1.0,0.0,0,2.5987
spironolactone,MONDO_0005301,multiple sclerosis,3.5340402945570055,1.0,0.0,0,2.4738
spironolactone,Orphanet_171871,Renal pseudohypoaldosteronism type 1,3.4961644104611516,1.0,0.0,0,2.4473
spironolactone,EFO_0000400,diabetes mellitus,3.4820054197067662,1.0,0.0,0,2.4374
spironolactone,EFO_0000729,ulcerative colitis,3.4431628292846135,1.0,0.0,0,2.4102
spironolactone,MONDO_0004992,cancer,3.4401182912402706,1.0,0.0,0,2.4081
spironolactone,EFO_0000565,leukemia,3.372260570121913,1.0,0.0,0,2.3606
spironolactone,EFO_0000544,infection,3.325775423018213,1.0,0.0,0,2.328
spironolactone,EFO_0000616,neoplasm,3.3185730013043244,1.0,0.0,0,2.323
spironolactone,EFO_0003144,heart failure,3.312145708420883,1.0,0.0,0,2.3185
spironolactone,EFO_0000574,lymphoma,3.2962438322604575,1.0,0.0,0,2.3074
spironolactone,EFO_0000275,atrial fibrillation,3.2798012995946566,1.0,0.0,0,2.2959
spironolactone,EFO_0000612,myocardial infarction,3.2766738610256025,1.0,0.0,0,2.2937
spironolactone,EFO_0000685,rheumatoid arthritis,3.2426071917878567,1.0,0.0,0,2.2698
spironolactone,MONDO_0011517,pseudohyperaldosteronism type 2,3.230367788178371,1.0,0.0,0,2.2613
spironolactone,MONDO_0004979,asthma,3.147540067005836,1.0,0.0,0,2.2033
spironolactone,EFO_0004274,gout,3.1299097619656937,1.0,0.0,0,2.1909
spironolactone,EFO_0000676,psoriasis,3.1256961482788186,1.0,0.0,0,2.188
spironolactone,EFO_0000384,Crohn's disease,3.095689656127832,1.0,0.0,0,2.167
spironolactone,EFO_0004255,nephrotic syndrome,3.0784166803245627,1.0,0.0,0,2.1549
spironolactone,EFO_0003884,chronic kidney disease,3.0478543102947,1.0,0.0,0,2.1335
spironolactone,EFO_0007160,autoimmune thrombocytopenic purpura,3.0429812993462235,1.0,0.0,0,2.1301
spironolactone,EFO_1000941,frozen shoulder,3.0338979817878395,1.0,0.0,0,2.1237
spironolactone,MONDO_0019338,sarcoidosis,3.0327456356286335,1.0,0.0,0,2.1229
spironolactone,EFO_0000274,atopic eczema,3.019195740605292,1.0,0.0,0,2.1134
spironolactone,EFO_0000319,cardiovascular disease,3.016699708616916,1.0,0.0,0,2.1117
spironolactone,MP_0001845,inflammation,3.006997800547206,1.0,0.0,0,2.1049
spironolactone,EFO_0005854,allergic rhinitis,3.006042419335226,1.0,0.0,0,2.1042
spironolactone,EFO_0003894,acne,2.997132685377313,1.0,0.0,0,2.098
spironolactone,EFO_0000701,skin disease,2.9929334325069954,1.0,0.0,0,2.0951
spironolactone,EFO_0002609,juvenile idiopathic arthritis,2.990407044284281,1.0,0.0,0,2.0933
spironolactone,MONDO_0005178,osteoarthritis,2.989520165321954,1.0,0.0,0,2.0927
spironolactone,EFO_1001494,psoriasis vulgaris,2.9742304363516987,1.0,0.0,0,2.082
spironolactone,MONDO_0018479,congenital adrenal hyperplasia,2.927444061976737,1.0,0.0,0,2.0492
spironolactone,MONDO_0008728,classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,2.921171249549041,1.0,0.0,0,2.0448
spironolactone,EFO_0003106,pneumonia,2.8947070229526095,1.0,0.0,0,2.0263
spironolactone,MONDO_0008315,prostate cancer,2.8815493915968036,1.0,0.0,0,2.0171
spironolactone,MONDO_0007915,systemic lupus erythematosus,2.8780456321909305,1.0,0.0,0,2.0146
spironolactone,MONDO_0015128,primary adrenal insufficiency,2.87244104316712,1.0,0.0,0,2.0107
spironolactone,EFO_0003956,seasonal allergic rhinitis,2.8724388794491267,1.0,0.0,0,2.0107
spironolactone,EFO_1001194,subacute thyroiditis,2.868354068647131,1.0,0.0,0,2.0078
spironolactone,EFO_0007141,allergic conjunctivitis,2.867318829368236,1.0,0.0,0,2.0071
spironolactone,MONDO_0005271,allergic disease,2.860548221490107,1.0,0.0,0,2.0024
spironolactone,EFO_1001119,posterior uveitis,2.8564697660959384,1.0,0.0,0,1.9995
spironolactone,EFO_1001417,"Rhinitis, Allergic, Perennial",2.852923279218524,1.0,0.0,0,1.997
spironolactone,EFO_0003778,psoriatic arthritis,2.85113765983826,1.0,0.0,0,1.9958
tacrolimus,MONDO_0007254,breast cancer,4.36354970568172,1.0,0.0,0,3.0545
tacrolimus,EFO_0000616,neoplasm,4.302556485240469,1.0,0.0,0,3.0118
tacrolimus,EFO_0000274,atopic eczema,4.267472418759634,1.0,0.0,0,2.9872
tacrolimus,EFO_0000681,renal cell carcinoma,4.226827753360094,1.0,0.0,0,2.9588
tacrolimus,EFO_0000305,breast carcinoma,3.8048658506694286,1.0,0.0,0,2.6634
tacrolimus,EFO_1001901,neuroendocrine neoplasm,3.78326490256037,1.0,0.0,0,2.6483
tacrolimus,EFO_1000634,hamartoma,3.700933960731117,1.0,0.0,0,2.5907
tacrolimus,MONDO_0004992,cancer,3.5226746607220067,1.0,0.0,0,2.4659
tacrolimus,MONDO_0001734,tuberous sclerosis,3.4462793551672464,1.0,0.0,0,2.4124
tacrolimus,EFO_1001469,Mantle cell lymphoma,3.3355782238734895,1.0,0.0,0,2.3349
tacrolimus,MONDO_0004555,kidney angiomyolipoma,3.307371227346051,1.0,0.0,0,2.3152
tacrolimus,EFO_0005772,neurodegenerative disease,3.28683745936882,1.0,0.0,0,2.3008
tacrolimus,HP_0000964,Eczematoid dermatitis,3.2496005508858583,1.0,0.0,0,2.2747
tacrolimus,MONDO_0002603,angiomyolipoma,3.2496005508858583,1.0,0.0,0,2.2747
tacrolimus,EFO_1000045,pancreatic neuroendocrine tumor,3.1625112561221167,1.0,0.0,0,2.2138
tacrolimus,MONDO_0013730,graft versus host disease,2.944161389250879,1.0,0.0,0,2.0609
tacrolimus,EFO_0000272,astrocytoma,2.926812832361449,1.0,0.0,0,2.0488
tacrolimus,EFO_0007141,allergic conjunctivitis,2.9105847174014468,1.0,0.0,0,2.0374
tacrolimus,EFO_1002048,kidney failure,2.8871649396381693,1.0,0.0,0,2.021
tacrolimus,EFO_0000729,ulcerative colitis,2.8840971558108324,1.0,0.0,0,2.0189
tacrolimus,EFO_0004599,acute graft vs. host disease,2.872701617139425,1.0,0.0,0,2.0109
tacrolimus,EFO_0000676,psoriasis,2.8725676781381395,1.0,0.0,0,2.0108
tacrolimus,EFO_0000183,Hodgkins lymphoma,2.842403757717707,1.0,0.0,0,1.9897
tacrolimus,EFO_0003086,kidney disease,2.8335474849031943,1.0,0.0,0,1.9835
tacrolimus,MONDO_0005147,type 1 diabetes mellitus,2.8242388237564846,1.0,0.0,0,1.977
tacrolimus,EFO_0004255,nephrotic syndrome,2.8192112596360808,1.0,0.0,0,1.9734
tacrolimus,EFO_0005761,lupus nephritis,2.8174853971434777,1.0,0.0,0,1.9722
tacrolimus,EFO_0001645,coronary artery disease,2.778072311951685,1.0,0.0,0,1.9447
tacrolimus,EFO_0000182,hepatocellular carcinoma,2.7757940392404676,1.0,0.0,0,1.9431
tacrolimus,EFO_0005952,non-Hodgkins lymphoma,2.765265815766736,1.0,0.0,0,1.9357
tacrolimus,EFO_0003884,chronic kidney disease,2.7623020140888457,1.0,0.0,0,1.9336
tacrolimus,HP_0009720,Adenoma sebaceum,2.729664462744121,1.0,0.0,0,1.9108
tacrolimus,EFO_0000685,rheumatoid arthritis,2.7241989872756567,1.0,0.0,0,1.9069
tacrolimus,EFO_0000694,severe acute respiratory syndrome,2.7177226152762395,1.0,0.0,0,1.9024
tacrolimus,MONDO_0008315,prostate cancer,2.659490799533046,1.0,0.0,0,1.8616
tacrolimus,EFO_0000540,immune system disease,2.655544238809696,1.0,0.0,0,1.8589
tacrolimus,EFO_0000574,lymphoma,2.6412452747715247,1.0,0.0,0,1.8489
tacrolimus,EFO_0003966,eye disease,2.622344697123819,1.0,0.0,0,1.8356
tacrolimus,EFO_0003869,breast neoplasm,2.611906400181027,1.0,0.0,0,1.8283
tacrolimus,MONDO_0002898,skin cancer,2.6110428695682852,1.0,0.0,0,1.8277
tacrolimus,MONDO_0001056,gastric cancer,2.6034047737892263,1.0,0.0,0,1.8224
tacrolimus,EFO_0010134,kidney transplant,2.599680440708686,1.0,0.0,0,1.8198
tacrolimus,MONDO_0004768,keratoconjunctivitis,2.5906537725117813,1.0,0.0,0,1.8135
tacrolimus,MONDO_0024327,chronic renal failure syndrome,2.5788903672844454,1.0,0.0,0,1.8052
tacrolimus,EFO_0000403,diffuse large B-cell lymphoma,2.5255456368747593,1.0,0.0,0,1.7679
tacrolimus,EFO_0004991,Myasthenia gravis,2.5122747069587343,1.0,0.0,0,1.7586
tacrolimus,EFO_1001496,Autosomal dominant polycystic kidney disease,2.503564477748041,1.0,0.0,0,1.7525
tacrolimus,EFO_0000349,clear cell renal carcinoma,2.4659497499206062,1.0,0.0,0,1.7262
tacrolimus,EFO_0000544,infection,2.463692092642948,1.0,0.0,0,1.7246
tacrolimus,EFO_1001947,childhood T acute lymphoblastic leukemia,2.4497885844333247,1.0,0.0,0,1.7149
temsirolimus,MONDO_0007254,breast cancer,4.36354970568172,1.0,0.0,0,3.0545
temsirolimus,EFO_0000616,neoplasm,4.302556485240469,1.0,0.0,0,3.0118
temsirolimus,EFO_0000274,atopic eczema,4.267472418759634,1.0,0.0,0,2.9872
temsirolimus,EFO_0000681,renal cell carcinoma,4.226827753360094,1.0,0.0,0,2.9588
temsirolimus,EFO_0000305,breast carcinoma,3.8048658506694286,1.0,0.0,0,2.6634
temsirolimus,EFO_1001901,neuroendocrine neoplasm,3.78326490256037,1.0,0.0,0,2.6483
temsirolimus,EFO_1000634,hamartoma,3.700933960731117,1.0,0.0,0,2.5907
temsirolimus,MONDO_0004992,cancer,3.5226746607220067,1.0,0.0,0,2.4659
temsirolimus,MONDO_0001734,tuberous sclerosis,3.4462793551672464,1.0,0.0,0,2.4124
temsirolimus,EFO_1001469,Mantle cell lymphoma,3.3355782238734895,1.0,0.0,0,2.3349
temsirolimus,MONDO_0004555,kidney angiomyolipoma,3.307371227346051,1.0,0.0,0,2.3152
temsirolimus,EFO_0005772,neurodegenerative disease,3.28683745936882,1.0,0.0,0,2.3008
temsirolimus,HP_0000964,Eczematoid dermatitis,3.2496005508858583,1.0,0.0,0,2.2747
temsirolimus,MONDO_0002603,angiomyolipoma,3.2496005508858583,1.0,0.0,0,2.2747
temsirolimus,EFO_1000045,pancreatic neuroendocrine tumor,3.1625112561221167,1.0,0.0,0,2.2138
temsirolimus,MONDO_0013730,graft versus host disease,2.944161389250879,1.0,0.0,0,2.0609
temsirolimus,EFO_0000272,astrocytoma,2.926812832361449,1.0,0.0,0,2.0488
temsirolimus,EFO_0007141,allergic conjunctivitis,2.9105847174014468,1.0,0.0,0,2.0374
temsirolimus,EFO_1002048,kidney failure,2.8871649396381693,1.0,0.0,0,2.021
temsirolimus,EFO_0000729,ulcerative colitis,2.8840971558108324,1.0,0.0,0,2.0189
temsirolimus,EFO_0004599,acute graft vs. host disease,2.872701617139425,1.0,0.0,0,2.0109
temsirolimus,EFO_0000676,psoriasis,2.8725676781381395,1.0,0.0,0,2.0108
temsirolimus,EFO_0000183,Hodgkins lymphoma,2.842403757717707,1.0,0.0,0,1.9897
temsirolimus,EFO_0003086,kidney disease,2.8335474849031943,1.0,0.0,0,1.9835
temsirolimus,MONDO_0005147,type 1 diabetes mellitus,2.8242388237564846,1.0,0.0,0,1.977
temsirolimus,EFO_0004255,nephrotic syndrome,2.8192112596360808,1.0,0.0,0,1.9734
temsirolimus,EFO_0005761,lupus nephritis,2.8174853971434777,1.0,0.0,0,1.9722
temsirolimus,EFO_0001645,coronary artery disease,2.778072311951685,1.0,0.0,0,1.9447
temsirolimus,EFO_0000182,hepatocellular carcinoma,2.7757940392404676,1.0,0.0,0,1.9431
temsirolimus,EFO_0005952,non-Hodgkins lymphoma,2.765265815766736,1.0,0.0,0,1.9357
temsirolimus,EFO_0003884,chronic kidney disease,2.7623020140888457,1.0,0.0,0,1.9336
temsirolimus,HP_0009720,Adenoma sebaceum,2.729664462744121,1.0,0.0,0,1.9108
temsirolimus,EFO_0000685,rheumatoid arthritis,2.7241989872756567,1.0,0.0,0,1.9069
temsirolimus,EFO_0000694,severe acute respiratory syndrome,2.7177226152762395,1.0,0.0,0,1.9024
temsirolimus,MONDO_0008315,prostate cancer,2.659490799533046,1.0,0.0,0,1.8616
temsirolimus,EFO_0000540,immune system disease,2.655544238809696,1.0,0.0,0,1.8589
temsirolimus,EFO_0000574,lymphoma,2.6412452747715247,1.0,0.0,0,1.8489
temsirolimus,EFO_0003966,eye disease,2.622344697123819,1.0,0.0,0,1.8356
temsirolimus,EFO_0003869,breast neoplasm,2.611906400181027,1.0,0.0,0,1.8283
temsirolimus,MONDO_0002898,skin cancer,2.6110428695682852,1.0,0.0,0,1.8277
temsirolimus,MONDO_0001056,gastric cancer,2.6034047737892263,1.0,0.0,0,1.8224
temsirolimus,EFO_0010134,kidney transplant,2.599680440708686,1.0,0.0,0,1.8198
temsirolimus,MONDO_0004768,keratoconjunctivitis,2.5906537725117813,1.0,0.0,0,1.8135
temsirolimus,MONDO_0024327,chronic renal failure syndrome,2.5788903672844454,1.0,0.0,0,1.8052
temsirolimus,EFO_0000403,diffuse large B-cell lymphoma,2.5255456368747593,1.0,0.0,0,1.7679
temsirolimus,EFO_0004991,Myasthenia gravis,2.5122747069587343,1.0,0.0,0,1.7586
temsirolimus,EFO_1001496,Autosomal dominant polycystic kidney disease,2.503564477748041,1.0,0.0,0,1.7525
temsirolimus,EFO_0000349,clear cell renal carcinoma,2.4659497499206062,1.0,0.0,0,1.7262
temsirolimus,EFO_0000544,infection,2.463692092642948,1.0,0.0,0,1.7246
temsirolimus,EFO_1001947,childhood T acute lymphoblastic leukemia,2.4497885844333247,1.0,0.0,0,1.7149
temsirolimus + dexamethasone sodium phosphate,MONDO_0014421,glucocorticoid resistance,10.29503164649183,0.0,0.0,0,10.295
temsirolimus + dexamethasone sodium phosphate,EFO_0000341,chronic obstructive pulmonary disease,9.52831771665366,0.0,0.0,0,9.5283
temsirolimus + dexamethasone sodium phosphate,MONDO_0005301,multiple sclerosis,9.14464754962289,0.0,0.0,0,9.1446
temsirolimus + dexamethasone sodium phosphate,MONDO_0004992,cancer,8.598526620880715,0.0,0.0,0,8.5985
temsirolimus + dexamethasone sodium phosphate,EFO_0000729,ulcerative colitis,8.534381000632088,0.0,0.0,0,8.5344
temsirolimus + dexamethasone sodium phosphate,EFO_0000565,leukemia,8.516854093136647,0.0,0.0,0,8.5169
temsirolimus + dexamethasone sodium phosphate,EFO_0000574,lymphoma,8.445517980732712,0.0,0.0,0,8.4455
temsirolimus + dexamethasone sodium phosphate,EFO_0000544,infection,8.41911520419772,0.0,0.0,0,8.4191
temsirolimus + dexamethasone sodium phosphate,EFO_0000685,rheumatoid arthritis,8.390538148770414,0.0,0.0,0,8.3905
temsirolimus + dexamethasone sodium phosphate,EFO_0000616,neoplasm,8.14061767185984,0.0,0.0,0,8.1406
temsirolimus + dexamethasone sodium phosphate,MONDO_0004979,asthma,8.120503370637106,0.0,0.0,0,8.1205
temsirolimus + dexamethasone sodium phosphate,EFO_0000676,psoriasis,8.116672660831703,0.0,0.0,0,8.1167
temsirolimus + dexamethasone sodium phosphate,EFO_0007160,autoimmune thrombocytopenic purpura,8.10704922658741,0.0,0.0,0,8.107
temsirolimus + dexamethasone sodium phosphate,EFO_0000384,Crohn's disease,8.071244235524912,0.0,0.0,0,8.0712
temsirolimus + dexamethasone sodium phosphate,EFO_0004255,nephrotic syndrome,8.062294009899656,0.0,0.0,0,8.0623
temsirolimus + dexamethasone sodium phosphate,EFO_0004274,gout,8.042349815358246,0.0,0.0,0,8.0423
temsirolimus + dexamethasone sodium phosphate,EFO_0000274,atopic eczema,7.964346536248601,0.0,0.0,0,7.9643
temsirolimus + dexamethasone sodium phosphate,MONDO_0005178,osteoarthritis,7.9361142248783905,0.0,0.0,0,7.9361
temsirolimus + dexamethasone sodium phosphate,EFO_1000941,frozen shoulder,7.911259654547156,0.0,0.0,0,7.9113
temsirolimus + dexamethasone sodium phosphate,MONDO_0019338,sarcoidosis,7.908254771148925,0.0,0.0,0,7.9083
temsirolimus + dexamethasone sodium phosphate,MP_0001845,inflammation,7.894378142237148,0.0,0.0,0,7.8944
temsirolimus + dexamethasone sodium phosphate,EFO_0005854,allergic rhinitis,7.891869946003687,0.0,0.0,0,7.8919
temsirolimus + dexamethasone sodium phosphate,EFO_0000701,skin disease,7.804439587446128,0.0,0.0,0,7.8044
temsirolimus + dexamethasone sodium phosphate,EFO_0002609,juvenile idiopathic arthritis,7.797851721493462,0.0,0.0,0,7.7979
temsirolimus + dexamethasone sodium phosphate,EFO_1001494,psoriasis vulgaris,7.75566923992925,0.0,0.0,0,7.7557
temsirolimus + dexamethasone sodium phosphate,EFO_0007141,allergic conjunctivitis,7.736198229392854,0.0,0.0,0,7.7362
temsirolimus + dexamethasone sodium phosphate,EFO_0003106,pneumonia,7.719218727873625,0.0,0.0,0,7.7192
temsirolimus + dexamethasone sodium phosphate,EFO_0003956,seasonal allergic rhinitis,7.712586250951357,0.0,0.0,0,7.7126
temsirolimus + dexamethasone sodium phosphate,EFO_1001417,"Rhinitis, Allergic, Perennial",7.660186267406198,0.0,0.0,0,7.6602
temsirolimus + dexamethasone sodium phosphate,EFO_0000275,atrial fibrillation,7.657766660821495,0.0,0.0,0,7.6578
temsirolimus + dexamethasone sodium phosphate,EFO_1001194,subacute thyroiditis,7.648944183059016,0.0,0.0,0,7.6489
temsirolimus + dexamethasone sodium phosphate,MONDO_0007915,systemic lupus erythematosus,7.620062414202699,0.0,0.0,0,7.6201
temsirolimus + dexamethasone sodium phosphate,EFO_0003778,psoriatic arthritis,7.603033759568693,0.0,0.0,0,7.603
temsirolimus + dexamethasone sodium phosphate,EFO_1001435,tenosynovitis,7.591653618201162,0.0,0.0,0,7.5917
temsirolimus + dexamethasone sodium phosphate,EFO_1001119,posterior uveitis,7.582912671608514,0.0,0.0,0,7.5829
temsirolimus + dexamethasone sodium phosphate,MONDO_0018479,congenital adrenal hyperplasia,7.551756008408467,0.0,0.0,0,7.5518
temsirolimus + dexamethasone sodium phosphate,MONDO_0008728,classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,7.535574401539955,0.0,0.0,0,7.5356
temsirolimus + dexamethasone sodium phosphate,EFO_0000768,idiopathic pulmonary fibrosis,7.505799873765328,0.0,0.0,0,7.5058
temsirolimus + dexamethasone sodium phosphate,HP_0001742,Nasal congestion,7.5045984860551025,0.0,0.0,0,7.5046
temsirolimus + dexamethasone sodium phosphate,EFO_0005752,eye inflammation,7.491554098204271,0.0,0.0,0,7.4916
temsirolimus + dexamethasone sodium phosphate,EFO_1001231,uveitis,7.474177572193679,0.0,0.0,0,7.4742
temsirolimus + dexamethasone sodium phosphate,EFO_1000764,seborrheic dermatitis,7.465252191922184,0.0,0.0,0,7.4653
temsirolimus + dexamethasone sodium phosphate,EFO_1000906,dry eye syndrome,7.454077157138731,0.0,0.0,0,7.4541
temsirolimus + dexamethasone sodium phosphate,HP_0001873,Thrombocytopenia,7.448017700828403,0.0,0.0,0,7.448
temsirolimus + dexamethasone sodium phosphate,EFO_1001222,type III hypersensitivity reaction disease,7.4214022520545155,0.0,0.0,0,7.4214
temsirolimus + dexamethasone sodium phosphate,MONDO_0002406,dermatitis,7.409889756542656,0.0,0.0,0,7.4099
temsirolimus + dexamethasone sodium phosphate,MONDO_0015128,primary adrenal insufficiency,7.409867941896394,0.0,0.0,0,7.4099
temsirolimus + dexamethasone sodium phosphate,EFO_0007257,eosinophilic pneumonia,7.402085643343408,0.0,0.0,0,7.4021
temsirolimus + dexamethasone sodium phosphate,HP_0012531,Pain,7.392603036598609,0.0,0.0,0,7.3926
temsirolimus + dexamethasone sodium phosphate,EFO_1000049,pulmonary tuberculosis,7.379173104960923,0.0,0.0,0,7.3792
ticagrelor,MONDO_0012354,platelet-type bleeding disorder 8,1.7194684294023383,1.0,0.0,0,1.2036
ticagrelor,Orphanet_36355,P2Y12 defect,1.6023435254816034,1.0,0.0,0,1.1216
ticagrelor,EFO_0000612,myocardial infarction,1.499999502316808,1.0,0.0,0,1.05
ticagrelor,EFO_0001645,coronary artery disease,1.488104565294434,1.0,0.0,0,1.0417
ticagrelor,EFO_0005672,acute coronary syndrome,1.4597556147353623,1.0,0.0,0,1.0218
ticagrelor,EFO_0008583,acute myocardial infarction,1.425978263976451,1.0,0.0,0,0.9982
ticagrelor,EFO_0000712,stroke,1.4160623664361789,1.0,0.0,0,0.9912
ticagrelor,EFO_0004265,peripheral arterial disease,1.3431350978152992,1.0,0.0,0,0.9402
ticagrelor,HP_0004419,Recurrent thrombophlebitis,1.32206549944891,1.0,0.0,0,0.9254
ticagrelor,MONDO_0000831,thrombotic disease,1.2950060458128914,1.0,0.0,0,0.9065
ticagrelor,MONDO_0030030,Nizon-Isidor syndrome,1.1834680998443794,1.0,0.0,0,0.8284
ticagrelor,EFO_0000556,ischemia,1.1313115877073967,1.0,0.0,0,0.7919
ticagrelor,EFO_0000508,genetic disorder,1.1214267344520552,1.0,0.0,0,0.785
ticagrelor,MP_0001914,hemorrhage,1.1131936560117404,1.0,0.0,0,0.7792
ticagrelor,MONDO_0005148,type 2 diabetes mellitus,1.0950218999031285,1.0,0.0,0,0.7665
ticagrelor,HP_0001249,Intellectual disability,1.011550814273387,1.0,0.0,0,0.7081
ticagrelor,HP_0002140,Ischemic stroke,1.00522261735663,1.0,0.0,0,0.7037
ticagrelor,EFO_0000275,atrial fibrillation,0.9940877376684802,1.0,0.0,0,0.6959
ticagrelor,EFO_0003884,chronic kidney disease,0.9830770900901408,1.0,0.0,0,0.6882
ticagrelor,HP_0001873,Thrombocytopenia,0.95948865206519,1.0,0.0,0,0.6716
ticagrelor,MONDO_0100096,COVID-19,0.9570458391205484,1.0,0.0,0,0.6699
ticagrelor,HP_0001892,Abnormal bleeding,0.953577362865437,1.0,0.0,0,0.6675
ticagrelor,EFO_0008585,ST Elevation Myocardial Infarction,0.9500770150638485,1.0,0.0,0,0.6651
ticagrelor,EFO_0003875,peripheral vascular disease,0.9354034733108256,1.0,0.0,0,0.6548
ticagrelor,EFO_1000985,intermediate coronary syndrome,0.8829420026531825,1.0,0.0,0,0.6181
ticagrelor,EFO_0000266,aortic stenosis,0.8820835868172695,1.0,0.0,0,0.6175
ticagrelor,MONDO_0011382,sickle cell disease,0.8695766833086198,1.0,0.0,0,0.6087
ticagrelor,EFO_0007328,influenza,0.8598431686956941,1.0,0.0,0,0.6019
ticagrelor,EFO_0003106,pneumonia,0.8522842942277244,1.0,0.0,0,0.5966
ticagrelor,EFO_0003914,atherosclerosis,0.841839671704794,1.0,0.0,0,0.5893
ticagrelor,EFO_0000341,chronic obstructive pulmonary disease,0.839281695698565,1.0,0.0,0,0.5875
ticagrelor,EFO_0002615,internal carotid artery stenosis,0.8092163454316417,1.0,0.0,0,0.5665
ticagrelor,MONDO_0024327,chronic renal failure syndrome,0.7823847190176809,1.0,0.0,0,0.5477
ticagrelor,EFO_0003870,brain aneurysm,0.7816444113397121,1.0,0.0,0,0.5472
ticagrelor,HP_0002239,Gastrointestinal hemorrhage,0.7725742523215346,1.0,0.0,0,0.5408
ticagrelor,HP_0030680,Abnormal cardiovascular system morphology,0.7725742523215346,1.0,0.0,0,0.5408
ticagrelor,EFO_0003913,angina pectoris,0.7481169656613191,1.0,0.0,0,0.5237
ticagrelor,HP_0004866,Impaired ADP-induced platelet aggregation,0.7377470955502146,1.0,0.0,0,0.5164
ticagrelor,EFO_0002618,pancreatic carcinoma,0.7166733156564862,1.0,0.0,0,0.5017
ticagrelor,EFO_0003764,transient ischemic attack,0.7021465675503611,1.0,0.0,0,0.4915
ticagrelor,GO_0070527,platelet aggregation,0.6793012402079219,1.0,0.0,0,0.4755
ticagrelor,MONDO_0004992,cancer,0.657005707677732,1.0,0.0,0,0.4599
ticagrelor,EFO_0009959,diverticular disease,0.6511849190966823,1.0,0.0,0,0.4558
ticagrelor,EFO_0003144,heart failure,0.6361434177182461,1.0,0.0,0,0.4453
ticagrelor,HP_0011869,Abnormal platelet function,0.6357182419102911,1.0,0.0,0,0.445
ticagrelor,EFO_0009086,arteriosclerosis,0.6303085518272392,1.0,0.0,0,0.4412
ticagrelor,EFO_0001365,age-related macular degeneration,0.6294093955478851,1.0,0.0,0,0.4406
ticagrelor,EFO_0020925,angina unstable,0.6278642200270136,1.0,0.0,0,0.4395
ticagrelor,EFO_1001375,Myocardial Ischemia,0.6267197521198498,1.0,0.0,0,0.4387
ticagrelor,EFO_1000044,pancreatic adenocarcinoma,0.6251229378784529,1.0,0.0,0,0.4376
trilipix,MONDO_0005148,type 2 diabetes mellitus,7.837992335340784,0.0,0.0,0,7.838
trilipix,EFO_0000400,diabetes mellitus,6.803715946129082,0.0,0.0,0,6.8037
trilipix,HP_0003124,Hypercholesterolemia,6.423956816306698,0.0,0.0,0,6.424
trilipix,EFO_0000319,cardiovascular disease,6.2704419081008735,0.0,0.0,0,6.2704
trilipix,EFO_0001645,coronary artery disease,6.071841149152083,0.0,0.0,0,6.0718
trilipix,HP_0003119,Abnormal circulating lipid concentration,5.503534078363644,0.0,0.0,0,5.5035
trilipix,MONDO_0021187,hyperlipidemia,4.86137110822923,0.0,0.0,0,4.8614
trilipix,EFO_0000537,hypertension,4.792973778444817,0.0,0.0,0,4.793
trilipix,Orphanet_309005,Disorder of lipid metabolism,4.592936956841971,0.0,0.0,0,4.5929
trilipix,MONDO_0011448,PPARG-related familial partial lipodystrophy,4.591598549494713,0.0,0.0,0,4.5916
trilipix,EFO_1001486,primary biliary cirrhosis,4.437461186046076,0.0,0.0,0,4.4375
trilipix,Orphanet_79211,Combined hyperlipidemia,4.359780940524052,0.0,0.0,0,4.3598
trilipix,EFO_0000729,ulcerative colitis,4.282324746257909,0.0,0.0,0,4.2823
trilipix,EFO_0000612,myocardial infarction,4.2822343211435125,0.0,0.0,0,4.2822
trilipix,EFO_0003770,diabetic retinopathy,4.180956798289074,0.0,0.0,0,4.181
trilipix,EFO_0004211,Hypertriglyceridemia,4.122533474358606,0.0,0.0,0,4.1225
trilipix,EFO_0001073,obesity,4.113635364154506,0.0,0.0,0,4.1136
trilipix,EFO_0003914,atherosclerosis,4.100104553534541,0.0,0.0,0,4.1001
trilipix,EFO_0004705,hypothyroidism,4.0350371122340265,0.0,0.0,0,4.035
trilipix,EFO_0000589,metabolic disease,4.0142682782789105,0.0,0.0,0,4.0143
trilipix,EFO_1000727,lipodystrophy,3.852092884139857,0.0,0.0,0,3.8521
trilipix,HP_0002027,Abdominal pain,3.71382920101241,0.0,0.0,0,3.7138
trilipix,EFO_0000195,metabolic syndrome,3.63821133271639,0.0,0.0,0,3.6382
trilipix,EFO_0001074,morbid obesity,3.5475227811069536,0.0,0.0,0,3.5475
trilipix,MONDO_0004975,Alzheimer disease,3.472067524174794,0.0,0.0,0,3.4721
trilipix,EFO_1001249,non-alcoholic steatohepatitis,3.420159042923246,0.0,0.0,0,3.4202
trilipix,HP_0001397,Hepatic steatosis,3.254286511047467,0.0,0.0,0,3.2543
trilipix,MONDO_0018473,hyperlipoproteinemia type 3,3.24376271713937,0.0,0.0,0,3.2438
trilipix,EFO_0009321,diabetic macular edema,3.197156002742531,0.0,0.0,0,3.1972
trilipix,EFO_1001375,Myocardial Ischemia,3.168624607999939,0.0,0.0,0,3.1686
trilipix,EFO_0000341,chronic obstructive pulmonary disease,3.073657286118092,0.0,0.0,0,3.0737
trilipix,EFO_0004268,sclerosing cholangitis,3.0444839405389423,0.0,0.0,0,3.0445
trilipix,EFO_0003095,non-alcoholic fatty liver disease,3.0067386780125336,0.0,0.0,0,3.0067
trilipix,EFO_0000384,Crohn's disease,2.993107770956096,0.0,0.0,0,2.9931
trilipix,MONDO_0005301,multiple sclerosis,2.9516808661785343,0.0,0.0,0,2.9517
trilipix,MONDO_0002009,major depressive disorder,2.9479932319360547,0.0,0.0,0,2.948
trilipix,MONDO_0015515,carnitine palmitoyltransferase II deficiency,2.9452508932403907,0.0,0.0,0,2.9453
trilipix,EFO_0000616,neoplasm,2.941449194334525,0.0,0.0,0,2.9414
trilipix,EFO_0005422,skin aging,2.902942752307782,0.0,0.0,0,2.9029
trilipix,MONDO_0005180,Parkinson disease,2.8496558571521673,0.0,0.0,0,2.8497
trilipix,MONDO_0004992,cancer,2.8006087437085863,0.0,0.0,0,2.8006
trilipix,MONDO_0004979,asthma,2.727969072159747,0.0,0.0,0,2.728
trilipix,EFO_0003777,heart disease,2.7113919414723693,0.0,0.0,0,2.7114
trilipix,EFO_0000275,atrial fibrillation,2.709518033505665,0.0,0.0,0,2.7095
trilipix,EFO_0003144,heart failure,2.6962248920364735,0.0,0.0,0,2.6962
trilipix,EFO_0005628,proctitis,2.6710169099448007,0.0,0.0,0,2.671
trilipix,EFO_0000182,hepatocellular carcinoma,2.6667970962337613,0.0,0.0,0,2.6668
trilipix,MONDO_0100096,COVID-19,2.6533927466597227,0.0,0.0,0,2.6534
trilipix,EFO_1001950,colon carcinoma,2.6458590447168007,0.0,0.0,0,2.6459
trilipix,EFO_0000373,congestive heart failure,2.6266739934880183,0.0,0.0,0,2.6267
urokinase,MONDO_0011136,Quebec platelet disorder,2.149329359108869,0.0,0.0,0,2.1493
urokinase,EFO_0004214,Abdominal Aortic Aneurysm,1.67368455313435,0.0,0.0,0,1.6737
urokinase,EFO_0000616,neoplasm,1.527242766961457,0.0,0.0,0,1.5272
urokinase,MONDO_0042490,"neutropenia, severe congenital, 1, autosomal dominant",1.5041761154058717,0.0,0.0,0,1.5042
urokinase,EFO_0005772,neurodegenerative disease,1.483249961890763,0.0,0.0,0,1.4832
urokinase,MONDO_0007254,breast cancer,1.483028500895293,0.0,0.0,0,1.483
urokinase,EFO_0003060,non-small cell lung carcinoma,1.448557980340013,0.0,0.0,0,1.4486
urokinase,MONDO_0008315,prostate cancer,1.443301977845966,0.0,0.0,0,1.4433
urokinase,EFO_0003767,inflammatory bowel disease,1.4322444457285242,0.0,0.0,0,1.4322
urokinase,MONDO_0004992,cancer,1.4124906114363114,0.0,0.0,0,1.4125
urokinase,EFO_0003914,atherosclerosis,1.3727157470070488,0.0,0.0,0,1.3727
urokinase,MONDO_0004976,amyotrophic lateral sclerosis,1.3489800099620737,0.0,0.0,0,1.349
urokinase,MONDO_0008090,cyclic hematopoiesis,1.320513540780356,0.0,0.0,0,1.3205
urokinase,Orphanet_2686,Cyclic neutropenia,1.3185250143717266,0.0,0.0,0,1.3185
urokinase,MONDO_0012703,lissencephaly due to TUBA1A mutation,1.31364144494075,0.0,0.0,0,1.3136
urokinase,Orphanet_300573,Polymicrogyria due to TUBB2B mutation,1.312919255867715,0.0,0.0,0,1.3129
urokinase,EFO_0003869,breast neoplasm,1.298066778620186,0.0,0.0,0,1.2981
urokinase,MONDO_0012399,complex cortical dysplasia with other brain malformations 7,1.297733536121243,0.0,0.0,0,1.2977
urokinase,EFO_0000305,breast carcinoma,1.2918005717506136,0.0,0.0,0,1.2918
urokinase,MONDO_0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement",1.2786414434034508,0.0,0.0,0,1.2786
urokinase,Orphanet_183506,Genetic central nervous system malformation,1.2763070556018696,0.0,0.0,0,1.2763
urokinase,MONDO_0008170,ovarian cancer,1.2698699513177494,0.0,0.0,0,1.2699
urokinase,EFO_1001985,congenital fibrosis of the extraocular muscles,1.2462325847941036,0.0,0.0,0,1.2462
urokinase,MONDO_0015372,autosomal dominant macrothrombocytopenia,1.244239704511393,0.0,0.0,0,1.2442
urokinase,MONDO_0002974,cervical cancer,1.2430877842693828,0.0,0.0,0,1.2431
urokinase,MONDO_0100153,tubulinopathy,1.241911280655119,0.0,0.0,0,1.2419
urokinase,MONDO_0012905,hypomyelinating leukodystrophy 6,1.2303472963501092,0.0,0.0,0,1.2303
urokinase,EFO_0001378,multiple myeloma,1.2240963885161458,0.0,0.0,0,1.2241
urokinase,MONDO_0019200,retinitis pigmentosa,1.2179778600235611,0.0,0.0,0,1.218
urokinase,Orphanet_404469,Female infertility due to fertilization defect,1.2136046598229504,0.0,0.0,0,1.2136
urokinase,Orphanet_300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,1.213336275379104,0.0,0.0,0,1.2133
urokinase,Orphanet_139441,Hypomyelination with atrophy of basal ganglia and cerebellum,1.2090169792908507,0.0,0.0,0,1.209
urokinase,MONDO_0014337,complex cortical dysplasia with other brain malformations 5,1.200098212718321,0.0,0.0,0,1.2001
urokinase,MONDO_0020738,multiple benign circumferential skin creases on limbs 1,1.200066497163491,0.0,0.0,0,1.2001
urokinase,MONDO_0013541,complex cortical dysplasia with other brain malformations 1,1.1875585571904996,0.0,0.0,0,1.1876
urokinase,Orphanet_98805,"Primary dystonia, DYT4 type",1.1805625585435782,0.0,0.0,0,1.1806
urokinase,HP_0004419,Recurrent thrombophlebitis,1.1772560035375763,0.0,0.0,0,1.1773
urokinase,EFO_0000574,lymphoma,1.1754456605380734,0.0,0.0,0,1.1754
urokinase,EFO_0004274,gout,1.1746332065396383,0.0,0.0,0,1.1746
urokinase,EFO_0000183,Hodgkins lymphoma,1.1498448496645723,0.0,0.0,0,1.1498
urokinase,MONDO_0007493,torsion dystonia 4,1.1464047185131627,0.0,0.0,0,1.1464
urokinase,EFO_0000403,diffuse large B-cell lymphoma,1.1458623674941588,0.0,0.0,0,1.1459
urokinase,MONDO_0018088,familial Mediterranean fever,1.1290054240048233,0.0,0.0,0,1.129
urokinase,EFO_0000313,carcinoma,1.121466106309048,0.0,0.0,0,1.1215
urokinase,EFO_0006859,head and neck malignant neoplasia,1.1192531992977357,0.0,0.0,0,1.1193
urokinase,MONDO_0018998,Leber congenital amaurosis,1.105326947068426,0.0,0.0,0,1.1053
urokinase,MONDO_0001475,neutropenia,1.0993475519975822,0.0,0.0,0,1.0993
urokinase,EFO_0000712,stroke,1.095789395668725,0.0,0.0,0,1.0958
urokinase,EFO_0000544,infection,1.0942665412938062,0.0,0.0,0,1.0943
urokinase,EFO_0001422,cirrhosis of liver,1.0940240067497369,0.0,0.0,0,1.094
veliflapon (dg-031),MONDO_0004985,bipolar disorder,1.9093555233579316,0.0,0.0,0,1.9094
veliflapon (dg-031),HP_0002140,Ischemic stroke,1.8275135044215132,0.0,0.0,0,1.8275
veliflapon (dg-031),EFO_0000729,ulcerative colitis,1.5353039648148106,0.0,0.0,0,1.5353
veliflapon (dg-031),EFO_0003767,inflammatory bowel disease,1.529250302691651,0.0,0.0,0,1.5293
veliflapon (dg-031),EFO_0005672,acute coronary syndrome,1.247682891332538,0.0,0.0,0,1.2477
veliflapon (dg-031),HP_0000924,Abnormality of the skeletal system,0.6145009866769142,0.0,0.0,0,0.6145
veliflapon (dg-031),EFO_0003898,ankylosing spondylitis,0.5597934951380291,0.0,0.0,0,0.5598
veliflapon (dg-031),MONDO_0004979,asthma,0.5466041894608349,0.0,0.0,0,0.5466
veliflapon (dg-031),MONDO_0009061,cystic fibrosis,0.4414710013265909,0.0,0.0,0,0.4415
veliflapon (dg-031),EFO_0000222,acute myeloid leukemia,0.3804008461430793,0.0,0.0,0,0.3804
veliflapon (dg-031),EFO_0005543,glioma,0.3652201299774622,0.0,0.0,0,0.3652
veliflapon (dg-031),EFO_0009003,ovarian dysfunction,0.3541579134567177,0.0,0.0,0,0.3542
veliflapon (dg-031),EFO_0009482,drug allergy,0.3541579134567177,0.0,0.0,0,0.3542
veliflapon (dg-031),HP_0000505,Visual impairment,0.3096103079464928,0.0,0.0,0,0.3096
veliflapon (dg-031),MONDO_0008170,ovarian cancer,0.3040636426870243,0.0,0.0,0,0.3041
veliflapon (dg-031),MONDO_0005178,osteoarthritis,0.2979599339801302,0.0,0.0,0,0.298
veliflapon (dg-031),EFO_0000637,osteosarcoma,0.2799338048974595,0.0,0.0,0,0.2799
veliflapon (dg-031),MONDO_0007319,chondrocalcinosis 2,0.2748833905460063,0.0,0.0,0,0.2749
veliflapon (dg-031),EFO_0000182,hepatocellular carcinoma,0.2398482518807279,0.0,0.0,0,0.2398
veliflapon (dg-031),EFO_1000860,cerebral atherosclerosis,0.2285065480483188,0.0,0.0,0,0.2285
veliflapon (dg-031),EFO_1001348,HIV-Associated Lipodystrophy Syndrome,0.2207355006632954,0.0,0.0,0,0.2207
veliflapon (dg-031),EFO_0000519,glioblastoma multiforme,0.2074277795358278,0.0,0.0,0,0.2074
veliflapon (dg-031),EFO_0000616,neoplasm,0.2013569281310758,0.0,0.0,0,0.2014
veliflapon (dg-031),MONDO_0015699,immunodeficiency due to a classical component pathway complement deficiency,0.1882520643856848,0.0,0.0,0,0.1883
veliflapon (dg-031),MONDO_0004975,Alzheimer disease,0.1847675429510512,0.0,0.0,0,0.1848
veliflapon (dg-031),EFO_0001645,coronary artery disease,0.1821715218864384,0.0,0.0,0,0.1822
veliflapon (dg-031),MONDO_0008903,lung cancer,0.1803536576486172,0.0,0.0,0,0.1804
veliflapon (dg-031),Orphanet_169142,Recurrent infection due to specific granule deficiency,0.1788134143773225,0.0,0.0,0,0.1788
veliflapon (dg-031),EFO_0001071,lung carcinoma,0.1747076233090338,0.0,0.0,0,0.1747
veliflapon (dg-031),EFO_0000571,lung adenocarcinoma,0.1734636489252585,0.0,0.0,0,0.1735
veliflapon (dg-031),MONDO_0004992,cancer,0.17335743623348,0.0,0.0,0,0.1734
veliflapon (dg-031),MONDO_0100319,COVID-19â€“associated multisystem inflammatory syndrome in adults,0.1677589805041043,0.0,0.0,0,0.1678
veliflapon (dg-031),MONDO_0007114,Angel-shaped phalango-epiphyseal dysplasia,0.1635208588913689,0.0,0.0,0,0.1635
veliflapon (dg-031),MONDO_0009296,glycoprotein storage disease,0.1598125024802259,0.0,0.0,0,0.1598
veliflapon (dg-031),EFO_0000341,chronic obstructive pulmonary disease,0.1590767174780146,0.0,0.0,0,0.1591
veliflapon (dg-031),MONDO_0012330,talo-patello-scaphoid osteolysis,0.1557509692680209,0.0,0.0,0,0.1558
veliflapon (dg-031),EFO_0009028,Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome,0.1481223503650974,0.0,0.0,0,0.1481
veliflapon (dg-031),HP_0001297,Stroke,0.1415911341666207,0.0,0.0,0,0.1416
veliflapon (dg-031),EFO_1000391,Nasal Cavity Polyp,0.1283209043855956,0.0,0.0,0,0.1283
veliflapon (dg-031),EFO_0004265,peripheral arterial disease,0.1183142283555263,0.0,0.0,0,0.1183
veliflapon (dg-031),EFO_0000612,myocardial infarction,0.1149935858093071,0.0,0.0,0,0.115
veliflapon (dg-031),MONDO_0005575,colorectal cancer,0.1119864773365117,0.0,0.0,0,0.112
veliflapon (dg-031),EFO_0003914,atherosclerosis,0.1118379233436397,0.0,0.0,0,0.1118
veliflapon (dg-031),MONDO_0002679,cerebral infarction,0.0993633359348576,0.0,0.0,0,0.0994
veliflapon (dg-031),EFO_0003075,xanthoma,0.0988895042971564,0.0,0.0,0,0.0989
veliflapon (dg-031),EFO_0004911,familial hypercholesterolemia,0.094376689616929,0.0,0.0,0,0.0944
veliflapon (dg-031),MONDO_0002108,thyroid cancer,0.0899619796036629,0.0,0.0,0,0.09
veliflapon (dg-031),EFO_0003060,non-small cell lung carcinoma,0.0833499322270873,0.0,0.0,0,0.0833
veliflapon (dg-031),HP_0100806,Sepsis,0.0832610292988191,0.0,0.0,0,0.0833
veliflapon (dg-031),EFO_0003918,obstructive sleep apnea,0.0820155015797841,0.0,0.0,0,0.082
vonapanitase,MONDO_0008504,supravalvular aortic stenosis,3.725054510332811,0.0,0.0,0,3.7251
vonapanitase,MONDO_0007411,"cutis laxa, autosomal dominant 1",3.510372775804687,0.0,0.0,0,3.5104
vonapanitase,MONDO_0019571,autosomal dominant cutis laxa,3.057560344296528,0.0,0.0,0,3.0576
vonapanitase,HP_0000023,Inguinal hernia,2.775243000607517,0.0,0.0,0,2.7752
vonapanitase,EFO_0009959,diverticular disease,2.651827977308746,0.0,0.0,0,2.6518
vonapanitase,HP_0004299,Hernia of the abdominal wall,2.599454783479925,0.0,0.0,0,2.5995
vonapanitase,EFO_0005422,skin aging,2.439673047715772,0.0,0.0,0,2.4397
vonapanitase,HP_0100790,Hernia,2.4364744610037583,0.0,0.0,0,2.4365
vonapanitase,EFO_0005772,neurodegenerative disease,2.3260187753664905,0.0,0.0,0,2.326
vonapanitase,MONDO_0008678,Williams syndrome,2.247321778506728,0.0,0.0,0,2.2473
vonapanitase,HP_0004381,Supravalvular aortic stenosis,2.2428785729336993,0.0,0.0,0,2.2429
vonapanitase,EFO_0009552,hemorrhoid,2.2282075292339405,0.0,0.0,0,2.2282
vonapanitase,EFO_0000508,genetic disorder,2.20339874251507,0.0,0.0,0,2.2034
vonapanitase,EFO_0009547,eyelid disease,2.1699429458025947,0.0,0.0,0,2.1699
vonapanitase,HP_0010750,Dermatochalasis,2.0770235316405823,0.0,0.0,0,2.077
vonapanitase,MONDO_0016175,cutis laxa,1.7954968342963848,0.0,0.0,0,1.7955
vonapanitase,EFO_0008561,diaphragmatic hernia,1.7169388219312045,0.0,0.0,0,1.7169
vonapanitase,EFO_0003884,chronic kidney disease,1.654478660596587,0.0,0.0,0,1.6545
vonapanitase,EFO_0009431,intestinal disease,1.6419356376858496,0.0,0.0,0,1.6419
vonapanitase,HP_0004936,Venous thrombosis,1.6402964847769153,0.0,0.0,0,1.6403
vonapanitase,HP_0000316,Hypertelorism,1.6246132848818555,0.0,0.0,0,1.6246
vonapanitase,HP_0011297,Abnormal digit morphology,1.6246132848818555,0.0,0.0,0,1.6246
vonapanitase,HP_0012721,Venous malformation,1.6246132848818555,0.0,0.0,0,1.6246
vonapanitase,HP_0100775,Dural ectasia,1.6246132848818555,0.0,0.0,0,1.6246
vonapanitase,EFO_0000341,chronic obstructive pulmonary disease,1.6175843601063264,0.0,0.0,0,1.6176
vonapanitase,EFO_0007233,diaphragm disease,1.4319384512928932,0.0,0.0,0,1.4319
vonapanitase,EFO_0009559,nerve plexus disease,1.424096014779507,0.0,0.0,0,1.4241
vonapanitase,EFO_0001666,aortic aneurysm,1.3612701563314389,0.0,0.0,0,1.3613
vonapanitase,HP_0011024,Abnormality of the gastrointestinal tract,1.334258756792658,0.0,0.0,0,1.3343
vonapanitase,MONDO_0008090,cyclic hematopoiesis,1.320513540780356,0.0,0.0,0,1.3205
vonapanitase,MONDO_0042490,"neutropenia, severe congenital, 1, autosomal dominant",1.3200815622781068,0.0,0.0,0,1.3201
vonapanitase,Orphanet_2686,Cyclic neutropenia,1.3185250143717266,0.0,0.0,0,1.3185
vonapanitase,EFO_0004282,thoracic aortic aneurysm,1.2533573554663566,0.0,0.0,0,1.2534
vonapanitase,EFO_0004329,alcohol drinking,1.0553098294977443,0.0,0.0,0,1.0553
vonapanitase,EFO_0006544,bladder transitional cell carcinoma,0.947418351873596,0.0,0.0,0,0.9474
vonapanitase,EFO_0000182,hepatocellular carcinoma,0.940819219197736,0.0,0.0,0,0.9408
vonapanitase,EFO_0000756,melanoma,0.9359987788640404,0.0,0.0,0,0.936
vonapanitase,EFO_0000222,acute myeloid leukemia,0.9174950745381708,0.0,0.0,0,0.9175
vonapanitase,EFO_0005543,glioma,0.9102749558706448,0.0,0.0,0,0.9103
vonapanitase,EFO_0000702,small cell lung carcinoma,0.9056751623794388,0.0,0.0,0,0.9057
vonapanitase,EFO_0000571,lung adenocarcinoma,0.9048104737574602,0.0,0.0,0,0.9048
vonapanitase,EFO_0000305,breast carcinoma,0.8983821906468918,0.0,0.0,0,0.8984
vonapanitase,EFO_0000095,chronic lymphocytic leukemia,0.8970690746956331,0.0,0.0,0,0.8971
vonapanitase,EFO_0000094,B-cell acute lymphoblastic leukemia,0.8939787776863473,0.0,0.0,0,0.894
vonapanitase,EFO_0000199,oral squamous cell carcinoma,0.8932371064041186,0.0,0.0,0,0.8932
vonapanitase,EFO_0001378,multiple myeloma,0.8917714226797144,0.0,0.0,0,0.8918
vonapanitase,EFO_0005922,esophageal squamous cell carcinoma,0.889760277007004,0.0,0.0,0,0.8898
vonapanitase,EFO_0001071,lung carcinoma,0.889637646173302,0.0,0.0,0,0.8896
vonapanitase,MONDO_0004986,urinary bladder carcinoma,0.889564067673081,0.0,0.0,0,0.8896
vonapanitase,EFO_0000365,colorectal adenocarcinoma,0.8882396546691015,0.0,0.0,0,0.8882
